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Cryptosporidium parvum is among the most common parasites in the known world and 
represents one of the leading causes of death among the immunocompromised. As an 
apicomplexan, C. parvum has many similarities to other globally important parasites such 
as Plasmodium falciparum and Toxoplasma gondii. Among these similarities are a 
complex life cycle and the ability to invade host cells. However, unlike most other 
apicomplexans, the cryptosporidia appear to have lost their namesake organelle, the 
apicoplast, and drastically reduced the size of their genome. For decades this caused 
issues in classifying the cryptosporidia. This has been potentially resolved, however, by 
recent phylogenetic studies that revealed a strong relationship between the cryptosporidia 
and the gregarines. The gregarines were parasites exclusively of invertebrates, until the 
reclassification to include the cryptosporidia. Though research into apicomplexan 
evolution and biology is still a nascent field, even less is known about the invertebrate 
portion. This is largely due to the lack of molecular tools and culturing techniques that 
are required to explore any organism beyond basic phylogenetics, in addition to their 
medical irrelevance prior to the inclusion of Cryptosporidium. 
Therefore, C. parvum represents a potential model organism for the gregarines and the 
evolutionary adaptations of apicomplexans from invertebrate to vertebrate hosts. It was 
the purpose of this thesis, therefore, to establish the tools and methodologies that would 
be required to begin developing C. parvum as such. To achieve this, first I successfully 
GHYHORSHGWKHZRUOG¶VILUVWORQJ-term culturing system of C. parvum, capable of maintain 
a live parasite culture for 60 days. Additionally, I developed novel methods of detecting 
and characterising the infection, including NMR based characterisation of infection 
metabolomes which also revealed a potentially more involved role for Taurine in the 
pathology of the infection. Furthermore, to demonstrate the power and applicability of 
this new system I produced the first experimental evidence for a functional ISC system 
within C. parvum. This also adds to a now growing list of non-canonical mitochondria 
containing organisms that still maintain an active mitochondrial Fe/S cluster biosynthetic 
pathway. 
In conclusion, this thesis represents a large step forward for both the C. parvum and 
gregarine fields and establishes many of the necessary techniques required for a new push 
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Chapter 1 An Introduction to Cryptosporidium parvum and the 
Cryptosporidia 
 
1.1 The Cryptosporidia 
 
The first species of Cryptosporidium to be described was the mouse parasite C. muris, in 
1907 by E. Tyzzer, who formed the name fURPWKH*UHHNIRU³KLGGHQVHHG´7KH³KLGGHQ
VHHG´UHIHUUHG to the appearance of the oocyst and the almost imperceptible sporozoites 
that were characteristically visible in other spore forming protozoa (Tyzzer, 1910). 
Tyzzer also noted that, unlike the majority of sporalating protozoa, members of 
cryptosporidia appeared to sporolate whilst still associated with the host cell, as opposed 
to once passed into the environment like the majority of sporalates (Tyzzer, 1910, 
Morrison, 2009). 
As Apicomplexans, Cryptosporidia are closely related to many other parasites of medical 
and veterinary importance such as Toxoplasma, Babesia and, perhaps most infamously, 
the malarial parasites Plasmodium (Kuo et al., 2008, Morrison, 2009, Abrahamsen et al., 
2004). Plasmodium and Toxoplasma are especially important parasites, as the causative 
agents of Malaria and Toxoplasmosis, respectively. Both of these diseases are notable for, 
among other things, a significant lack of preventative or curative treatment options, a 
common theme amongst the Apicomplexa (Flegr et al., 2014, Torgerson and Macpherson, 
2011, Liu et al., 2012). 
Among its similarities to the other Apicomplexans are the multitudes of life cycle stages 
that Cryptosporidium experiences. In order to complete a full cycle, from the excystation 
of sporozoites from an oocyst, back to the sporulation of an oocyst and its eventual release 
from the host, members of the Cryptosporidia undergo both asexual and sexual life cycle 
stages (Borowski et al., 2010, Hijjawi et al., 2010, Leitch and He, 2012). Paradoxically, 
several aspects of the life cycle mark it as significantly different from the rest of its 
apicomplexan relatives, for example members of Cryptosporidium sporulate prior to 
release from the host, whereas close relative Toxoplasma gondii only undergoes 
sporulation after release into the environment (Tyzzer, 1910, Dubey, 1998, Wilhelm and 
Yarovinsky, 2014). Similarly, unlike members of Eimeria, Toxoplasma or Plasmodium, 
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members of Cryptosporidium are uniquely capable of autoinfection; the ability to 
complete an entire life cycle, sexual stages included, within one host and infect again 
without passing into the environment (Kuo et al., 2008, Muller and Hemphill, 2013). 
Also, unlike all coccidia, many Cryptosporidium species are capable of infecting and 
completing entire life cycles within a broad range of hosts, as opposed to being host 
species specific. This is a trend seen throughout the biology of the parasite, including the 
absence of an otherwise essential organelle, the apicoplast, found unilaterally throughout 
all members of the Apicomplexa, with the exception of the gregarines, confounding the 
difficulty found in placing the parasite phylogenetically (Carreno et al., 1999, Borowski 
et al., 2010, Fichera and Roos, 1997, Lim and McFadden, 2010, Lemgruber and Lupetti, 
2012, Abrahamsen et al., 2004, Omoto et al., 2004). This observation has led many to 
begin proposing that the Cryptosporidium spp. may, therefore, be better suited within the 
gregarines as opposed to their own separate class. Recent attempts using 18S rDNA 
sequencing techniques have shown compelling evidence for the official classification of 





Figure 1-1: Phylogeny of the Apicomplexa. A recent phylogenetic placement of Cryptosporidium spp. 
(highlighted in red) removed them from the coccidia and placed them with the gregarines (also in 
UHG7KLVQHZSODFHPHQWZDVLQIRUPHGYLD³6U'1$DOLJQPHQWVDQGD3K\OR%D\HV&$7-GTR-
GAMMA tree and 1577 well-DOLJQHGQXFOHRWLGHSRVLWLRQV´DVGHPRQVWUDWHGLQ&DYDOLHU-Smith (2014, 
Figure 4). Although not a universally accepted model, it nonetheless highlights the interesting nature 
of &U\SWRVSRULGLXP¶V genetic heraldry. 
Recent publications have also presented a strong case for the re-location via observations 
in cell biology, including the discovery of extra-cellular gamete stages and the purported 
ability to culture several species of Cryptosporidium in-vitro without host cells 
(Arrowood, 2002, Hijjawi et al., 2010, Karanis and Aldeyarbi, 2011, Carreno et al., 1999, 
Ryan et al., 2016). 
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This lack of organelles, which will be described in greater details in subsequent chapters, 
indicates that what remains within Cryptosporidium represents the core, essential 
components of any apicomplexan, Gregarina, Coccidia or Haematozoa. It is theoretically 
possible, therefore, that Cryptosporidium could be established as a model around which 
aspects of a conceptual Last Apicomplexan Common Ancestor (LACA) may be built and 
thus a model for the evolution of Apicomplexa. In addition to its reduced organellar 
complement, the members of Cryptosporidium, especially the human pathogen 
Cryptosporidium parvum. possesses a radically reduced genome compared to its closest 
genetic relatives. Compared to the 22.9 Mb genome of P. falciparum, C. parvum holds 
only 9 Mb (Widmer and Sullivan, 2012, Gardner et al., 2002). This sharp reduction in 
genome size and phylogenetic placing suggest that C. parvum lost approximately half its 




Cryptosporidiosis is a disease of global significance, constituting a significant burden on 
developing economies in addition to being the cause of a considerable number of infantile 
deaths (<5 years old) and is among the leading causes of fatalities in HIV patients (Shirley 
et al., 2012, Striepen, 2013, Checkley et al., 2014, Torgerson and Macpherson, 2011, 
Wanyiri et al., 2014). As our knowledge of this disease has progressed, it has become 
apparent that it needs an urgent response. Advances in epidemiological research, 
including wider and more reliable networks of communication, have identified 
cryptosporidiosis among the top four causes of pathogen-induced diarrhoea (Briggs et al., 
2014, Checkley et al., 2014, Deshpande et al., 2014, Wanyiri et al., 2014). 
Whilst the disease is termed from the collective group of Cryptosporidium, their medical 
relevance varies from species to species. Amongst them, many species of 
Cryptosporidium have shown an ability to infect and cause symptoms in humans, 
including those commonly found in house hold pets such as C. muris, C. felis, and C. 
canis (Table 1-1). Cattle also appear to be a source of human infectious Cryptosporidium, 
both C. andersoni and C. bovis are common parasites of cattle that can also infect humans 
(Table 1-1). However, the causes of human cryptosporidiosis are overwhelmingly 
populated by C. parvum and to a lesser extent C. hominis. This is in large part due to the 
1-5 
 
highly zoonotic nature of C. parvum, showing a much broader range of suitable hosts than 
many of the other Cryptosporidia, enhancing its coverage.  
Table 1-1: Host specificity of Cryptosporidium. Although members of the Cryptosporidia display 
relatively specific host specificity, several them can infect humans in addition to their typical hosts. 
In this table, the column entitled; Major hosts, lists the animal in which the species of Cryptosporidium 
is most commonly found. The authors listed are typically the preliminary publishers of human 
infection. *Additionally, though originally described as a parasite of many ruminants, C. parvum is 
increasingly detected within Humans and in some studies had comparable or even higher incidences 
in human populations than C. hominis, which is considered to have the highest preference for humans 
of the Cryptosporidia (Xiao, 2010) 
 
It is also of interest to note that different species will typically infect different regions of 
the gastro-intestinal tract, a trait that appears to be relatively conserved within 
phylogenetic groupings (Fayer and Ungar, 1986, Widmer et al., 2007). For example, C. 
parvum and the closely related C. hominis are frequently found to infect regions of the 
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intestinal tract, typically the ileum, whereas C. muris is most commonly found within the 
stomach of the host (Widmer et al., 2007, Gertler et al., 2015, Slapeta, 2017).  
As a waterborne and zoonotic disease, the parasite is particularly prevalent in developing 
countries, particularly rural areas and especially those which lack sufficient water 
treatment networks (Caccio, 2005, Striepen, 2013, Checkley et al., 2014, Wanyiri et al., 
2014, Ungar et al., 1989). It is therefore unsurprising that human cryptosporidiosis 
outbreaks most often occur in the equatorial climates, in regions such as Sub-Saharan 
Africa and Central America. In one study, it was estimated that 6 % of travellers returning 
from Mexico had contracted cryptosporidiosis during their visit (Nair et al., 2008). 
However, outbreaks still occur in modern countries, with typical water treatment 
infrastructure still largely incapable of filtering out the parasites, resulting in almost 
yearly outbreaks (Dreelin et al., Cantey et al., 2012, Widmer and Sullivan, 2012, 
Deshpande et al., 2014, Gertler et al., 2015, McKerr et al., 2015, Thivierge et al., 2016, 
Utsi et al., 2016). Several mass outbreaks have been recorded in the US in recent decades 
(Yoder et al., 2008, Yoder et al., 2010, Brunkard et al., 2011, Hlavsa et al., 2011, Hlavsa 
et al., 2014, Cope et al., 2015, Hlavsa et al., 2015, Mac Kenzie et al., 1994). The most 
notable, being that of Milwaukee, Wisconsin in 1993 which saw over 400,000 homes 
affected and a record 104 deaths from a single outbreak (Mac Kenzie et al., 1994). 
A significant factor which contributes to the seeming world-wide distribution of 
cryptosporidiosis is the extremely resistant environmental stage of the parasite, the 
oocyst. Responsible for protecting the infectious forms of the parasite until ingestion by 
a potential host, the oocyst has been shown to resist most forms of water purification; 
such as heating, bleaching and biological filtering (Kar et al., 2011, Chauret et al., 1998, 
Widmer et al., 2007, Hayes et al., 2013). Whilst heat inactivation of the parasite is 
possible, it requires a sustained temperature of 60°C for greater than 15 minutes, a largely 
inefficient and unachievable methodology for large scale water purification plants. UV 
irradiation is an effective, yet uncommon technique employed by water companies, 
killing a significant number of oocysts in a relatively short period of time (Hayes et al., 
2013). Unfortunately, this is difficult to implement in the construction of water services 
and even more so retroactively. This leaves much of the world, regardless of economic 
prosperity, woefully ill-prepared to prevent or control an outbreak of cryptosporidiosis.  
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Cryptosporidiosis symptoms can vary from asymptomatic to severe, with abdominal pain 
and diarrhoea being most common. For those with compromised immune systems, 
particularly HIV sufferers, death from dehydration is the most imminent threat; 
particularly in those areas identified above that lack sufficient water infrastructure 
(DuPont et al., 1995, Meisel et al., 1976, Egger et al., 1990, Flanigan and Graham, 1990, 
Gatei et al., 2006). In immunocompromised individuals the parasite can also be found in 
other epithelial tissues, including most of the upper stages of the digestive tract and the 
respiratory tract (Wanyiri et al., 2014, Sponseller et al., 2014). However, emerging 
evidence has shown that immunocompetent individuals may also be at risk of respiratory 
infections (Sponseller et al., 2014).  
Unfortunately, current methods of treatment are limited to basic symptomatic relief and 
a handful of promising yet ultimately insufficiently effective drugs (Checkley et al., 2014, 
Domjahn et al., 2014, Sparks et al., 2015, Manjunatha et al., 2016). With no universally 
accepted treatment regimen, patients can expect treatment with any combination of 
therapies including anti-parasitics such as paromomycin or azithromycin and diarrheal 
treatments such as loperamide.  
For otherwise immunocompetent individuals, the only established treatment, although not 
approved within the EU for treating cryptosporidiosis, is the broad-spectrum anti-
parasitic nitazoxanide (Sparks et al., 2015, Manjunatha et al., 2016). Nitazoxanide is a 
thiazolide, which acts by interfering with the respiratory system of the parasite, 
effectively preventing it from proliferating within the host until effective clearance by the 
immune system (Rossignol, 1994, Rossignol, 1999).  Trials and subsequent widespread 
use of the drug throughout the US have shown moderate efficacy in reducing symptoms 
and disease patent period. However, nitazoxanide appears to be largely ineffective in 
treating the disease in the most at risk groups; the young, the old and medically 
immunocompromised due to a reliance on a healthy immune system for effective drug 
action (Rossignol et al., 1998, Hussien et al., 2013, Sparks et al., 2015, Manjunatha et al., 
2016). Additionally, nitazoxanide has been associated with an array of unpleasant side 
effects including diarrhoea, headache, nausea and stomach pain (Stockis et al., 2002) . 
Alternative treatments rely on other broad-spectrum drugs with varying degrees of 
efficacy. Paromomycin, an anti-parasitic, has been shown to significantly reduce 
diarrheal episodes in patients, although complete eradication of the parasite is seen in less 
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than half of cases (Hussien et al., 2013). Azithromycin, an antibiotic typically used in 
treating bacterial infections, has shown promising potential to reduce parasite load, 
clearing the patient of the symptoms of cryptosporidiosis, however studies have shown 
WKDW WKH GUXJ IDLOHG WR HUDGLFDWH WKH LQIHFWLRQ HQWLUHO\ ZLWK WKH SDUDVLWH¶V DELOLW\ WR
autoinfect rendering the treatment ultimately symptomatic only (Fichera and Roos, 1997, 
Wang and Zhang, 2013).  In each case a functioning immune system is required for the 
effective patient responses, for immunocompromised individuals, available treatments 
are restricted to bed rest, hydration and symptomatic treatments (Checkley et al., 2014, 
Mead, 2014, Sparks et al., 2015, Goodgame et al., 1995, Wanyiri et al., 2014). Although 
anti-cryptosporidial drug development investment is similar to neglected tropical diseases 
and is therefore largely lacking in novel compounds, a few potential therapeutics have 
been discovered recently. Combination treatment with garlicin and acetylspiramycin had 
an average success rate of 76.2% in clearing the parasite in a study in China, in addition 
to the identification of the compounds: broxyquinoline, cloxyquin, cloxacillin sodium and 
sodium dehdrocholate, which showed effective reduction of Cryptosporidium activity in-
vitro (Huang et al., 2015, Fritzler and Zhu, 2012) 
 
1.3 Life cycle of the cryptosporidia 
 
A defining feature of almost all apicomplexans, especially the species of 
Cryptosporidium, is a complex life cycle. Though the exact nature of the life-cycles can 
vary between groups, most apicomplexans incorporate elements of sexual and asexual 
reproduction (Morrison, 2009). Species of Cryptosporidium are no different, displaying 
characteristic apicomplexan stages such as merogony (asexual) and gametogony (sexual) 
(Figure 1-2) (Current et al., 1986, Borowski et al., 2010, Hijjawi et al., 2010, Leitch and 
He, 2012, Ryan et al., 2016). In most cases, the host within which the parasite completes 
its sexual stages is determined as the definitive (as opposed to reservoir or secondary) 
host. For Plasmodium species the definitive hosts are the female members of the 
Anopheles group of mosquito (Florens et al., 2002). For Toxoplasma gondii the definitive 
hosts are members of the Felidae, or domestic cats (Dubey, 1998). Unlike Plasmodium 
or Toxoplasma, which are parasites with indirect life cycles (more than one host is 
required for a complete life cycle); members of the cryptosporidia are direct life cycle 
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parasites; requiring only one host to begin and finish both sexual and asexual life cycles 
stages. Because they only require one host to complete the life cycle, the parasite is 
capable of propagating in almost any environment, regardless of zoological diversity. 
Additionally, unlike many apicomplexans, the cryptosporidia are capable of 
autoinfection, i.e. infecting the same host from a new infectious cycle without entering 
the environment first (Dubey, 1998, Florens et al., 2002, Leitch and He, 2012, Morrison, 
2009). 
 
Figure 1-2: The general life cycle of Cryptosporidium species. Upon consumption of the oocyst by the 
host, typically through drinking water, the parasite passes into the gut and undergoes the process of 
excystation. At this point 4 sporozoites, each haploid, emerge from the approximately 5-ȝP
diameter oocyst and proceed via a gliding motility to interact with and invade host epithelial cells, 
developing into trophozoites and soon merozoites. This represents the asexual stages of replication 
within the life cycle. (Adapted from Bouzid et al., 2013) 
The progression of the life cycle stages for Cryptosporidium is one of the few extensively 
covered areas of research into this group of parasites (Current et al., 1986, Arrowood, 
2002, Girouard et al., 2006, Borowski et al., 2010, Hijjawi et al., 2010, Hijjawi, 2010, 
Karanis and Aldeyarbi, 2011, King et al., 2011, Leitch and He, 2012, Muller and 
Hemphill, 2013, Ryan et al., 2016). Typically, the infection begins with the consumption 
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of an oocyst by the potential host, usually by drinking contaminated water, although 
infection through contaminated food stuffs is possible (Torgerson et al., 2014, McKerr et 
al., 2015). Upon entering the host digestive tract, a yet unknown series of chemical and/or 
physiological triggers cause the four sporozoites contained within the oocyst to make their 
ZD\RXWGXULQJDSURFHVVWHUPHG³H[F\VWDWLRQ´2QFHIUHHLQWKHKRVWJXWW\SLFDOO\WKH
ileum, these sporozoites will proceed to move along the epithelial surface in what has 
been described as ³JOLGLQJ´PRWLOLWy. Eventually settling on the surface of a potential host 
cell and invading. At this point, unlike many intracellular apicomplexans (excluding the 
gregarines), the parasite develops its parasitophorous vacuole (PV) separate from the host 
cytoplasm, usually along the brush boarder of the epithelial cilia. This aspect of the life 
cycle of Cryptosporidium is like the gregarines, which also appear to form a 
parasitophorous vacuole at the point of contact with the host cell. However, gregarines 
are typically too large to be fully engulfed by host membranous intrusions.  It is the exact 
nature of the location of the PV that has become a topic of much contention within the 
research community, with much debate over the definition of the terms intra- and epi- 
cellular (Fritzler and Zhu, 2012, Guo et al., 2016, Leitch and He, 2012, Wilhelm and 
Yarovinsky, 2014, Ryan et al., 2016). 
Once fully enclosed by the PV the sporozoite then undergoes a transformation from its 
rod like form to a genetically dispersed roughly spherical stage termed the trophozoite. 
Like both Plasmodium and Toxoplasma trophozoites in form, it has not yet been 
determined whether the Cryptosporidium trophozoite is the main feeding stage as it is for 
the other apicomplexans or an adaptation step where the parasite prepares for the 
following infectious stages. 
From the disseminated genetic mass begins to form individual rod like bodies, 
approximately two micrometres in length. Eventually a division becomes apparent, 
between a central genetic mass and surrounding individual bodies, from six to eight in 
total, signalling the formation of a type I meront from the trophozoite. These smaller 
bodies eventually mature into individual merozoites and emerge from the PV back into 
the host ileum. 
The merozoites, morphologically similar to smaller sporozoites, migrate across the gut 
epithelia before invading new cells in a similar manner to the sporozoites, establishing 
another PV within the membrane of an epithelial cell at the cilia brush border. Once 
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encapsulated by the PV, the merozoites undergo merogony where either a type I meront 
is formed again or the next step, a type II meront, is produced. The pathways and signals 
responsible for the determination of type I or type II are yet unknown. 
Merozoites that emerge from a type II meront are typically fewer in number but larger in 
size when compared to their type I analogues. After emerging from the host cell, like each 
time before, the type II merozoite will find a new host cell, invade and form a PV. This 
marks the end of the asexual section of the life cycle and the beginning of the sexual 
stage. After the establishment of the PV, instead of forming into another meront stage, 
the encapsulated merozoite instead transforms into either of the main sexual forms of 
Cryptosporidium: the macrogamont or the microgamont. Despite the naming scheme, 
microgamonts are only slightly smaller than the macrogamonts on average. Rather, 
microgamonts are named for the less than one micrometre long microgametes, analogous 
to sperm, that they produce. Each microgamete is theoretically capable of fertilising a 
single microgamont, in turn producing a zygote. It is not known how many microgametes 
can be produced by a microgamont. 
At this point the zygote which forms is the only diploid stage of C. parvum. During the 
process of maturing from a zygote to a sporolated oocyst, the organism becomes haploid 
again through the production of four sporozoites after one round of mitosis and another 
of meiosis. 
Unlike most apicomplexans, the matured oocyst that forms from the zygote leaves the 
host cell fully sporulated and infectious. Many cyst forming apicomplexans, such as 
Toxoplasma gondii do not fully sporulate until after release from the host cell and often 
not until being passed back into the environment (Dubey, 1998). C. parvum oocysts come 
in two varieties: the typical form, produced in roughly 80% of cases from a zygote, is the 
³tKLFNZDOOHG´RRF\VW7KLV particularly resilient form of the parasite is often found in 
contaminated water supplies and is incredibly resistant to a plethora of environmental 
hardships, including UV exposure, heat, dehydration, salt and pH levels. Alternatively, in 
theoretically RIFDVHVD³WKLQZDOOHG´RRF\VWFDQIRUP (Current et al., 1986). As the 
name implies, the normally environmentally resistant shell surrounding the four 
VSRUR]RLWHVLVVXEVWDQWLDOO\WKLQQHUDQGOHVVUHVLOLHQWWKDQWKH³WKLFNZDOOHG´ edition³7KLQ
ZDOOHG´RRF\VWVH[F\VWUDSLGO\XSRQemergence from the host cell, repeating the entire 
life cycle asexual to sexual, within the original host. This makes Cryptosporidium the 
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only apicomplexans capable of true autoinfection. These assumptions, however, are 
mainly based on in-vitro studies and due to the nature of thin walled oocysts, observations 
via in-vivo studies are lacking. 
 
1.4 Cell biology of cryptosporidia 
 
1.4.1 Similarities between cryptosporidia and other apicomplexans 
 
The organelle complement of the sporozoite stage of Cryptosporidium species shares 
many similarities to the sporozoites of other apicomplexans, including the presence of the 
apical complex and its complement of micronemes and a single rhoptry (although other 
apicomplexans typically have four). In the Apicomplexa, the apical complex is a region 
found on the apical (hence the name) end of motile life-cycle stages. It is typically 
electron dense and houses a variety of enzymes, depending on the organisms, that interact 
with the potential host cell to initiate and/or facilitate invasion. C. parvum is no different 
and a number of proteins have been expressed, localised and functionally characterised 
from its apical complex, including a potentially protective antigen involved in invasion 
(Elongation factor-ĮDQGDJO\FRSURWHLQWKDWDFWVDVDOLJDQG&6/IDFLOLWDWLQJELQGLQJ
between the sporozoite stage and a host epithelial cell (Langer and Riggs, 1999, 
Matsubayashi et al., 2013). 
Additionally, upon invading a host cell C. parvum demonstrates the generation of a 
parasitophorous vacuole (PV), a common feature among intracellular stages of the 
apicomplexans (Morrison, 2009). The PV forms upon successful invasion of the host cell 
and serves to separate the host cytoplasm from that of the parasite, providing a number 
of advantages such as limiting the effectiveness of the host MHC class I based immune 
response and other defences such as phagolysosomes (Lingelbach and Joiner, 1998). In 
Cryptosporidium this structure is derived primarily from host cytoskeleton and 
membrane, with high concentrations of actin at the site of invasion preceding the creation 
of the PV (Leitch and He, 2012, Elliott and Clark, 2000). Host membrane proteins, 
however, are excluded to a significant degree by all known apicomplexans in the 
formation of their respective PVs (Lingelbach and Joiner, 1998). 
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Species of Cryptosporidium also display a cryptic organelle currently termed the 
³&U\VWDOORLG %RG\´ (CB), found in only a select few other apicomplexans such as 
Plasmodium. The CB of Cryptosporidium is an electron dense, honeycomb like structure 
like that of the other apicomplexans. Though little is known about this diminutive 
organelle, one study demonstrated localisation of the C. parvum pyruvate:NADP+ 
oxidoreductase fusion protein (CpPNO) to the CB, suggesting an active membrane 
potential (Ctrnacta et al., 2006). However, doubt has been raised as to whether they are 
the same organelle and the structure remains largely unexplored and unexplained 
(Lemgruber and Lupetti, 2012) 
 
1.4.2 Differences between the cell biology of cryptosporidia and other apicomplexans 
 
Perhaps most immediately noticeable is the lack of the phylum namesake organelle: the 
apicoplast (Rider and Zhu, 2010). Thought to be a remnant plastid obtained via secondary 
endosymbiosis by an ancestor of LACA. This is proposed due to the presence of 4 
membranes, suggesting multiple endosymbiotic events and genes with close homology to 
plant/algal plastids and ultimately a bacterial origin (Lim and McFadden, 2010, Seeber 
and Soldati-Favre, 2010, Lemgruber and Lupetti, 2012, van Dooren and Striepen, 2013). 
Although the apicoplast no longer performs any photosynthetic role, it is typically 
involved in biosynthetic pathways of important biological compounds such as iron 
sulphur clusters, heme groups and Fatty Acid Synthesis. As such the organelle is typically 
essential for the survival of the parasite (Seeber and Soldati-Favre, 2010, Kumar et al., 
2011, van Dooren and Striepen, 2013, Fichera and Roos, 1997, Lemgruber and Lupetti, 
2012).  
These characteristics make a compelling case for the apicoplast as an essential aspect of 
apicomplexan biology and yet it is completely absent from Cryptosporidium and 
potentially many gregarines. The only evidence of the prior existence of anything 
resembling the organelle is the presence of several plant derived proteins encoded within 
the genome of Cryptosporidium which may have been exported from an Apicoplast 




Another defining feature of the Cryptosporidium is the success to which they survive in 
the environment due to an effective protective shell, termed an oocyst. The components 
of this resilient structure largely comprise of fatty acids and carbohydrates although the 
majority (>90%) is composed of proteins (Reduker et al., 1985, Kar et al., 2011, Widmer 
et al., 2007, Mitschler et al., 1994, Nanduri et al., 1999).  
 
1.5 Cell biology of C. parvum 
 
Whilst basic microscopic observation of C. parvum provides little evidence for the 
singling out of this particular species of Cryptosporidium, it is nevertheless an 
observational truth that C. parvum is distinct from many other members of 
Cryptosporidium. Epidemiologically C. parvum is capable of a far greater range of hosts 
than most, biologically C. parvum displays both structural and enzymatic diversions. 
 
1.5.1 The mitosome 
 
The primary differences of C. parvum FDQEHOLQNHGWRWKHRUJDQLVP¶VPLWRFKRQGULDRU
rather lack thereof. Unlike the majority of the Apicomplexa and indeed several 
Cryptosporidia (such as the physically and genetically larger C. muris), C. parvum lacks 
typical or µFDQRQLFDO¶PLWRFKRQGULD ,QVWHDG the motile stages of C. parvum appear to 
maintain a single mitosome, a morphologically and metabolically distinct organelle from 
mitochondria (Mogi and Kita, 2010). The mitosome is a member of a recently described 
group of potential mitochondrial adaptations or descendants; the other member so far has 
been labelled the hydrogenosome and is also both morphologically and metabolically 
distinct from the canonical mitochondrion, collectively the organelles in this group are 
referred to as Mitochondrial Related Organelles or MROs (Dyall and Johnson, 2000, 
Makiuchi and Nozaki, 2014, Regoes et al., 2005). The distribution of MROs across the 
tree of life covers most known organisms, with only members of Plantae and Rhizaria 
lacking examples of either mitosomes or hydrogenosomes. However recent publications 
have used genomic data to predict the absence of a canonical mitochondrion in the 
rhizarian Mikrocytos mackini (Dyall and Johnson, 2000, Mogi and Kita, 2010, Burki et 
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al., 2013, Makiuchi and Nozaki, 2014, Regoes et al., 2005). Additionally, study of the 
Monocercomonoides species has revealed evidence for the first amitochondriate to have 
evolved through secondary loss of the organelle (Karnkowska et al., 2016). This 
discovery lends further credence to the idea that all Eukaryotes descended from an 
organism with an organelle that developed into the modern mitochondrion/MROs, as 
opposed to previous proposals that some eukaryotes may have diverged before the 
endosymbiotic event. 
The current hypothesis regarding the evolution of the mitosome suggests it is a descendant 
of original canonical mitochondria from the Last Eukaryotic Common Ancestor (LECA) 
(Dyall and Johnson, 2000, Makiuchi and Nozaki, 2014). As such, understanding the roles 
and functions of these MROs may hold the key to understanding the evolution of modern 
eukaryotes, by deciphering which aspects of the original symbiont were significant in the 
development of the endosymbiotic event. 
The mitosome displays a host of modifications, usually losses, compared to the canonical 
organelle, for example: genome sequences of organisms containing mitosomes appear to 
show an almost complete loss of ATP generation via oxidative phosphorylation, lack of 
organellar genome, with little to no components of the TCA cycle or electron transport 
chain remaining (Mogi and Kita, 2010, Makiuchi and Nozaki, 2014).  
7KLV ORVV RI IXQFWLRQ DOVR FRUUHODWHV ZLWK WKH RUJDQHOOH¶V VWUXFWXUDO FKDQJHV ZKLOVW
mitosomes have retained the dual membrane aspect of the mitochondrion, electron 
microscopy has revealed that the mitosome has nonetheless lost all traces of the 
characteristic cristae (Figure 1-3) (Regoes et al., 2005). It is possible, that with the absence 
of the TCA cycle and majority of the electron transport chain, that the surface area 
provided by the cristae no longer provided any benefit to the organelle and therefore was 
not conserved. In its stead, C. parvum appears to rely entirely on ATP production from a 
plant type glycolytic pathway, although ATP scavenging from the host is theorised there 
ultimately remains no evidence to support this (Entrala and Mascaro, 1997, Mogi and 
Kita, 2010, Cook et al., 2012, Abrahamsen et al., 2004).  Mitosomes also show a 
significant reduction in locally stored genetic content, with some examples (such as those 
within C. parvum) showing a complete translocation of mitochondrial sequences to the 
RUJDQLVP¶VQXFOHXV (Regoes et al., 2005, Mogi and Kita, 2010, Makiuchi and Nozaki, 




Figure 1-3: The spectrum of Mitochondrial Related Organelles (MROs). The distribution of 
structural changes between canonical mitochondria (1, from chicken cerebellum), hydrogenosomes 
(2 and 3 from Neocallimastic patricarium and Tritrichomonas foetus) and mitosomes (4-6 from 
Entamoeba histolytica, Trachipleitophora hominis and Giardia intestinalis). The size of the mitosome 
FDQ YDU\ JUHDWO\ EHWZHHQ VSHFLHV ZLWK VRPH UHDFKLQJ VHYHUDO ȝP LQ VL]H VXFK DV WKRVH VHHQ in 
Entamoeba histolytica (4) to others of less than 500nm such as those found in Trachipleistophora 
hominis and Giardia intestinalis (5 and 6). The scale bars represent 100nm from 1-4 and 50nm for 5-
6.  (Reproduced from van der Giezen and Tovar, 2005) 
 
Many other traditionally conserved aspects of mitochondrial metabolism have also been 
lost. In the apicomplexans, porphyrin biosynthesis is highly reported to be performed 
within the apicoplast organelle, which interestingly neither the gregarines nor 
Cryptosporidia have retained. It has been confirmed that Cryptosporidia lack the ability 
to synthesise porphyrin groups and by extension haem or cytochrome compounds (Lim 
and McFadden, 2010, Seeber and Soldati-Favre, 2010, van Dooren and Striepen, 2013). 
In contrast, iron-sulphur cluster biosynthesis has been conserved within organisms with 
MROs, and C. parvum is no exception. Iron-sulphur clusters are amongst the most 
ubiquitous compounds in life, conserved almost unilaterally across all domains of life 
(Xu and Moller, 2011, Lill et al., 2012, Ali and Nozaki, 2013). The methods of 
biosynthesis of these compounds is therefore unsurprisingly also highly conserved. 
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Current understanding of these pathways identifies three predominant types: The Sulphur 
mobilisation (SUF), Iron-Sulphur Cluster formation (ISC) and Cytosolic Iron-sulphur 
protein Assembly (CIA) pathways. ISC and CIA pathways are the most common 
pathways found in eukaryotic cells, typically within the mitochondrion and cytosol 
respectively (Ali and Nozaki, 2013). The SUF pathway appears to have been a bacterial 
innovation and appears throughout those eukaryotes typically containing plastids and all 
apicomplexans with an apicoplast (Kumar et al., 2011, Xu and Moller, 2011, Ali and 
Nozaki, 2013). Of these pathways, it has been observed that even organisms with an MRO 
have maintained the mitochondrial ISC pathway, often in addition to CIA or SUF (Kumar 
et al., 2011, Xu and Moller, 2011, Tsaousis et al., 2012, Ali and Nozaki, 2013).  
The mitosome of C. parvum appears as circle or oval, five-hundred nanometres in 
diameter, encased in a dual membrane. The only mitochondrial proteins that have thus far 
been localised to this organelle are the heat shock proteins 60 (hsp60) and hsp70 (Mogi 
and Kita, 2010, Ali and Nozaki, 2013, Makiuchi and Nozaki, 2014, Alcock et al., 2012, 
Putignani et al., 2004). The C. parvum mitosome also appears to be completely absent of 
the typical mitochondrial proteins such as cytochromes, with only the Alternative Oxidase 
(AOX) remaining of any complex Electron Transport Chain (ETC) biosynthetic pathway 
(Roberts et al., 2004, Suzuki et al., 2004). In-silico predictions and preliminary functional 
studies also describe the presence of a complete ISC pathway, as is also typical of 
mitosomes (Ali and Nozaki, 2013, LaGier et al., 2003). Whilst genome sequencing has 
also identified the presence of the CIA machinery, it appears to have lost (or never 
inherited) the SUF pathway that other Apicomplexa maintain within the apicoplast 
(Kumar et al., 2011, Abrahamsen et al., 2004). Current understanding of the mitosome 
within C. parvum is limited and based primarily on in-silico predictions, with the only 
experimental evidence being the localisation of recombinant C. parvum ISC components 
to yeast mitochondria, though no such experiments have been performed in C. parvum 




Figure 1-4: Metabolic pathways of the µW\SLFDO¶ mitosome. The metabolic content of the mitosome 
within C. parvum as predicted so far via the published genome has both a basic glycolytic and ISC 
iron-sulphur cluster biosynthesis pathways, with putative mitochondrial/mitosomal targeting 
sequences. Mitochondrial targeting of recombinant Isu1/2 (IscU), Ferrodoxin (Fd1) and Nfs1 (IscS) 
has been confirmed within yeast expression systems although no experimental evidence exists 
replicating this in a mitosome. (Adapted from Mogi and Kita, 2010) 
As can be expected from a group so lacking in apparently essential organelles, members 
of the Cryptosporidia are obligate parasites, entirely reliant on scavenging components 
from a host to survive. 
 
1.5.2 Metabolism of C. parvum 
 
Most of that which is currently understood of the metabolic pathways of C. parvum is 
based on in-silico predictions, from genome sequences that have been published over the 
last decade (Abrahamsen et al., 2004). The data has produced numerous interesting 
observations regarding the metabolism of C. parvum, a significantly reduced ability to 
produce essential biological compounds de novo (Rider and Zhu, 2010).  
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Perhaps foremost amongst this is that C. parvum is incapable of synthesising fatty acids, 
with the absence of an apicoplast resulting in the loss of the type II Fatty Acid Synthases 
(FAS) typically found in the Apicomplexa. C. parvum does, however, maintain a 
cytosolic, type 1 fatty acid synthase (CpFAS1), although it appears to be incapable of de 
novo fatty acid synthesis (Zhu et al., 2000). Functional analysis of CpFAS1 revealed that 
it instead acted as an elongase, showing a preference for 16 carbon chains, to which 
CpFAS1 has been shown to add an additional six carbons (Zhu, 2004, Zhu et al., 2004, 
Zhu et al., 2010). The lack of de novo fatty acid synthesis is unusual, considering the high 
fatty acid FRQWHQWRIWKHSDUDVLWH¶VHQYLURQPHQWDOO\UHVLVWDQWRRF\VWVWDJH (Jenkins et al., 
2010). This suggests that the parasite is capable of scavenging fatty acids from either the 
host cell or extracellular matrix surrounding it, which is not unusual for a  parasite 
(Mazumdar and Striepen, 2007). This hypothesis is further supported by the nature of the 
individual fatty acid compounds found within the parasite; whilst both 12 and 14 carbon 
long chains (dodecanoic acid and tetradecanoic acid) have been identified the oocyst wall 
consists exclusively those fatty acLGV&S)$6LVFDSDEOHRIµSURGXFLQJ¶  
Additionally, C. parvum appears to be completely incapable of synthesising core 
biological compounds such as the amino acids Valine and Leucine, with limited ability 
to produce others such as Glycine and Tryptophan  
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Table 1-2: Essential and non-essential amino acids of Cryptosporidium parvum. Although C. parvum 
lacks the metabolic functions to produce most of amino acids de novo, it retains some limited capacity 
to produce most of the uncharged and a single hydrophobic amino acid through 1 or 2 step processes. 
This list is split into two major columns: essential and non-essential amino acids. It is important to 
note, that except for proline, C. parvum cannot produce any amino acid without obtaining already 
complex molecules from an external source (Zhu and Guo, 2014, Rider and Zhu, 2010). 
 
 
The trend continues into folate biosynthesis. Traditionally targeted during drug design 
against Apicomplexa, as a means of interrupting pyrimidine synthesis, it appears that the 
C. parvum maintains only two enzymes within the pathway (Abrahamsen et al., 2004). 
Of the two folate enzymes that are maintained by C. parvum, a putative 
phosphodiesterase/alkaline phosphatase D appears to be either plant or bacterial in origin, 
a common theme amongst the Apicomplexa in general, which appear to have benefited 
from numerous horizontal gene transfer events. Similar blast searches also reveal that 
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several components of the glycolytic pathway within C. parvum are also more likely to 
be bacterial or plant in origin. 
C. parvum also displays several interesting adaptations within its ATP biosynthetic 
pathways. A mitochondrial-type AOX, which is not found in any other apicomplexans, 
has been expressed and characterised from the C. parvum (Putignani et al., 2004, Mogi 
and Kita, 2010, Roberts et al., 2004, Suzuki et al., 2004). In C. parvum as well as much 
of Cryptosporidium species AOX is acting as the terminal enzyme in the electron 
transport chain, donating an electron to the final oxygen in the pathway.  
Traditionally, AOX is often found as a part of damage mitigation pathways in a variety 
of organisms, particularly obligate anaerobes, as it coveys resistance to oxygen free 
radical formation by curtailing the electron transport chain at complex II (Mogi and Kita, 
2010, Williams et al., 2010, Saha et al., 2016, Dahal and Vanlerberghe, 2017). Similarly, 
C. parvum also maintains a pyruvate-NADP+ oxidoreductase (PNO), though most 
apicomplexans do not (Rotte et al., 2001, Mogi and Kita, 2010). Interestingly, outside of 
the Apicomplexa, C. parvum becomes less unique as the parasitic early dinoflagellate 
Perkinsus marinus and the photosynthetic chromerid Vitrella brassicaformis both share 
homology with CpAOX and the genome of V. brassicaformis also contains a significantly 
similar (E value of 2e-92) sequence to the putative phosphodiesterase/alkaline phosphatase 
D. 
From this it is clear that C. parvum is greatly lacking several key biological pathways, 
often completely incapable of producing essential biochemical components. This makes 
it clear as to why C. parvum cannot survive as a facultative parasite; however, it does not 
explain how C. parvum compensates for these deficiencies. To understand this, it is 
important to consider the interactions between host and parasite on a molecular level.  
 
1.5.3 Host-parasite interactions 
 
During host cell invasion by a sporozoite, C. parvum has been observed inducing an array 
of physiological effects upon the host cell, this preliminary aspect of the infection is so 
far, the most studied and well understood of the host-parasite interactions in C. parvum 
infections. Among the reactions determined to be necessary for successful host-cell 
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invasion are host-cell tyrosine phosphorylation, which allows the recruitment of host-cell 
actin to the site of invasion (Elliott and Clark, 2000, Chen et al., 2003). C. parvum has 
also been shown activating host-cell Cdc42, a component of membrane import via 
endocytosis, through the recruitment of phosphatidylinositol 3-kinase to the host-parasite 
interface during invasion, the inhibition of which was shown to significantly reduce the 
SDUDVLWH¶VDELOLty to invade the host cell (Chen et al., 2004a, Chen et al., 2004b). Inhibition 
of host-cell Galactose-N-acetylgalactosamine (Gal/GalNAc) has also been shown to 
prevent parasite invasion of host-cells and a putative Gal/GalNAc binding lectin has 
recently been localised to the apical region of the C. parvum sporozoite (Joe et al., 1994, 
Bhat et al., 2007, Edwinson et al., 2016). There have been numerous additional 
proteins/molecules identified which appear to be involved in some manner with host-cell 
invasion, including multiple Calvin Cycle proteins, Lectins and several glycoproteins 
such as GP900 and GP40/15, although many of their exact roles and/or importance remain 
largely unexplored (Petersen et al., 1997, Barnes et al., 1998, Bonnin et al., 2001, Bhat et 
al., 2007, Sturbaum et al., 2008, Chatterjee et al., 2010). 
Once established within the host cell, plaques consisting of host f-actin and Į-actinin were 
described within the host membrane, localised to the interface with the PV, although other 
typical components of actin utilisation were unusually absent (Elliott and Clark, 2000). 
This accumulation of actin at the host-parasite interface is not observed in similar PV 
forming parasite Toxoplasma gondii. 
Once established within a host-cell, C. parvum undergoes merogony and the remainder 
of its life cycle, alternating through various extra and intracellular stages (Figure 1-2) 
(Leitch and He, 2012). Although, as previously mentioned C. parvum cannot produce 
many essential metabolic compounds de novo, which suggests that they are instead 
scavenged from the host during the intracellular stages. Keeping with the theme of C. 
parvum, however, experimental evidence of metabolite scavenging remains largely at the 
in-silico or even purely hypothetical level. 
Whilst the exact nature of which compounds are scavenged remains largely unexplored, 
investigations into how the intracellular stages interact with the host have provided some 
insight into the host-parasite interactions at this stage. Ultra-structural analysis of the 
parasites routinely reveal that C. parvum never makes direct contact with the host 
cytoplasm, instead residing within the PV, and as such may possess some means of 
1-24 
 
µFKDQQHOOLQJ¶VFDYHQJHGQXWULHQWVWKURXJKit, into the parasite cytoplasm (Current et al., 
1986, Arrowood, 2002, Borowski et al., 2010, Karanis and Aldeyarbi, 2011, King et al., 
2011, Leitch and He, 2012, Muller and Hemphill, 2013).  Observation via electron 
microscopy has revealed a potential candidate for this role, tHUPHGWKHµIHHGHURUJDQHOOH¶
due to its proposed function, consisting of an unusual highly folded membrane that forms 
between the host membrane and PV (Leitch and He, 2012). However, unlike other 
Apicomplexa, the PV of C. parvum has not been observed penetrating the host cytoplasm, 
remaining ultimately extra-cytoplasmic. 
Attempts to characterise the metabolic activity of the feeder organelle have revealed an 
ATP-binding cassette (ABC) protein CpABC1, with sequence and structural homologies 
suggesting a role in ion and possibly organic anion transport (Zapata et al., 2002, Sauvage 
et al., 2009, Perkins et al., 1999).  
Preliminary investigations into the effects C. parvum infections have on patient 
metabolomes have also provided some insight into the nature of the host-parasite 
interaction. Of the observations made, one of note is the change in Hexadecanoic acid 
content of host faecal samples (Ng Hublin et al., 2012, Ng Hublin et al., 2013). 
Hexadecanoic acid is the shortest chained fatty acid C. parvum is capable of metabolising, 
as the preferred substrate of CpFAS1, routinely metabolised into the 22 chained 
Docosanoic acid (Zhu et al., 2010, Zhu et al., 2000). 
Despite this, knowledge regarding C. parvum remains scattered. Investigations into its 
cellular biology are marred by ineffective culturing systems and this in turn makes it 
difficult to properly interpret the results of experiments such as the metabolomics just 
discussed. 
 
1.5.4 Culturing C. parvum 
 
The limits in our knowledge regarding this particular parasite, as well as the restrictive 
pool of available medications are in large part due to the state of available culturing 
techniques (Striepen, 2013). C. muris and C. hominis have shown some progress in in-
vitro culture systems, especially those of a host-cell-free nature and over the last 40 years 
a multitude of tissue based cultures have been developed to allow the growth of C. parvum 
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in-vitro also (Hijjawi et al., 2010, Upton et al., 1994, Meloni and Thompson, 1996, 
Arrowood, 2002, Hijjawi, 2010, Yin et al., 2010, Karanis and Aldeyarbi, 2011, King et 
al., 2011, Muller and Hemphill, 2013, Miller et al., 2017, Morada et al., 2016). To date 
C. parvum culture relies primarily on infected HCT-8 cell lines or variations of the 
previously identified CACO-2 or MDCK cells. Unfortunately, these solutions bring with 
them numerous crippling flaws, such as short culture life-spans and aberrant life-cycles. 
Recent advances in the field have seen the introduction of more advanced culturing 
systems, such as simulated micro-gravity and hollow fibre/organoid approaches, in 
attempts to overcome the inherent issues of these cell lines with promising results 
(Morada et al., 2016, Alcantara Warren et al., 2008). 
Despite these advances, however, the culturing systems are still insufficient for most 
research purposes and the most reliable systems that exist at this time for C. parvum 
production require the continued infection of immune-suppressed or naive animals, 
typically the young of livestock such as cows or sheep, or laboratory animals such as mice 
(Girouard et al., 2006, Striepen, 2013). 
This has resulted in a seasonal, expensive and labour-intensive supply method, with heavy 
reliance on animals in an age of rapidly declining tolerance for animal experimentation. 
 
1.6 The hypothesis 
 
As covered in the preceding introduction, C. parvum is among one of the more unique 
members of the eukaryotes and especially the apicomplexans, eschewing traditional 
levels of genetic and organellar conservation for a highly streamlined and presumably 
efficient cellular biology. These traits, combined with the presence of a largely 
unexplored organelle, a potentially basal phylogenetic routing among the apicomplexans, 
in addition to &SDUYXP¶Vrising global medical importance, show there has never been 
a more important time to study this parasite. 
Therefore, it is the purpose of this thesis to provide the building blocks and preliminary 
experimental evidence required to establish C. parvum as a model organism for the 
Cryptosporidia and potentially the Gregarina and Apicomplexa. This will be achieved 
through the exploration of three key hypothesis or objectives, as listed below: 
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1. C. parvum can be successfully cultured on a scale, both volume and time-wise, 
conducive to broad experimentation. Because of the production levels, the 
developed culturing technique will allow unprecedented exploration of the 
parasites¶ genetic, metabolic and cellular biology as well as opening new routes 
into exploring the genetic tractability of the currently difficult to modify organism. 
Once established, the culture will allow the exploration of &SDUYXP¶V adaptations to 
parasitism and the role played by the mitosome. These concepts will be explored via the 
following hypotheses: 
2. The parasitic adaptations of C. parvum have led to the development of specific 
host-SDUDVLWHLQWHUDFWLRQVZKLFKGLUHFWO\DIIHFW WKHKRVW¶VPHWDEROLFPDFKLQHU\
including host mitochondria. The identification and cataloguing of these effects 
will allow for metabolomics-based diagnosis of the disease. Furthermore, this 
work will shed light on the role of host-specificity and the adaptations C. parvum 
maintains that provide it with a significantly larger repertoire of potential hosts 
compared with almost any other apicomplexan. 
3. The ISC pathway is present and active within the mitosome of C. parvum. 
Specifically, the components: IscS, IscU and Frataxin. This would show for the 
first time a metabolic function for the relict mitochondrion of C. parvum. 
The results of these theories and how they were tested is described in the following 
chapters of this thesis, in addition to suggestions how they may be further improved upon 






Chapter 2 Materials and Methods 
 
2.1 Cell culture  
 
During the initial experiments in 3.3 the following cell lines were used: COLO-680N 
(Human oesophageal squamous-cell carcinoma), obtained from Cell Line Services, 
Eppelheim, Germany; DLD-1 (Human colon adenocarcinoma), KYSE-30 (Human 
oesophageal squamous-cell carcinoma) and HCT-15 (human colorectal 
adenocarcinoma), obtained from DSMZ, Braunschweig, Germany; SJSA-1 
(osteosarcoma) and HCT-8 (ileocecal colorectal adenocarcinoma), obtained from ATCC, 
Manassas, VA, US, Cat No. CRL-2098 and CCL-244, respectively; MKN-1 (gastric 
carcinoma), obtained from JCRB Cell Bank, Osaka, Japan.  
Cells were cultivated in RPMI-1640 medium (Sigma-Aldrich, Cat No R8758) 
supplemented with 10 % foetal bovine serum (Sigma-Aldrich, Cat No F8084), 100 U/mL 
penicillin, 100 µg/mL streptomycin and 250 ng/mL amphotericin B (Antibiotic 
Antimycotic solution, Sigma-Aldrich, Cat No A5955) at 37 °C and 5 % CO2. All 
experiments used the COLO-680N cell line unless otherwise stated. Experiments using 
the standard RPMI-1640 + FBS +Antibiotic mixture are referred to as XVLQJ³FRPSOHWH´
RPMI-1640 in the rest of this thesis. 
 
2.2 Sources of Cryptosporidium oocysts 
 
Several species and strains of Cryptosporidium were used for the experiments described 
hence. Their origins are as follows: 
Initial studies were performed on Cryptosporidium parvum oocysts provided by the 
Creative Science Company pre-SXULILHGDQGLGHQWLILHGDVWKHµ0RUHGXQ¶VWUDLQZKLFKZDV
originally acquired from the gastrointestinal contents of a dead red deer calf (Cervus 
elaphus), sourced from the Glen Saugh experimental deer farm (Scotland, UK) in 1987 
(Moredun strains of Cryptosporidium parvum 2015).  
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C. parvum Iowa II was obtained from Bunch Grass Farm in the United States, isolated 
from infected calves and is a commercially available species/strain that is frequently used 
in C. parvum experimentation (Girouard et al., 2006, Sturbaum et al., 2008) 
C. parvum, :HUX VWUDLQ ZDV VXSSOLHG FRXUWHV\ RI 'U 0DUWLQ .Yiþ RI WKH ,QVWLWXWH RI
Parasitology Biology Centre CAS, Czech Republic. The Weru strain was originally 
isolated from an infected human patient and subsequently maintained by passing through 
SCID mice.  
C. hominis was supplied courtesy of Prof. Rachel Chalmers from the Cryptosporidium 
Reference Unit, Singleton Hospital of NHS Wales. The C. hominis used in this 
H[SHULPHQWZDVIURPDQRULJLQDOVWRFNSXULILHGIURPDSDWLHQW¶VVWRROVDPSOH 
 
2.3 Cell line infections 
 
Infections of cell cultures were performed at 1 x 105 oocysts per 10ml of cultured cells in 
a 25 cm2 cell culture flask, once the cell culture density had reached 70% coverage of the 
flask surface (70% confluent) unless otherwise stated. 
Excystation was achieved by adding 100 ȝO of 0.01% Trypsin and 400 ȝO of 0.5 % Sodium 
Hypochlorite to a pellet containing the desired number of oocysts, as had been established 
by prior publications (Upton et al., 1994, Gold et al., 2001).  The oocyst suspension was 
incubated in a 37°C water bath for one hour, with intermittent vortexing. The excystation 
procedure was monitored by phase contrast microscopy, using a haemocytometer and 
stopped when visible sporozoites exceeded 80 % of the theoretical maximum (4x the 
original number of oocysts present per sample). Samples were pelleted at 2,200 g for eight 
minutes, and suspended in cell culture medium, prior to cell infection. 24-26 h post-
infection, T25 flasks were washed twice with 10 ml of 1x PBS, to remove un-excysted 
oocysts and remaining sporozoites. Fresh media was then added. To ensure that 
extracellular parasites (included non-excysted oocysts) had been efficiently removed 
following the wash procedure and that no traces of Cryptosporidium parvum could be 




2.4 Purification of Cryptosporidium from infected cultures  
 
Growth media from infected cultures and a subsequent 5 mL wash (with 1x PBS) were 
collected.  The suspensions were centrifuged at 500 g for 5 minutes to remove host cells 
and debris. The supernatant, which contain the oocysts, was then transferred to fresh 
tubes, and the oocysts were pelleted by centrifugation at 2,100 g for 8 minutes. The pellets 
were re-suspended in 1 mL of 1x PBS and carefully laid on top of 9 mL of saturated 
(37%) sodium chloride solution, in a 15 mL Falcon tube. These two layers were then 
topped up with 1 mL of sterile water before being centrifuged at 2,100 g for 8 minutes. 
This centrifugation steps resulted in the formation of a milky white phase between the 
PBS and salt layers, which contained the live oocysts. Using this methodology, empty 
and non-viable oocysts fall to the bottom of the tube during centrifugation. The oocysts 
were carefully pipetted from the interface. Because, the isolated oocysts may contain a 
carryover from the sodium chloride solution, 9 mL of 1x PBS were added to dilute the 
mixture and the oocysts were pelleted again at 2,100 g for 8 minutes. The pipetting/ 
dilution steps were repeated twice. 
 
2.5 Cryopreservation and resuscitation of infected cells  
 
Medium was discarded from infected cell cultures and the cell monolayer was washed 
once with 1x PBS. Cells were then trypsinised and suspended in 9 mL of cell culture 
medium prior to centrifugation at 500 x g for 5 minutes at 4°C. The supernatant was 
discarded, and the pellet suspended in 10 mL of cryo-media (RPMI-1640, 20% FBS, 10% 
DMSO). The cell suspension was then aliquoted into 2 mL samples in cryo-tubes and 
stored at -80°C inside a Mr. Frosty TM freezing container (ThermoFisher Scientific, Cat 
No 5100-0001). The cells were left for a minimum of two weeks before resuscitation. To 
resuscitate cells, cryo-tubes were removed from the freezer and immediately thawed at 
37°C in a water bath for 5 minutes. The cell suspension was then added to 8 mL of cell 
culture medium, mixed gently, and then centrifuged at 500 x g for 5 minutes at 4°C. The 
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supernatant was discarded, and the cell pellet suspended in 10 mL of pre-warmed cell 
culture medium.  
 
2.6 DNA extraction from oocysts and infected cultures  
 
COLO-680N cells infected using the protocol above, were washed twice with 1x PBS, 
prior to DNA extraction. Samples were taken six hours post infection and subsequently 
on days 1, 2, 3, 4, 5, 6, 9 and 12. 
For COLO-680N cells and epicellular Cryptosporidium stages, DNA extraction was 
performed using the Qiagen DNeasy Blood and Tissue kit (Qiagen, Cat. No 69504) 
following the manufacturer's instruction. For C. parvum oocysts, samples were collected 
from cell culture supernatants as described above. Then, DNA extraction was performed 
using the Omega E.Z.N.A. fungal extraction kit (Cat. No. D3390-1) following the 
manufacturer's instructions.  Extracted DNA was quantified using a NanoDrop 1000 
6SHFWURSKRWRPHWHUE\SODFLQJȝOGURSVRIWKHVDPSOHRQWKHGHWHFWRUDQGREVHUYLQJWKH
readout obtained, samples were restricted to those that gave relatively high purities for 
wavelengths between 260/280 (~1.7-1.8) to reduce the possibility of unreliable results 
from RNA/Protein contamination. 
 
2.7 PCR amplification  
 
PCR reactions were performed with the following general parameters: 
)RUDUHDFWLRQWRWDOYROXPHRIȝOȝL 3&5[)OH[LEXIIHU3URPHJD0ȝ/
MgCl2 ȝ0ȝ/G173V10 ȝ0ȝ/RIIRUZDUGSULPHUDQGȝ/RIUHYHUVHSULPHU
(10 ȝM)(See Table 2-1 IRUFRPELQDWLRQVXVHGȝ/+22ȝ/RI*R7DT*+RW
6WDUW3RO\PHUDVH3URPHJD&DW1R0$DQGȝ/RI'1$FRQFHQWUDWLRQ varied 
GHSHQGDQWRQVDPSOHVRXUFHILQDOWRWDO'1$FRQWHQWGLGQRWH[FHHGȝJ 
PCR set up conditions were as follows: 1 cycle of 95 °C of initial denaturation for 5 
minutes, followed by 36 cycles of 35 seconds denaturation steps at 95 °C, 30 second 
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annealing steps (see Table 2-1 for temperature) and an elongation step at 72 °C (see Table 
2-1 for time). Then a final 10 minutes elongation step at 72 °C. 
Table 2-1: PCR Primers. Custom Nucleotide sequences of the PCR primers used in Chapter 5 to 
produce recombinant ISC structures in a selection of plasmids. Sequences are colour coded to 
highlight GC clamp (blue) and restriction site (red). Each was designed based on sequences obtained 
from using Blasting yeast ISC sequences against published C. parvum genomes. 
 
The resulting amplified DNA was visualised on a 1.8 % agarose-TAE gel and stained 
with ethidium bromide. 
 
2.8 Electron Microscopy (EM)  
 
FPGLDPHWHUȝPWKLFNDFODUILOPGLVFV+RQH\ZHOOLQWHUQDWLRQDO,QF
were sterilised by UV light/Ozone exposure for 30-60 minutes in a sterilised tissue culture 
cabinet. The disks were then deposited into 24-well plates. For each well, 1 mL of COLO-
680N cells at a concentration of 2.4 x 104 cells/ml was added. Once the cells had reached 
50 to 60 % confluency, the cultures were infected with 50,000 C. parvum oocysts, giving 
an approximate MOI of 0.4.  On days 6, 7, 8, 9, 12, the supernatant was removed, and 
cells were washed with 200 mM cacodylate buffer (pH 7.4). The buffer was aspirated and 
1 mL of fixative, containing 2.5% Glutaraldehyde in 100 mM cacodylate buffer (pH 7.4), 
was then added and left at 4oC overnight. Next, each well was washed twice (10 minutes) 
with cacodylate buffer prior to staining with 1 mL of 1% osmium for 30 minutes at room 
temperature.  The samples were washed and dehydrated through an ethanol series (30 %, 
50%, 70 %, 90% and twice 100%) before being embedded in Agar (Agar Scientific) low 
viscosity resin.  
Sections were cut initially with a glass knife and ultrathin sections of 65 nm were cut with 
a Di$720( diamond knife on a RMC-MTXL ultramicrotome.  The sections were 
2-32 
 
placed onto 400 mesh uncoated copper grids.  The grids were then stained for 45 minutes 
in 4.5 % aqueous Uranyl Acetate, washed again, and subsequently stained for 7 minutes 
ZLWK5H\QROG¶VOHDGFLWUDWH6WDLQHGJULGVZHUHWKHQGULHGIRUPLQXWHVEHIRUHEHLQJ
visualised with a Jeol 1230 Transmission Electron Microscope at 80kV equipped with a 
Gatan Multiscan digital camera.  
 
2.9 Fluorescence microscopy  
 
50-60% confluent cultures were infected with Cryptosporidium oocysts in 2-well 
permanox base chamber slides (Sigma-Aldrich, Cat No C6682), with varying oocyst 
numbers dependant on the nature of the experiment. Detection was achieved through 
extensive use of Indirect Immuno-fluorescence assays (IFA) and a variety of fluorophores 
(Table 2-2) 
Table 2-2: Fluorophore Emission and Excitation peaks. A variety of fluorescent antibodies and 
stains were used in the experiments to detect and visualise the infection and a variety of organelles. 
This list encompasses the various wavelengths utilised by these fluorophores and the colour used to 






peak Colour in Figures 
DAPI Nuclear material  350 470   Blue 
Crypt-a-glo 
Cryptosporidium 
oocyst wall protein  490 525   Green 
SporoGlo 
Apicomplexan 
sporozoites  490 525   Green 
Propidium 
Iodide Nuclear Material 535 617 Red 
CMXRos Mitochondria 580 600 Red 
VVL 
Various parasite 
proteins  490 525   Green 
Anti-rabbit 
rabbit derived 
antibodies  557 576   Red 
Anti-rat 
rat derived 
antibodies  557 576   Red 
 




At harvesting points, cultures were washed with 1x PBS and then fixed in methanol for 
10 minutes at room temperature.  Next, the methanol was removed, and the cells were 
permeabilised with 0.002 % Triton-X100 in 1x PBS at room temperature for 30 minutes.  
Cells were then washed three times prior to incubation for 1 hour with FITC conjugated 
Cryptosporidium-specific antibodies (Crypt-a-glo, WaterborneTM, dilution 1:10; 
SporoGlo, WaterborneTM, dilution 1:10), non-conjugated anti-CpClec (dilution 1:60), 
propidium iodide (500 nM), or FITC conjugated 9LFLD9LOORVDOHFWLQ99/ȝJPl). 
Cells were washed a further three times with 1x PBS and then mounted with an aqueous 
mounting medium. This was done using either Fluromount (Sigma-Aldrich, Cat No 
F4680, with no DAPI) or Fluoroshield (Sigma-Aldrich, Cat No F6057, with DAPI). 
Slides were visualised by fluorescence microscopy using an Olympus 1X82 or Zeiss 
Elyra P1 confocal microscope.  
On ten days post-infection, the supernatant of infected cells (containing oocysts and 
COLO-680N cells and debris) was filtered through 40 µm nylon Corning cell strainers. 
The flow through was spun down at 2,000 x g for 8 min. The supernatant was then 
discarded, the oocysts and debris were resuspended in 100 µl 1x PBS and added on poly-
L lysine coated slides. The slides were rinsed once in 1x PBS, then the oocysts were fixed 
with 4% paraformaldehyde for 30 min. The slides were rinsed one more time in 1x PBS 
and blocked overnight in 3% filtered BSA. The slides were washed once in 1x PBS and 
1 drop of FITC conjugated Crypt-a-glo (Waterborne inc.) was added for 1 hour. The slide 
was quickly rinsed and mounting media containing DAPI (Sigma-Aldrich, Cat No F6057) 
was then added prior to covering with coverslip and sealing with nail polish. 
 
2.9.2 Cellular biology and localisation 
 
COLO-680N cells were used exclusively and infected with 1x106 Cryptosporidium 
oocysts. For comparison, control non-infected cells were seeded on the same day. 
Following 48 hours post-infection the supernatant was replaced by fresh media for all 
samples.  
At seven and ten days post infection the media was aspirated from the cultures and washed 
twice with 1 x PBS. The media was removed and replaced with further pre-warmed 
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complete RPMI-1640 (1% Antibiotic/Antimycotic), containing 3.5% formaldehyde, for 
PLQXWHVDW&DVSHUWKHPDQXIDFWXUHU¶VSURWRFRO 
For mitochondrial observation fresh, pre-warmed, serum free RPMI-1640 (Sigma 
Aldrich, Cat. No R8758) (1% Antibiotic/Antimycotic) containing 200 nM ThermoFisher 
Mitotracker Red CMXRos (Molecular probes; Cat. No M7512), was added to the wells 
and incubated in the dark at 37°C for 45 minutes prior to fixation. 
The cells were then briefly permeabilised with 0.2% Triton-x100 in 1x PBS for 10 
minutes, washed twice with 1x PBS and four drops of FITC conjugated 6SRUR*OR
(WATERBORNE, INC) or Crypt-a-glo (WATERBORNE, INC) added, with incubation 
at 37°C for a further 45 minutes. The final sample was then washed three times with PBS, 
GULHGDQG)OXRURVKLHOGZLWK'$3,6LJPD$OGULFK&DW1R)RU3UR/RQJ*ROG
Antifade mount (Sigma Aldrich, Cat. No P10144) was added before applying a glass 
coverslip and sealing. Slides were visualised by fluorescence microscopy using an 
Olympus IX82 or Zeiss Elyra P1 confocal microscope. 
  
2.10 Atomic Force Microscopy (AFM)  
 
 1 x 105 RRF\VWVZHUHVXVSHQGHGLQȝ/[3%6SLSHWWHGRQWRDIUHVKO\FOHDYHGPLFD
sheet pre-mounted on a magnetic specimen disc (Agar scientific) and left to sediment for 
DQKRXUDWR&LQDKXPLGLILHGFKDPEHU2RF\VWVZHUHWKHQIL[HGIRUKZLWKȝ/RI
5% Glutaraldehyde in 1x PBS.  Samples were then washed twice with 1x PBS, once with 
deionised water and air-dried at room temperature in a dust free area for 2 hours.  Samples 
were then washed twice more with deionised water, left to air-dry again followed by a 
final drying step using a gentle stream of nitrogen.   
 Samples were analysed by Atomic force microscopy (AFM) using a Bruker multimode 
8 (Bruker Corporation, Massachusetts) scanning probe microscope with a Nanoscope V 
controller. The samples were imaged using the ScanAsyst peak force tapping mode, with 
RTESPA silicon cantilever probes (Bruker Corporation, Massachusetts), which have a 
nominal spring constant of 40 N/m and a nominal tip radius of 8 nm. Data collection and 
processing was performed using the Nanoscope software (version 1.40, Bruker 
Corporation, Massachusetts).  Images were scanned over a surface area of at least 10 x 
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ȝPDW D UHsolution of 2048 x 2048 pixels. The scan rate was 0.2 Hz. Images were 
processed using the Nanoscope Analysis software (version 1.40, Bruker Corporation, 
Massachusetts) and custom scripts written in MATLAB to remove the sample surface tilt 
and scanner bow.  3-D representations of the data in height and peak-force error channels 
were subsequently rendered in Nanoscope Analysis. 
 
2.11 MALDI-ToF Mass Spectrometry ± Lipid analysis of oocysts 
 
Aliquots of 1.25 x 105 or 2.5 x 105 cattle-produced or COLO-680N-produced oocysts 
suspended in 1x PBS were pelleted at 2,100 x g for 8 minutes. A matrix buffer was 
prepared by dissolving 20 mg/mL (saturated) alpha-cyano-4-hydroxycinnamic acid 
matrix into a 40% acetonitrile 0.15% trifluoroacetic acid, which was then placed in a 
sonicating water bath for 15 minutes. Undissolved matrix was subsequently removed by 
centrifugation at 16,000 x g for 10 minutes. The oocysts were re-VXVSHQGHGLQȝ/RI
matrix buffer. Samples were left to incubate in suspension for 30 minutes. The samples 
were then re-VXVSHQGHGE\JHQWO\WDSSLQJWKHWXEHVEHIRUHȝ/VDPSOHVZHUHDGGHGWR
384 MTP ground steel MALDI-ToF plate wells (Bruker) in triplicate. Samples were 
allowed to air dry before the plate was placed into the MALDI-ToF mass spectrometry 
instrument (Bruker UltrafleXtreme).  
For negative polarity compounds the following set-up was used; Laser frequency: 2000 
Hz;  
Ion sources: (1) 19.94 kV, (2) 17.79 kV; Lens 6.09 kV; Reflector 1: 21.22 kV, 2: 10.74 
kV; Suppress at 500 Da; Pulsed ion extraction 80 nS; Matrix Suppression mode- 
Deflection; Range 600-2000 Da; Sample rate 1 Gs/s; For each sample 7500 shots were 
summed and saved.  
For positive polarity compounds the following set up was used; Laser frequency: 2000 
Hz;  
Ion sources: (1) 24.92 kV, (2) 22.27 kV; Lens 7.47 kV; Reflector 1: 26.53 kV 2: 13.39kV;  
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Suppress at 500 Da; Pulsed ion extraction 80 nS; Matrix Suppression mode- Deflection; 
Range 600-2000 Da; Sample rate 1 Gs/s; For each sample 7500 shots were summed and 
saved.  
The mass spectrometry data files were exported from the Bruker Flex Analysis software 
in ASCII format for pre-processing in MATLAB prior to the application of PCA 41.   
  
2.12 MALDI-ToF Mass Spectrometry of infected cultures 
 
Cell cultures were trypsinised and cell numbers adjusted to 3 x 104 cells/mL. 1 mL of 
each sample was then transferred into a fresh tube and pelleted at 500 x g for 5 minutes 
at 4°C. The samples were then mixed in the alpha-cyano matrix as per the lipidomics 
protocol.  
To analyse the cell pellets, the MALDI-ToF Mass Spectrometry instrument (Bruker 
UltrafleXtreme) was calibrated before use with the commercially available Bruker 
Calibration Standard 1 protein mixture (Bruker, part number 206355). The spectra of the 
intact cell pellets were then collected using the MALDI-ToF Mass Spectrometry 
instrument settings described below and the inbuilt calibration program for this 
calibration mixture provided with the instrument.  
The spectra were collected using the following settings on the mass spectrometer: Linear 
mode; Laser frequency: 500 Hz.  
A positive polarity was implemented with the following set up was used; Ion sources: (1)  
24.93 kV, (2) 23.08 kV; Lens 7.49 kV; Suppress at 5000 Da; Pulsed ion extraction: 400 
nS;  
Range 5000±60,000 Da; Sample rate 0.13 Gs/s; Resolution enhanced 100 mV electronic 
gain; Smooth high. For each sample 3600 shots were summed and saved.  
The mass spectrometry data files were exported from the Bruker Flex Analysis software 





2.13 Scanning electron microscopy (SEM) 
 
Samples were prepared using the same method as with the specimens for AFM with the 
exception that instead of the mica the sample was deposited on a 15 mm SEM carbon 
tape disc. The samples were visualised in a Hitachi s3400 variable pressure SEM at 50 pa 
and 5 kV.  
 
2.14 Real-time cell viability analysis  
 
Cell viability and proliferation was determined by electrical impedance monitoring using 
the xCELLigence system (Acea Biosciences, San Diego, CA, US). 16 well xCELLigence 
SODWHV FRQWDLQLQJ  ȝO RI FRPSOHWH 530,  ZHUH LQFXEDWHG DW & RQ WKH
xCELLigence system for 30 minutes prior to initial calibration. Non-negative-control 
wells were then seeded with 3x104 COLO-1FHOOV LQȝORISUHSDUHGFRPSOHWH
RPMI-QHJDWLYHFRQWUROVKDGȝORIDGGLWLRQDOHPSW\PHGLD5HFHVVHVSUHVHQW
between the wells were topped up to approximately 75% full with pre-warmed PBS at 
37°C. The plates were again incubated for a further 30 minutes before executing the 
xCELLigence programme. The programmes used were monitored and altered during 
H[SHULPHQWDWLRQWRHLWKHUHORQJDWHRUSUHPDWXUHO\HQGWKHREVHUYDWLRQRIWKHµFHOOLQGH[¶
depending on whether a continued growth trend or early complete senescence was 
observed. The results were exported to an excel spreadsheet and the data analysed. 
 
2.15 Animals and infection 
 
For this study, seven-day old BALB/c mice (n=9) were infected at the Czech Institute of 
Parasitology, Biology Centre using pre-established protocols detailed in Meloni and 
Thompson, totalling three mice per condition (Meloni and Thompson 1996). Three 
separate groups were used, one infected with 100,000 oocysts of C. parvum Iowa II, 
another group was infected with 100,000 oocysts of the C. parvum Weru isolate and the 
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final group were given a PBS control. The groups were kept physically spate and never 
allowed to interact. Infection was monitored from Day-1 post-infection by aniline-carbol-
methyl violet staining of faecal smears staining of faecal smears (Figure 2-1), in addition 
WR DQ DQWLJHQ EDVHG VWULS WHVW ³RIDA®QUICK Cryptosporidium´, supplied by R-
Biopharm (Milacek and Vitovec 1985). At ten days post-infection, the mice were 
euthanized by cervical dislocation and decapitation. This study was carried out in 
accordance with Act No 246/1992 Coll. of the Czech Republic. The protocol was 
approved by the 'Committee for Animal Welfare of Biology Centre Czech Academy of 
Science and the veterinary administration authorities with regards to the animal 
experiments. 
 
Figure 2-1: Confirmation of a mouse infection via modified aniline-carbol-methyl stain. Following a 
similar rationale as acid fast staining, the purple methyl-violet stain cannot be decoloured by ethanol 
when taken up by the oocyst. This leaves Cryptosporidium oocysts as bright purple objects, as 
indicated by the arrows. Estimates regarding parasite-load of the animal can be made from the 
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enumeration of average oocysts per oil field (shown is an image representative of a 1000x 
magnification oil field from a mouse of typical infection). 
 
2.16 Sample preparation for NMR 
 
Sample preparation was largely based upon an original methodology published by 
Gonzalez et al in 1997 (Gonzalez et al., 1997). 
 
2.16.1 Animal samples 
 
Animal samples were retrieved from the contents of the ileum and surrounding intestinal 
structure by dissecting out the area of interest and washing through with three ml 100% 
ethanol at room temperature via syringe inserted into the opening, collecting the wash 
through.  
 
2.16.2 Tissue culture samples 
 
COLO-680N models of infection (n=18) were established as noted in 2.3, in 30ml 
cultures within 75 cm2 flasks and maintained for 10 days. The infected monolayers were 
then washed three times with PBS and removed from the surface of the flask via cell 
scraper. Cells were collected from the flask via 5 ml of PBS. 
 
2.16.3 Metabolite extraction and NMR analysis 
 
Collected samples were then centrifuged for three minutes at 10,000 x g, the supernatant 
discarded and the pellet weights recorded. The samples were then suspended by vortex in 




Two ml of two mm diameter glass beads were added to the samples and agitated by vortex 
for 30 seconds before incubating the samples for three minutes at 80°C. The samples were 
vortexed for a further 30 seconds or until the sample was completely homogenised. Tissue 
culture samples were collected by draining the media, adding six ml of ethanol at 80°C 
to the culture flask and scraping the cells off the surface by cell scraper, decanting the 
mixture of lysed cells into 15 ml polyethylene tubes. 
The samples were then decanted into two ml tubes, retaining the glass beads in the falcon 
tubes. The beads were washed with an additional two ml of 80°C, 75% ethanol and again 
the liquid was decanted into sterile two ml tubes, retaining the glass beads in the tube. 
Cell debris and general detritus were removed from the samples by centrifugation at 
16,000 x g for 10 minutes and the supernatant transferred to new, sterile two ml 
microcentrifuge tubes. The samples were then dried via Rotorvac overnight at 40°C, 
VXVSHQGHGLQȝOGRXEOHGLVWLOOHGZDWHUDQGFHQWULIXJHGDWg for 10 minutes. The 
supernatant for the samples were recombined into a single 1.5 ml microcentrifuge tube 
per original samples and frozen at -20 °C until the day before NMR analysis. Twenty-
four hours prior to analysis, the sample tubes were placed into a freeze drier until 
completely desiccated. For NMR analysis, the samples were suspended in one ml of 
deuterated water and spiked with the sodium salt of the calibration control compound 3-
(Trimethylsilyl)-1-propanesulfonic acid (DSS) to a final concentration of 20 mM and a 
tested pH of 7.5. 
 
2.17 NMR protocol and analysis 
 
Samples were analysed using a 4-channel Bruker Avance III 14.1 T NMR spectrometer 
(600 MHz 1H) equipped with a 5 mm QCI-F cryoprobe. For controls: six separate, 
uninfected 25 cm2 COLO-680N 100% confluent monolayer cultures were analysed in 
addition to three uninfected BALB/c mice. Infected samples consisted of six 25 cm2 
COLO-680N 100% confluent monolayers in addition to three Iowa infected BALB/c and 
three Weru infected BALB/c mice. One-dimension NMR datasets were acquired with a 
pulse repetition rate of 5 s over 128 scans, preceded by eight equilibrating dummy scans 
and suppression of the residual Deuterium Oxide solvent (D2O) resonance using 
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presaturation. Processed NMR spectrographic datasets were produced by Topspin 3.2 and 
analysed using Chenomx NMR Suite version 8.2. Partial Least Squares Discriminant 
Analysis (PLS-DA) of the Chenomx data were generated with the freely available 
Microsoft Excel Add-LQ³PXOWL-EDVH´E\1XPHULFDO'\QDPLFV-DSDQ 0XWOLEDVH
for Microsoft Excel 2015). Pathway predictions were produced by the MetaboAnalyst 3.0 
web tool, using a hypergeometric test and relative-betweenness centrality against Homo 
sapiens and Mus musculus databases for the tissue culture and mouse models respectively 
(Xia et al. 2015). 
 
2.18 ISC antibodies 
 
2.18.1 Identification of target gene sequences 
 
Frataxin, IscS and IscU sequences were successfully identified within the genome of C. 
parvum utilising blast searches against the NCBI database, using the published sequences 
of the protein homologues of S. cerevisiae as the search template (Table 2-3).  
Table 2-3: Accession numbers of the putative C. parvum ISC genes identified via a blastn search and 
the corresponding S. cerevisiae homologues. These sequences were used to identify potential 




C. parvum Protein (yeast homologue) C. parvum S. cerevisiae  
IscS (Nfs1p) AY029212 NP_009912 
IscU (Isu1p) XM_627477 KZV07380 
Frataxin (YFH1p) XM_625594 AJV18575 
 
Complementary primers were then designed for each sequence, to allow for the 
amplification of the target gene, with the intentional addition of a 3¶ RU¶ UHVWULFWLRQ




2.18.2 pET14b recombinant protein construct cloning 
 
To produce the desired antibodies, it was first necessary to construct plasmids containing 
the recombinant proteins, suitable for expression in an E. coli line. pET14b (Figure 2-2) 
was chosen due to its high expression rate, n-terminal poly-histamine tail addition, T7 
promoter and Ampicillin resistance selection marker. This would allow quick and 
efficient identification of successful transformants as well as easy purification of the 
desired protein via affinity chromatography.  
 
Figure 2-2 Site map of pET14b. Map obtained from addgene 2017, restriction sites utilised in these 
experiments have been underlined with red (BamHI and NdeI). pET14b was utilised for its 
combination of restriction sites that would allow universal insertion of any of the 3 target 
recombinant sequences without conflicting restriction sites. 
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Initial plasmid cloning and production was achieved via transformation of competent 
'+Į E. coli, due to their rapid replication rate and lack of T7 expression. The 
recombinant protein was expressed via the transformation of the plasmid into 
BL21(DE3)pLysS competent E. coli cells. This strain was chosen due to their inducible 
expression of T7, via a lac UV5 promoter, decreased protease activity and low 
background expression levels. 
Transformations were performed with pre-prepared, chemically competent E. coli cells otherwise 
stored at -80°C. All further steps are performed under flamed sterile conditions. Once removed 
from the -80°C freezer, the cells were allowed to thaw on ice for no more than five minutes before 
DOLTXRWLQJȝORIFHOOVLQWRVWHULOHPOHSSHQGRUIWXEHVȝORISODVPLGPL[WXUHZRXOGWKHQ
be added to the thawed cells and mixed by gently tapping the edge of the eppendorf. The 
cell/plasmid mixture would be left to incubate, on ice, for fifteen minutes. During this time freshly 
prepared LB agar plates, with appropriate selective antibiotic, would be removed from cold 
storage and placed into a 37°C incubator to pre-warm. A heat block or water-bath would also be 
set to warm to 42°C. After the cells had completed their incubation, the containing eppendorfs 
would be added to the 42°C heat block/water-bath and left for 45 seconds then immediately placed 
back on ice. The tubes would be left on ice for a minimum of one minute and a maximum of two 
EHIRUHDGGLQJȝORI62&PHGLXP7ZRDOLTXRWVRQHRIȝODQGDQRWKHURIȝOZRXOG
then be taken from each eppendorf by pipette and used to seed a pre-warmed agar growth plate. 
The seeded plates would be left, agar side up, for two minutes before placing them back into the 
37°C incubator and incubating for 16 hours. Once colonies had formed they were picked via 
sterile pipette tip and used to inoculate 5 ml of sterile LB broth with selective anti-biotic in a 
sterile test-tube and incubated for a further 16 hours at 37°C, shaking. Plasmids could then be 
purified from the culture utilising the reagents and protocol of the QIAGEN, QIAprep Spin 
MinLSUHS.LW 4,$*(1 &DW 1R,'  W\SLFDOO\ \LHOGLQJ  ȝO RI SODVPLG 6XFFHVVIXO
SODVPLGH[WUDFWLRQDQGJHQHLQVHUWLRQZHUHWKHQWHVWHGIRUE\GLJHVWLQJȝORIWKHSXULILHGSODVPLG
with complementary restriction endo-nucleases and visualising the results on an ethidium 
bromide agarose gel. Any plasmid that appeared to contain the desired insert was then mailed to 
Eurogentec for sanger sequencing. Only those plasmids that displayed the insert without mutation 
were used in the transformation of the expressing E. coli lines.2.18.3 Expression and purification 
of recombinant ISC proteins 
 
Cultures of successfully transformed BL21(DE3)pLysS E. coli were incubated at 37°C 
for 16 hours in a shaking incubator and used to inoculate 2 litres of sterile LB media, 
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which was incubated and shaken until an OD600 of 0.5 was achieved at which point IPTG 
was added to a final concentration of 0.5 mM. The cultures were then left to incubate for 
4 hours before centrifuging at 3,000 x g for 30 minutes. The supernatant was then 
discarded, and the pellet washed twice in PBS. The pellet was then weighed before 
resuspending in Novagen BugBuster reagent at 5ml/g of pellet DQGȝOPORI%HQ]RQDVH
was added to the mixture to inhibit proteolysis. The mixture was left to shake at a low 
setting for 20 minutes at room temperature and subsequently centrifuged at 16,000 x g 
for 20 minutes at 4°C. 
The supernatant was then added to an equilibrated NiCl affinity column and the flow-
through and elution fractions collected. 
Aliquots of the fractions were then mixed 3:1 with 4x SDS-PAGE loading buffer and 
boiled at 95°C for 10 minutes to denature the enzymes and any remaining DNA. The 
mixture was then passed through a 20-gauge needle to ensure any remaining cells were 
completely shredded before being loaded on a suitable SDS-PAGE gel. The identity of 
potential bands was corroborated by subsequent poly-his antibody detection based 
western blot. Once fractions containing the protein of interest were identified, the 
remaining volume of the correct fractions were combined and added to large scale SDS-
PAGE gels. The bands corresponding to the proteins of interest were then excised from 
the gels and used to inoculate Rabbits (for IscS) or Rats (for IscU or Frataxin) which 
subsequently produced polyclonal antibodies to the target proteins. 
 
2.18.4 Target verification 
 
Antibody target verification was performed via a two-step process: 
1. Western blot of recombinant expressed target peptide and a negative control 
2. Mass spec identification of the labelled peptide, via analysis of the appropriately 
sectioned acrylamide gel slice 
Additional confirmation was performed using lysates from purified oocysts to test for the 




2.18.5 Localisation in in-vitro cultures 
 
The main methodologies followed are as written in Chapter 2.9. The dilutions used for 
antibody staining of the cultures was originally inferred from the optimum Western blot 
dilutions, but later optimised based on the results of the IFA (Table 2-3). Anti-rat (CpIscU 
and CpFrataxin) and anti-rabbit (anti-IscS) secondaries, conjugated to TRITC (Excitation 
557, Emission 576), were used in the IFA to visualise the locations of protein-antibody 
binding. 
Table 2-4: Antibody dilutions. Optimum dilutions for the use of custom antibodies for C. parvum ISC 
detection, as inferred through a trial and error process. 
 
Optimum dilution of antibody 
Antibody 
Target Western blot IFA 
CpIscS 1 in 300 1 in 100 
CpFrataxin 1 in 1000 1 in 200 
CpIscU 1 in 200 1 in 50 
 
2.19 IscS Complementation in yeast 
 
To demonstrate CpIscS was truly a functional homologue NFS1, it was necessary to 
utilise a transgenic method, recovering Nfs1p function with the C. parvum protein. I 
elected to use plasmid transformation of an NFS1 knockout strain. Plasmid 
transformation would provide a quick, efficient and easy method of introducing 
recombinant CpIscS to the yeast, using tools already at hand from the production of the 
recombinant proteins for antibody generation. 
 
2.19.1 pBEVY-L recombinant protein construct cloning 
 
pBEVY-L (Figure 2-3) was selected as the most suitable vector for CpIscS due to the 
following key aspects: 
x +LJKFRS\QXPEHULQ'+ĮE. coli 
x Ampicillin resistance marker 
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x LEU2 selection 
x Compatible restriction sites for target gene insertion that did not conflict with the 
sequence of CpIscS 
x simple expression profile (constitutive) 
These traits would provide for a simple but effective process to confidently assess the 
complementation of CpIscS in yeast. 
The CpIscS construct was assembled in a manner similar to that noted in Chapter 2.18.1, 
with appropriate use of restriction endo-nucleases as listed in Table 2-1. In place of C. 
parvum genomic DNA, the CpIscS pET14b plasmid was used as the template in PCR. 
Similarly, successful PCR/transformants were tested for using a complementary 
restriction endo-nuclease digest and visualising the results on an agarose gel. 
 
Figure 2-3: Site map for pBEVY-L. Obtained from addgene in 2017, restriction sites utilised in these 
experiments have been underlined in red (SmaI and SacI). Selection of this plasmid was based on 
optimum insertion site restriction sequences, absent from the target recombinant sequence and a 




2.19.2 Transformation of IscS heterozygous knockouts 
 
Transformation of the IscS heterozygous knockout strains of yeast were performed via 
the following protocol: 
A frozen aliquot of the yeast HetDip NFS1 Knock Out Strain, YCL017C 
(CloneId:23424), was removed from a -80°C freezer and scraped, under flamed sterile 
conditions (as are all further steps), with a sterile pipette tip which was then used to 
inoculate a pre-warmed (to 30°C) YPD agar plate containing the G418 selective 
antibiotic. Once inoculated, the plate was placed agar side up in a 30°C incubator and left 
for 30 hours. A sterile pipette tip was then usHGWRSLFNDSSUR[LPDWHO\ȝORIFHOOVIURP
a single colony on the plate and added to 1 ml of sterile, de-ionised water in a 1.5 ml 
eppendorf. The tube was then spun at 17,000 x g for 20 seconds and the supernatant 
carefully removed then replaced with 1 ml of 0.1 M LiAc. The tube was spun again at 
17,000 x g for a further 20 seconds and the supernatant again carefully discarded. The 




4. ȝORI&S,VF6S%(9<-L plasmid 
5. ȝORIZDWHU 
The tube, now containing all the above in addition to the yeast cells, was vortexed for 1 
minute before placing into a 30°C incubator for 25 minutes. During this team a heat block 
was warmed to 42°C. The tube was then placed in the 42°C, pre-warmed heat block for 
another 25 minutes. The tube was then removed from the heat block and spun at 800 x g 
for 2 minutes and once more the supernatant was carefully discarded. The cells within the 
tube were then re-VXVSHQGHGLQȝORIVWHULOe, de-LRQLVHGZDWHU$OLTXRWVRIȝODQG
then the remaining mixture were used to inoculate pre-warmed G418/LEU- minimal 




2.19.3 Sporulation of transformants 
 
Successful colonies from the G418/LEU- selective plates were picked and grown for 8 
hours in 5% Glucose YPD. They were then spun down at 17,000 x g for 20 seconds, the 
supernatant discarded, washed with water and finally re-suspended in a glass test-tube at 
an OD600 of approximately 0.25 in 1 ml of 1%KAc, at 25°C for 4 days, shaking. Aliquots 
were taken from the culture and analysed for signs of sporulation. If less than 60% of the 
culture was sporolated at this point, the mixture was incubated for a further 24 hours. 
6SKHUREODVWLQJRI WKHVSRUHVZDVSHUIRUPHGE\ WDNLQJȝORIVSRURODWHGFXOWXUHDQG
DGGLQJ  ȝO RI VWHULOH GH-LRQLVHG ZDWHU DQG  ȝO RI  XQLWVPO O\WLFDVH DQG
incubating at room temperature for 30 minutes. The mixture was then observed under the 
microscope to confirm the formation of spheroblasts. If spheroblasting was insufficient, 
the mixture was left to incubate for a further 30 minutes. 
&RPSOHWHGLVUXSWLRQRI WKHVSKHUREODVWHGDVFLLZDVDFKLHYHGE\WKHDGGLWLRQRIȝO
sterile mineral oil and vortexing for two minutes. The mixture was then spun down at 
17,000 x g for 20 seconds. 
The hydrophobic spores, now liberated from the ascii, would remain in the mineral oil 
OD\HURQWKHVXUIDFHRIWKHPL[WXUHȝORIWKHWRSPLQHUDORLOOD\HUZDV removed by 
careful pipetting and diluted 1 in 20 YPD. Serial dilutions of this mixture were then added 
WR<3'SODWHVLQȝODOLTXRWVDQGLQFXEDWHGDW&XSVLGHGRZQIRUKRXUV 
2.19.4 Identification of functional complementation 
 
20 randomly selected colonies from the sporolated YPD plate were analysed for mating 
W\SHYLD3&5XVLQJSULPHUVVSHFLILFWRHLWKHUPDWLQJW\SHĮRUDTable 2-5). 
Table 2-5: Yeast mating type primers. Oligonucleotide sequences of specific primers for the detection 
of yeast mating types via PCR, used in the complementation experiment to detect alpha, A or 
heterozygous mating types.  







The successful sporulation of Saccharomyces cerevisiae would result in haploid cells, 
LGHQWLILHGE\DVLQJOHPDWLQJW\SHDRUĮFigure 2-4). Haploid cells would contain either 
native NFS1 or the G418 resistance gene selective marker, in addition to the plasmid. 
 
Figure 2-4: The mating cycle of the yeast Saccharomyces cerevisiae. Under normal conditions, the 
yeast replicates asexually, via budding and the creation of a daughter cell (Budding). Under stressful 
conditions, such as insufficient environmental nutrients, the yeast replicates sexually via the 
production of haploid spores through meiosis (Sporolation). The use of KAc as a growth media, 







Chapter 3 Developing a robust and easy to use 
Cryptosporidium parvum culturing system 
 
3.1 An introduction to C. parvum culture 
 
C. parvum culture is an inherently complicated matter. During the natural life cycle of the 
parasite, C. parvum has both intra-cellular and extra-cellular life cycle stages, invading a 
multitude of host cells during this time (Leitch and He, 2012). Though different species 
of Cryptosporidium can infect a variety of regions along the digestive tract, C. parvum 
typically infects epithelial tissues of the upper intestinal region, typically the ileum 
(Current Wl Fau - Reese and Reese, 1986). 
Typical pathophysiology of a C. parvum infection includes localised deterioration of 
microvilli, leading to dehydration and a variety of nutrient based deficiencies as the gut 
lining loses its capacity to absorb passing foodstuffs (Leitch and He, 2012).  In 
immunocompromised individuals, C. parvum can also be found in most other epithelial 
tissues, including most of the upper stages of the digestive and respiratory tracts as well 
as other unrelated organ systems such as the liver and heart (Flanigan and Graham, 1990, 
DuPont et al., 1995, Sponseller et al., 2014). In each case, C. parvum undergoes the same 
complex life cycle, consisting of multiple intracellular and extracellular stages, many of 
which share morphological similarities with other apicomplexans (Morrison, 2009). As 
such, developing a means of studying these life cycle stages in detail would provide an 
insight not just into C. parvum or Cryptosporidium genus but possibly the gregarines or 
even Apicomplexa. The new understandings that could arise from this work range from 
determining the contributions of host versus parasite during the invasion processes, to 
mapping the chronological generation of various organelles in each life cycle stage. 
Though animal models of C. parvum infection are well established, they contain a large 
number of disadvantages with regards to studying the parasite (Striepen, 2013). In-vivo 
studies are inherently impractical for any live cell experimentation and whilst there are 
times the inclusion of a whole organism can help understand the pathology of a parasite, 
a more limited model can provide a better resolution of cause and effect. As is often the 
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case in molecular pathology, a simpler, in-vitro monoculture can be used to equal effect, 
often opening up avenues of research previously unexplored (Striepen, 2013).  
Unfortunately, whilst many attempts have been made and partial success witnessed over 
the last 30 years, a sufficiently effective long term in-vitro culture of C. parvum still does 
not exist (Striepen, 2013). Human Colo-rectal carcinoma (HCT-8) and Madin Darby 
Caninine Kidney (MDCK) cells have both shown promise during the previous decades 
of C. parvum experiments, yet often fall short either due to rapid culture senescence or an 
inability to properly cultivate the range of endogenous phases of C. parvum noted in the 
medical literature (Upton et al., 1994, Hijjawi et al., 2001, Girouard et al., 2006, 
Arrowood, 2002). However, with the advent of increasing advanced mono-culture 
systems, advances have been made whilst maintaining the use of HCT-8 and MDCK cells 
(Alcantara Warren et al., 2008, Karanis and Aldeyarbi, 2011, Muller and Hemphill, 2013, 
Morada et al., 2016).  A recent publication tackled the challenge of cell culture-based 
oocyst production using a hollow fiber technology that mimics the dynamic oxygen 
gradient of a blood vessel system within the gut (Morada et al., 2016).  However, 
specialised equipment is needed, and the required cell culture media supplements are 
expensive.  In addition, the complex nature of the system precludes the studying of the C. 
parvum life cycle or cell biology in real time, relying instead on destructive sample 
acquisition for static time point observations. 
As a direct result of this lack in suitable culture systems, C. parvum research is also 
lacking an effective genetic manipulation tool. CRISPR (Clustered Regularly Interspaced 
Short Palindromic Repeats) is a technique that has rapidly gained popularity across the 
various fields of biology as both an effective and easy to use system. Whilst some 
headway has been made showing the viability of C. parvum as a target of CRISPR 
mediated genetic exploration; the current HCT-8 and MDCK models are incapable of 
sustaining the transgenic results (Vinayak et al., 2015). This has left the field relying on 
in-vivo models, again, which are highly inappropriate solutions due to cost, laboriousness 






It is clear from the advances made, that whilst HCT-8 and MDCK cells provide useful 
platforms for C. parvum study, they nevertheless continue to fall short of providing a 
comprehensive model of infection. It is of significant importance that new methodologies 
and systems for culturing this parasite are found, especially those that allow live 
observation of the infection and parasite biology (Striepen, 2013). Therefore, I decided to 
approach the issue by attempting to develop a C. parvum culture from a different cell 
culture than those already studied, continuing in the footsteps of previous attempts whilst 
applying modern techniques and knowledge of the parasite. To achieve this would 
involve a preliminary screening of semi-randomly selected tissue cultures, with the only 
selection based on the shared usage of a single media type. This would allow for both a 
simpler execution of a large-scale experiment, as well as minimising the possibility of 
disassociating media-based effects with the host cells. 
I also intend to validate these results using a multitude of established and novel 
methodologies, not only to ensure the best reliability but also to develop and present new 
methods of exploring and validating future culturing techniques. 
 
3.3 Results  
 
3.3.1 Screening for new host-cell cultures 
 
A panel of seven human cancer cell lines were tested for their capacity to support C. 
parvum propagation including COLO-680N (oesophageal squamous-cell carcinoma), 
DLD-1 (colon adenocarcinoma), KYSE-30 (oesophageal squamous-cell carcinoma), 
HCT-15 (colorectal adenocarcinoma), SJSA-1 (osteosarcoma), MKN-1 (gastric 
carcinoma), and the colon adenoma carcinoma cell line HCT-8, which has most 
commonly been used for the investigation of C. parvum in cell culture.  The cell lines 
were infected with the C. parvum strain Moredun using an input of 50,000 of excysted 
oocysts per ml, as described in 2.3. After an incubation period of two weeks, COLO-
680N cultures were the only ones that had produced a noteworthy number of C. parvum 
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oocysts, with an approximate increase of 75-fold over the number of input oocysts (Figure 
3-1a). Additionally, while the HCT-8 cultures had succumbed to senescence after 14 days 
of infection, COLO-680N cultures remained viable and produced oocysts for almost eight 
weeks in total without sub-culturing, requiring only weekly media replacement (Figure 
3-1b). As a result, total C. parvum oocyst production in the COLO-680N cell line 
exceeded the HCT-8-mediated oocyst production (2.5 x 105 oocysts/ mL) by 20 times (5 
x 106) after ten days of incubation (Figure 3-1c). At day 60, COLO-680N cells had 
produced a total of 1.2 x 107 oocysts/ ml. 
 
Figure 3-1: C. parvum culture screen results. (a) Oocysts recovered from culture after an initial 
inoculum of 1x105 and a 2-week incubation period. Initial tests showed a clear disparity between a 
single cell type, COLO-680N, and the other cultures. COLO-680N appeared to demonstrate a much 
higher capacity for producing C. parvum oocysts than the previous gold-standard HCT-8 (b) culture 
lifespans of infected COLO-680N and HCT-8, when compared, showed that COLO-680N was 
capable of maintain a viable and productive culture for a longer period than HCT-8. Although 
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uninfected cultures showed similar disparities and therefore this result should be interpreted as an 
innate advantage of COLO-1LQGHSHQGHQWIURPHLWKHUFHOOW\SH¶VVSHFLILFUHVSRQVHWRLQIHFWLRQ(c) 
oocyst production of HCT-8 and COLO680N cultures over the course of a culture lifespan. 
 
 
3.3.2 Verification  
 
3.3.2.1 by PCR 
 
C. parvum infection of COLO-680N cells was further confirmed using PCR to detect C. 
parvum DNA. The primers were designed around C. parvum specific sequences and 
optimised by testing on DNA obtained from purified commercial oocysts (Figure 3-2). C. 
parvum-specific primers did not produce bands in non-infected COLO-680N cells. 
Examination of culture media taken during a standard 12-day infection revealed 
successful detection by day six by the HSP70 primers and day nine by the 18sRNA 
primers Figure 3-3. The amplified DNA regions were sequenced to confirm their identity. 
 
Figure 3-2: Optimisation of C. parvum detection via PCR. Custom primers, designed for specificity 
towards C. parvum gene segments (with the exemption of Hs18S which was used as a positive control 
to test for host DNA), were used in PCR performed on C. parvum DNA purified from whole oocyst 
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fractions and on COLO-680N DNA from 25cm2 flasks to select for the greatest sensitivity and 
specificity to C. parvum DNA and not host DNA. Primers HSP70F4/R4 and Cr18s2F/JR2 were 
selected for further experiments. 
 
Figure 3-3: Detection of C. parvum in culture via PCR. Successful detection of C. parvum DNA after 
a period of six days was achieved by the HSP70 primers. Although slight, successful detection of C. 
parvum was also achieved by 18sRNA primers at nine days post-infection.  
 
3.3.2.2 by Indirect Fluorescence Antibody assay 
 
The identity of the COLO-680N-produced C. parvum oocysts was further confirmed 
using different specific staining methods. Crypt-a-glo (WaterborneTM); an antibody that 
recognises the oocyst cell wall), Vicia Villosa lectin (VVL, Vector labs; binds to specific 
O-glycan mucin repeats on C. parvum sporozoites), a mucin-like glycoprotein that 
contains a C-type lectin domain (CpClec; binds to surface of the apical region and to 
dense granules of sporozoites and merozoites) and direct sporozoite staining using 
propidium iodide and SporoGlo (WaterborneTM) resulted in near identical staining 
patterns in C. parvum-infected COLO-680N cells indicating the presence of oocysts and 




Figure 3-4: Infection detection via Indirect Immunofluorescence Assay (IFA). COLO-680N infections 
as visualised by a variety of commercially available IFA techniques including: (a-f) a FITC 
conjugated anti-oocyst wall protein COWP-1 antibody, Crypt-a-glo, (g-l) a FITC conjugated anti-
apicomplexan sporozoite antibody, SporoGlo, and (m and n) TRITC conjugated lectin VVL. Scale 
bars: c and f: ȝPLDQGOȝPPDQGQȝP Each method produced corroborating imagery 
of cultures containing roughly spherical bodies, approximating 5-ȝP LQ GLDPHWHU PDWFKLQJ WKH
description of a typical C. parvum oocyst. The oocysts were also visible via conventional light 
microscopy, but typically were considerably hard to spot without guidance from the IFA. 
To confirm the production of fresh oocysts and eliminate the possibility of recounting the 
initial infection (though steps were taken to prevent this, as described in Chapter 2, section 
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2.3), Crypt-a-glo stained oocysts were excysted and used for the infection of COLO-680N 
cultures.  Then, cell cultures were washed to remove remaining Crypt-a-glo stained 
oocysts.  Upon harvesting neither the infected cultures nor the newly produced oocysts 
displayed Crypt-a-glo staining (Figure 3-5b i and iv). Imaging of stained oocysts that had 
been kept in a cell-free media suspension, did, however, display fluorescence confirming 
its viability as an experimental parameter (Figure 3-5a).  However, oocysts were detected 
using DAPI and the corresponding phase contrast imaging, supporting the conclusion that 
only the new oocysts were being detected (Figure 3-5b ii, iii, v, vi). Subsequent 
experimentation with Iowa II and Weru strains also produced similar, successful 




Figure 3-5: Confirmation of novel C. parvum production, via DAPI nuclear staining. (a) C. parvum 
oocyst stained with Crypt-a-glo retained its fluorescence after ten days in RPMI-1640, providing 
evidence that any original oocysts from the infection could be detected by fluorescence. (b i and iv) 
IFA of the ten-day cultures could not detect any green fluorescence, indicating that none of the 
original oocsysts from the infection remained in culture, being successfully removed during the post-
infection wash step. (ii and V), nuclear DNA staining by DAPI revealed multiple circular structures 
that suggested the presence of C. parvum oocysts. (iii and vi) Phase contrast imaging of the same areas 
produced corroborating imagery of oocyst like structures that aligned with the structures from ii and 
v, strongly suggesting that there was a successful infection and the oocysts observed where not simply 
the remnants of the original infection. $OOVFDOHEDUVUHSUHVHQWȝP 
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Conventional Crypt-a-glo and SporoGlo IFA studies also showed a clearly intracellular 
population of C. parvum. Moreover, it can be clearly seen that the larger stages of the 
parasite (most likely zygotes/developing oocysts) exert significant pressure on host 
nuclei, appearing to impact into the typically ovoid host nuclei. I consider this to be a 
sufficient body of evidence that C. parvum is an intracellular and not epicellular parasite. 
 
3.3.2.3 by Scanning Electron Microscopy 
 
Final verification of the presence of oocysts within the culture was performed via 
Scanning Electron Microscopy (SEM) as described in 2.13. The resulting images detailed 
WKH SUHVHQFH RI URXJKO\ VSKHULFDO ERGLHV DSSUR[LPDWHO\  ȝP LQ GLDPHWHU Figure 3-6. 
Combined with the IFA and PCR results, this data is conclusive evidence that COLO-
680N can maintain a C. parvum infection and furthermore, at a rate that exceeds previous 
cultures such as HCT-8 and MDCK.  
 
Figure 3-6 Scanning Electron Microscopy of purified oocysts recovered from a COLO-680N culture. 
7KHVSKHULFDOERGLHVDSSUR[LPDWHO\ȝPLQGLDPHWHUPDWFKWKHSURILOHRIDW\SLFDOC. parvum oocyst 




3.3.3 Infectivity of COLO680N derived C. parvum oocysts 
 
Early exploration of the possible benefits of a COLO-680N culture focussed on the 
infectivity of C. parvum oocysts produced by the culture. Oocysts derived from the 
supernatants of COLO-680N cell cultures, but not from the supernatants of HCT-8 cell 
cultures, were able to initiate infection of novel cell cultures.  Infection of COLO-680N 
cells with cattle-derived C. parvum oocysts resulted in similar amounts of infectious 
oocysts in 25 independent experiments. In addition, three rounds of infection using 
COLO-680N culture-derived oocysts were performed with no noticeable changes in 
oocyst production efficacy showing that COLO-680N cells are suited for the continuous 
long-term cultivation of C. parvum oocysts. These preliminary findings show that a 
COLO-680N platform for C. parvum propagation already provides many advantages over 
the previous platforms. This warranted further exploration, to establish the abilities and 
limits of this novel C. parvum culture and potential monoculture model of infection. 
 
3.3.4 Cryopreservation of C. parvum-infected COLO-680N cultures 
 
Among the other limitations of C. parvum culture that COLO-680N may address, is the 
nature of long term storage. Currently, cryopreservation of any Cryptosporidium results 
in parasite death and is therefore not a suitable method of storage.  However, preservation 
of infected cell cultures was hypothesised to provide a solution to this. During the early 
experiments, the extended nature of COLO-680N parasite cultures suggested that the cell 
line may be suitably hardy to be used in this manner. Two-week-old C. parvum Moredun 
strain-infected COLO-680N cells were cryopreserved, as per 2.5, stored for two weeks at 
-80°C, and resuscitated.  Three days after resuscitation, the presence of new C. parvum 
stages was detected Figure 3-7.  This demonstrates that C. parvum-infected COLO-680N 





Figure 3-7: Detection of oocysts within COLO-680N cultures after resuscitation from 
cryoconservation. An upward trend in oocysts recovered from the culture, confirmed via IFA, 
suggests that oocysts survived the initial freezing process and can undergo the typical life cycle, 
producing oocysts, after resuscitation via typical mammalian cell cryoconservation methodology. 
  
3.3.5 Comparing HCT-8 and COLO-680N cultures 
 
3.3.5.1 Long term culture viability 
 
To continue detailing the properties of C. parvum infected COLO-680N, the viability of 
infected and non-infected cultures was compared by electrical impedance monitoring 
using an xCELLigence system.  Initial results were promising, with no evidence of 
significant culture death during infection in COLO-680N. However, longer studies 
revealed an unexpected effect wherein C. parvum infection appeared to increase the life-
span of COLO-680N cultures.  While the number of viable cells in non-infected COLO-
680N cultures dropped after two weeks, C. parvum-infected cultures remained viable 
during the whole observation period of 50 days (Figure 3-8a, data only shown for first 10 
days).  HCT-8 cell cultures infected with 50 oocysts displayed a continuous proliferation 
rate of host cells until day five, after which cell cultures displayed data consistent with no 
change in cell numbers (Figure 3-8b). To test if the different growth patterns observed 
were of statistical significance I applied a one-way ANOVA analysis to the data. The 
results revealed infections of 500-1,000 oocysts (a multiplicity of infection of 0.01-0.05 
at inoculation) resulted in significantly different data compared to the other infection 
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doses. Infected HCT-8 cultures did not display any noticeable differences.  Following 
these results, I decided to examine the comparisons between the novel COLO-680N and 
established HCT-8 cultures further. 
 
Figure 3-8: Infected culture growth patterns. Graphical representations of culture viability as 
detected by the xCELLigence cell viability detection system. The xCELLigence experiment 
monitored the changes in cell growth rates, utilising electroconductivity as an indirect measure of 
total cells in population. COLO680N cultures (a) displayed some degree of reactivity to infection, 
with certain ratios of parasite to host cell appearing to increase host longevity. HCT-8 cells (b) 
displayed no significant interaction, both the negative and infected samples confirmed the long 
observed notion that HCT-8 has a markedly short life-span in culture and undergoes rapid 
senescence at the end of a 7-8 culture cycle. 
 
3.3.5.2 Mass Spectrometry fingerprinting of cultures 
 
By comparing the changes of the proteomes of each culture, I theorised it may be possible 
to determine if signatures of successful infections could be detected, granting insight into 
the array of potential similarities or differences between COLO-680N and HCT-8 
cultures during an infection. To achieve this, a MALDI-TOF mass spectrometry-based 
fingerprinting approach was used on infected and uninfected cultures (Figure 3-9b-f). PCA 
analysis of the resulting data produced separate groupings of the COLO-680N but not the 
HCT-8 sample conditions, suggesting either a greater amount of C. parvum proteins or a 
more profound change in the proteome of COLO-680N compared to HCT-8 (Figure 3-9a).  
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The principle component 1 value of over 95% indicates that the separations/groupings 
shown on the 2-dimensional graphs are an accurate representation of how 






Figure 3-9: : MALDI-TOFF Protein fingerprinting of C. parvum infections. (a) PCA analysis of the raw data showed substantial separation between COLO-680N 
control and infected cultures. However, little to no separation could be established between HCT-8 cultures, suggesting a greater shift in protein content in the 
COLO-680N scenario, likely due to an increase in parasite. Manual analysis of the graphical data produced (b-e) identified 4 protein peaks in the infected culture 
(e) which differed from the relative pattern displayed in the uninfected control (d). Closer examination (f) revealed these peaks to approximate proteins of 12kDa, 
12.4kDa and 15kDa. The y-axis was adjusted to display the patterns in their most comparable state, y-axis units (intensity, were arbitrary and not directly 
comparable, instead the relative sizes of the peaks are used to gauge differences between samples. 
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3.3.6 Comparing culture produced oocysts with commercial product 
 
3.3.6.1 COLO-680N culture viability 
 
COLO-680N cultures that were infected with either Cattle-produced oocysts or Lab 
produced (COLO-680N) oocysts showed similar growth patterns (Figure 3-10), a strong 
correlation co-efficient and insignificant ANOVA result from the numerical data strongly 
indicate that there was no statistically significant variation. 
 
Figure 3-10: COLO-680N growth patterns. COLO-680N cultures were infected with either standard, 
commercially available oocysts (purple) or oocysts purified from COLO-680N cultures (orange). 
ANOVA and correlation statistical tests were used to determine the results reliability/significance. 
Uninfected cultures were used as the negative control. No differences in cell growth patterns could 
be determined from comparing the two populations infected with the different oocysts, confirming 
that the effect on growth rate was independat of extraneous factors such as potential 





3.3.6.2 Mass Spectrometry fingerprinting of oocyst lipidomics 
 
COLO-680N and cattle-produced C. parvum oocysts were compared via a lipidomics 
approach.  The lipidomics characterisation was performed using MALDI-TOF mass 
spectrometry for the analysis of lipids within the range of 600 to 2,000 Daltons (Figure 
3-11 a-d). Principal Component Analysis at a 95% confidence level showed a pattern 
consistent with samples having a large degree of similarity between one another. The 
algorithm did not separate the sample groups, although some subtle differences seemed 
to be detectable. This can be seen in the 2D graphical representation of the results, with 
high X and Y axis scores (PC1 and PC2) indicating that the majority of the 
differences/similarities observed by the data analysis can be accurately represented in a 2 
dimensional format for interpretation (Figure 3-11e and f). 
 
Figure 3-11: Lipidomic fingerprinting of the lipid contents of lab produced and commercially sourced 
oocysts. The spectra produced by both the positive (a-b) and negative (c-d) sampling sets appeared 
to be similar. PCA (e and f) analysis revealed that some differences could be detected between the 
Commercial and lab grown populations of oocyst. Y-axis units are arbitrary and not useful in direct 
comparison, instead graphs are compared via relative peak heights. However, the analysis was 
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unable to resolve the two sets completely, suggesting that whilst differences existed, they were not 
substantial enough to rule out the use of lab oocysts as an alternative to commercially sourced oocyst. 
 
3.3.7 Life cycle stage identification 
 
After establishing the initial validity of the parasite culture as a method of producing 
oocysts, it was important to explore the progression of the characteristic life cycle of C. 
parvum within COLO-680N. 
The current understanding of the major stages of the Cryptosporidium life cycle, 
including sporozoite, trophozoite, meront, macrogamont, microgamont, zygote, 
immature oocyst, and matured oocyst have been defined based on the investigation of 
infected tissue from patient biopsies and animal dissections. However, mono-culture 
models of infection, such as HCT-8, have repeatedly fallen short of displaying full life 
cycle progression. 
 
3.3.7.1 Identification of life cycle stages via Electron Microscopy 
 
Examination of infected COLO-680N cells via conventional Transition Electron 
Microscopy (TEM) successfully identified the entire life cycle of the parasite could be 
demonstrated within a single COLO-680N culture (Figure 3-12a-h). Among those 
observed, the most frequently occurring were the larger extracellular stages, including 
type II merozoites and sporozoites (Figure 3-12 a and c). In each case a mitosome, nucleus, 
crystalloid body and typically the rhoptry could be observed. This is in keeping with 
previous findings in the in-vivo models of infection, whereas previous in-vitro models 
commonly failed to demonstrate comprehensive examples of typical life-cycle stages. 
Interestingly, again in keeping with previous findings, mitosomes could only regularly be 
observed in the extracellular stages, with exceptions occurring in very young intra-
cellular stages (Figure 3-12b). This suggests that the mitosome is maintained throughout 
host-cell invasion and is instead lost during the maturation of the intracellular stage. This 
adds a point on the life cycle timeline that was previously vaguer. 
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Additionally, due to the high-resolution nature of EM, detailed parasite organelle and 
previously unreported structures were observed within the infected cells that do not 
constitute normal host-cell morphology. Among those features present was the feeder 
organelle that connects the host cell to the parasitophorous vacuole. Feeder organelles 
have been postulated to be involved in facilitating nutrient transport to the parasite; 
however, their exact roles during infection are largely not understood.  The C. parvum 
mitosome and the crystalloid body were also identified. Notably, these cryptic organelles 
were described in life-stages other than the sporozoites which had not been previously, 
including trophozoites, merozoites and microgamonts.  Previously, both organelles had 
only been detected in C. parvum oocysts or the excysted sporozoites.  In addition, we 
observed the presence of dense arrangements of the host cytoskeleton around the 
periphery of the parasitophorous vacuole of C. parvum, suggesting a parasite-induced 
intracellular/epicellular rearrangement of host cells as supported by previous work. These 
observations also lend significant weight to the argument that C. parvum is indeed and 
intracellular and not epicellular parasite. A further and more novel observation was the 
peculiar arrangement of host cell cytoskeleton and host-mitochondrion. Whilst networks 
of host cytoskeleton interacting with the parasite is not un-described, this is the first time 
that evidence has been presented that this interaction includes the host mitochondria and 






Figure 3-12: EM images of a C. parvum infection. the main stages of C. parvum during an infection. Starting from top left and going row by row the stages 
are: Sporozoite (a), trophozoite (b), meront, macrogamont (c), microgamont (d), zygote (e), immature oocyst (f) and matured oocyst (g and h). During these 




 Figure 3-13:  EM images of C. parvum structures of interest. (a) Clearly visible is the feeder organelle of an 
intracellular stage of C. parvum, most likely a meront. An enhanced image of the region (ai) reveals interesting 
topology of the organelle, suggesting that it may derive from the host machinery as invagination is clearly shown 
to occur on the parasite (arrows). (b) A merozoite, the same as imaged in Figure 3-12, reveals a number of 
interesting organelles including the nucleus (n), crystalloid body (cb), C. parvum¶VVLQJOHUKRSWU\UDQGWKH
apical complex (ac). Also visible is the remnant mitochondrion that C. parvum possess, the mitosome (bi). The 
individual layers of the characteristic double membrane are clearly visible in the close-up (arrows). 
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3.3.7.2 Atomic force microscopy of isolated oocysts 
 
AFM was employed to investigate the nature of the oocysts in a high magnification 
topological approach.  AFM has been previously used to elucidate unique surface details 
at a level of resolution not visible using any other imaging modalities in other parasites 
(e.g. Giardia and of Trypanosoma spp.). Two distinct types of oocysts were observed in 
the force-distance curve-based imaging from C. parvum-infected COLO-680N cultures. 
Most oocysts imaged were of a larger type that was indistinguishable from the images 
obtained from the cattle-produced oocysts (Figure 3-14). The identity of these oocysts was 
GHWHUPLQHGWREHWKHµWKLFN-ZDOOHG¶YDULHW\RZLQJWRWKHQDWXUHRI WKLQZDOOHGRRF\VWV
rarely passing into the environment and therefore unlikely to be present in the commercial 
sample. However, a smaller type was also observed that most likely represents thin-
walled oocysts and may contribute to the continuous C. parvum infection pattern that we 
observed in cell culture, since thin-walled oocysts are thought to be responsible for 
infection dissemination within organisms and tissues. 
 
Figure 3-14: Atomic force microscopy (AFM) imaging of purified oocysts from COLO-680N cultures 
revealed two distinct populations. Population (a) is believed to be representative of the thin walled 
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variant of an oocyst, indicated by its slumped posture and comparatively less rigid structure when 
compared to oocysts from population (b), which are believed to be thick walled oocysts. Current 
understanding of C. parvum life cycle biology places the thick-walled oocyst (b) as essential for 
completing the life cycle and passing from the host into the environment whereas thin walled oocysts 
(a) are believed to be responsible for maintaining C. parvum autoinfection in healthy individuals 
where the asexual life cycle does not continue indefinitely (unlike in immunocompromised patients) 
 
Similar observations of commercially supplied oocysts failed to produce evidence of thin-
walled oocyst populations but did show comparable thick-walled oocysts, similar to those 
purified from the COLO-680N cultures Figure 3-15. No observations could be made that 
markedly distinguished commercial and COLO-680N produced oocysts except for the 
WHQGHQF\IRUFRPPHUFLDORRF\VWVWRµFOXPS¶WRJHWher. However, this could be explained 
due to the expected hydrophobic nature of the lipid rich oocyst wall, which could be 
lessened in the COLO-680N oocyst sample due to the remaining cellular detritus after the 
simple purification method employed. 
 
Figure 3-15: AFM captured images of commercial (a) and COLO-680N produced (b) oocysts. Whilst 
both commercial and COLO-680N produced oocysts displayed similar structures, typical of those 
described in the literature, commercially supplied oocysts showed a greatly enhanced likelihood of 
grouping together. This resulted in all AFM image captures of commercial oocysts capturing at least 





3.3.8 Observation of host, HUMAN-FASN activity during infection 
 
Western blots of infected and control group cultures revealed an interesting difference in 
the response of COLO-680N cultures when infected, compared to the previous gold-
standard HCT-8 and non-C. parvum permissible DLD-1 (Figure 3-16). Although COLO-
680N has been shown to maintain higher than expected levels of fatty acids/lipids in 
previous literature, these results show that FASN activity is wholly insufficient in 
determining potentially effective host cell cultures for C. parvum, as DLD-1 clearly 
expresses a much higher level of FASN compared to either COLO-680N or HCT-8 and 
yet cannot be observed to maintain C. parvum cultures to any degree. However, unique 
to COLO-680N was a marked increase in FASN activity once infected, unlike HCT-8 or 
DLD-1. Perhaps as interestingly, HCT-8 FASN expression levels decreased in response 
to infection, highlighting further the potential importance of FASN responsiveness to 




Figure 3-16: Anti-FASN western blot of various cancer cell lines and their subsequent response to C. 
parvum infection. Each sample was obtained from identically aged, 5 days post-infection, 2D, 75cm2, 
30ml cultures and adjusted via dilution with ddH2O to obtain identical cell numbers. DLD-1 
displayed the highest natural expression of FASN, whereas only COLO-680N and HCT-8 levels 




Here I have presented a novel cell culture that enables the sustainable, continuous 
propagation of infectious C. parvum oocysts and the systematic investigation of the 
Cryptosporidium life cycle. Previously attempts to cultivate Cryptosporidium in cell 
culture were affected by a lack of oocyst production or required sophisticated, expensive 
equipment and methodologies to support 3D cultures that are not commonly available to 
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research laboratories (Striepen, 2013, Hijjawi, 2010, Yin et al., 2010, Karanis and 
Aldeyarbi, 2011, Muller and Hemphill, 2013, Morada et al., 2016). The COLO-680N 
platform does not share these flaws. The COLO-680N platform enables C. parvum 
propagation, the sustainable production of C. parvum oocysts, and the investigation of 
the C. parvum biology at a laboratory scale in standard, easy to use 2D tissue cultures 
with commonly available equipment and know-how. 
In addition, this data demonstrates a long-term maintenance of the cell-line and 
subsequently a prolonged production of oocysts as well, in addition to a first of its kind 
ability to cryoconserve the parasite for greater long term storage or transportation, 
systems both urgently needed by the field (Striepen, 2013, Checkley et al., 2014). 
All C. parvum life cycle stages could be detected in infected COLO-680N cells, 
PRUHRYHU WKH SUHVHQFH RI DGGLWLRQDO SUHYLRXVO\ XQUHFRJQLVHG DQG µDEVHQW¶ VWUXFWXUHV
indicate that the systematic analysis of C. parvum replication in COLO-680N cells will 
provide novel insights resulting in a substantially improved understanding of C. parvum 
biology.  COLO-680N-produced oocysts were indistinguishable from cattle-produced 
oocysts by staining with antibodies that specifically bind to the C. parvum oocyst cell 
wall and though some variation could be seen utilising lipidomics, and atomic force 
microscopy techniques, it was often to the same degree as the variation seen within the 
groups. Thus, I present for the first time, a new collection of tools (lipidomics and AFM) 
for investigating the cell biology and the composition of Cryptosporidium, which can be 
incorporated in further studies to provide a better understanding of the infection and life-
cycle of the parasite.  
It remains unclear why COLO-680N cells, in contrast to other cell lines that have been 
investigated so far, support C. parvum propagation.  Nevertheless, the whole cell 
MALDI-ToF fingerprinting studies suggested that C. parvum infection of COLO-680N 
cells results in a substantial change in the features of the cultures, while C. parvum 
infection of HCT-8 cells, a model commonly used for the studying of C. parvum, does 
not.  This may indicate a specific susceptibility of COLO-680N cells towards C. parvum 
infection.  There also exists a mounting body of evidence that suggests a link between 
squamous cell carcinomas and cryptosporidiosis which, given the nature of these results, 
I believe warrants closer examination (Shebl et al., 2012, Benamrouz et al., 2012b, 
Benamrouz et al., 2012a).  In addition, the presence of two different populations of 
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oocysts (suggestive of the presence of thin oocysts) was detected in COLO-680N cultures 
by Crypt-a-glo/ DAPI double staining and atomic force microscopy. The presence of thin-
walled oocysts may also contribute to the successful C. parvum propagation, since thin-
walled oocysts are thought to be responsible for the maintenance and dissemination of 
infection within tissues and organisms it stands to reason that they would perform a 
FUXFLDOUROHLQPDLQWDLQLQJWKHµDXWRLQIHFWLRQ¶F\FOHZLWKLQDQXQ-interfered with in-vitro 
culture (Current Wl Fau - Reese and Reese, 1986, Current et al., 1986, Mitschler et al., 
1994, Hijjawi et al., 2001). 
Additionally, previous studies of COLO-680N had suggested that the expression of high-
levels of fatty acid synthase (FASN) might promote cell viability, and could also be 
beneficial to the parasite, since it is unable to synthesize fatty acids de novo (Orita et al., 
2010, Abrahamsen et al., 2004). Rather, C. parvum has been shown to maintain a peculiar 
Fatty Acid Synthase, dubbed CpFAS-1, whilst no de-novo synthesis activity could be not 
observed, it was found that CpFAS-1 can act as an elongase, limited to expanding fatty 
acids at least 16 carbons long (Zhu et al., 2000). This is a potentially crucial insight into 
WKHSDUDVLWH¶VPHWDEROLFUHOLDQFHRQWKHKRst cell as a significant portion of the oocyst wall 
C. parvum maintains in comprised of long chain fatty acids. Preliminary experiments 
exploring the potential links between this host fatty-acid dependence and COLO-1¶V
FASN activity displayed interesting results. Whereas high levels, such as those found in 
DLD-1, proved insignificant in determining permissibility, COLO-680N displayed a 
FASN expression level response to infection with the parasite. With the emerging, 
published, evidence that C. parvum RNA is exported into the host cell, the question is 
raised as to whether a) host FASN expression is a potential target of this RNA secretion 
and b) if COLO-680N is more susceptible, somehow, to the C. parvum RNA, which could 
explain the results I observed (Wang et al., 2017). This could represent a revolutionary 
step forward in not only predicting potentially suitable in-vitro cell cultures but in 
understanding host-and even specific host-cell specificity and warrants further 
examination by future investigations. 
In conclusion, the discovery of COLO-680N as a cell culture platform to produce C. 
parvum will provide a step-change regarding research on Cryptosporidium:  1) It is the 
first easy-to-handle system that enables the long-term sustainable production of infectious 
oocysts at a laboratory scale and removes the constant dependence on immunosuppressed 
animals for production of Cryptosporidium oocysts along with all its ethical implications.  
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2) C. parvum-infected cell cultures can be frozen and stored. Prior to the establishment 
of the COLO-680N cultivation system for C. parvum, oocysts had to be freshly acquired 
from animals and could not be stored over longer periods.  3) This study paves the way 
for establishment of compound-screening platforms for the identification of anti-C. 
parvum drugs and the systematic elucidation of C. parvum biology, including the 
utilisation of a CRISPR transfection system (Vinayak et al., 2015).  
The establishment of a robust culturing system also allows a more in-depth examination 
of the host-parasite relationship than previously possible as well as a life-cycle wide 
examination of parasite metabolic processes. As such it is the purpose of Chapter 4 to 
investigate the broader metabolic nature of the host-parasite interaction and Chapter 5 
will investigate the potential role of the mitosome in iron-sulphur cluster biosynthesis, a 





Chapter 4 Host-pathogen interaction of a Cryptosporidium 
infection in a metabolic context 
 
4.1 An introduction to metabolomics in parasitology 
 
Among the collection of experiments now made available by the existence of long term 
culturing is the concept of metabolomics. As a parasite, C. parvum interacts directly with 
host tissue and therefore it is likely to have an array of complex relationships with the 
host metabolic processes. Previous studies utilised a Gas Chromatography Mass 
Spectrometry (GC-MS) approach to explore this concept, though only two papers have 
been published on the subject one on mouse and the other on human faecal samples, both 
showing a clear relation between infection and a change in metabolite levels (Ng Hublin 
et al., 2012, Ng Hublin et al., 2013). Whilst working on different sample sources, each 
identified hexadecanoic acid as a significant contributor to the change in the metabolome 
during infection. Hexadecanoic, RU µPalmitic¶, acid is a common fatty acid, found 
throughout the tree of life; its appearance is not surprising when considering that C. 
parvum appears to rely heavily on the host for fatty acid synthesis. Among the other 
shared observations was the large change in relative abundance of various amino acids 
and components of their pathways. However, while most of these metabolites appeared 
to decrease in infected mice faeces, an increase was seen in humans. This is not unusual, 
previous explorations of other metabolomes have highlighted a tendency for otherwise 
similar organisms to have almost contradictory changes in their metabolomes occur under 
the same environmental pressures (such as a change in diet or infection) (Lindon and 
Nicholson, 2008, Bezabeh et al., 2009, Jansson et al., 2009, Le Gall et al., 2011). Their 
closing marks included the call for further studies and the development of new methods 
of study to broaden the knowledgebase of metabolomics to shed light on its often-
paradoxical qualities. 
In response to the growing need for an alternative method of exploring metabolomes, the 
scientific community has begun exploring the usage of 1H Nuclear Magnetic Resonance 
(NMR) (Sengupta et al., 2016, Jacobs et al., 2008, Saric et al., 2008, Bezabeh et al., 2009, 
Hong et al., 2010). 1H NMR based metabolomics has been shown to be a powerful 
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alternative to GC-MS for metabolic screening. The methodology is simpler and with 
fewer steps between sample recovery and analysis, resulting in reduced loss of sample 
during preparation. This translates to a more reliable result in terms of quantification and 
reproducibility, although GC-MS still provides a higher level of resolution and NMR 
should not be considered a wholesale replacement of the technique.  
Initially established in 2002 as a tool for toxicology, 1H NMR has seen a significant 
uptake in the last five years, becoming an established technique in a variety of disciplines 
including immunology, drug design and increasingly within the medical field as an early 
warning diagnostic. However, adoption of 1H NMR based metabolomics within the field 
of parasitology is still in its infancy, with less than 20 published papers, mostly 
concerning malaria (Sengupta et al., 2016, Teng et al., 2009, Wu et al., 2010, Balog et al., 
2011, Li et al., 2011, Sengupta et al., 2011, Ghosh et al., 2012, Lamour et al., 2012, 
Sonawat and Sharma, 2012, Sengupta et al., 2013, Teng et al., 2014, Cheng et al., 2015, 
Arjmand et al., 2016). Although still early in its adoption, the results produced by these 
experiments have shown great promise in exploring host-parasite interactions and as such 
warrant further exploration. 
As a potential model species for the evolutionary move from gregarines to other 
Apicomplexa, the development of a 1H NMR protocol for the exploration of C. parvum 
infections could provide the necessary tools to bring 1H NMR to the rest of the phylum 





I decided to take a novel approach to exploring the metabolome of a C. parvum infection. 
Whilst I will examine the metabolic shift within mouse models of the infection, I will also 
examine for the first time the effects an infection has on the metabolome of a cell culture, 
an unprecedented observation in both the Apicomplexa and parasitology. One potential 
drawback of the methods used so far, especially in the previous GC-MS studies of 
cryptosporidiosis, is centred on the use of faecal samples as a sample source. Whilst a 
change in faecal metabolites is an important indicator of altered processes within the host, 
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it is impossible to comment on the cause of an observed change in a PHWDEROLWH¶V 
abundance. An increased amount of a metabolite within a faecal sample could equally be 
the result of decreased absorption or increased production of the metabolite. By exploring 
the effects on the metabolome of the in-vitro culture I have developed, we can 
comfortably eliminate the effects of a decreased absorption by removing external 
contributors to the metabolome and, by comparing to the observations from the mouse 





4.3.1 Mice faecal sample extractions 
 
Mouse models of infection, infected with C. parvum strains Weru or Iowa II, were 
monitored for several days for successful infection before culling and intra-intestinal 
faecal extraction as detailed in 2.16.1 before processing the samples for metabolite 
extraction and 1H NMR analysis as detailed in 2.16.3. 
Casual observations of the spectra produced by the 1H NMR already revealed clear 
distinctions between the infected and uninfected mice, as well as between the different 
strains of infections (Figure 4-1a). Several metabolites were readily distinguishable, 
including the peaks of metabolites indicating mitochondrial ADP-ATP synthesis; creatine 
and creatine phosphate (Figure 4-1b), taurine (Figure 4-1c) and lactate (Figure 4-1d) 
(Wallimann et al., 2011, Hansen and Grunnet, 2013, Schaffer et al., 2014). 
These preliminary indicators of mitochondrial activity suggested that whatever effects the 





Figure 4-1: NMR spectra of infected mice intestinal samples. a) Stacked Spectra produced from 
infected mice samples after processing via the Chenomx software package, representing the average 
spectra obtained from each infection condition (from triplicate), including the negative control and 
Weru and Iowa II infections. Amongst other noticeable differences were the changes in peak 
intensities and shapes, displayed overlaid are the peaks for creatine and creatine phosphate (b), 
taurine (c) and Lactate (d). In each case higher peaks can be observed for the Iowa II infections, 
indicating more abundant amounts of these metabolites were present in Iowa II infected cultures. 
Further experimentation would be required to determine definitively if this was a result of over 
production or under-utilisation. 
 
To explore the spectra in detail, the data from the mice guts (n=9) was processed through 
the Chenomx NMR Suite, version 8.2. The result was a list of 151 compounds that were 
detected within the spectra (Table 4-1). 
Statistical analysis of the data, with freely available Microsoft Excel Add-LQ³PXOWL-base 
´E\3DUWLDO/HDVW6TXDUHV'LVFULPLQDQW$QDO\VLV3/6-DA) determined significant 
separation of the three conditions, (Uninfected control, C. parvum Iowa II and C. parvum 
Weru infections), whilst maintaining group cohesion (Figure 4-2a). The loading values of 
the variable compound contributions (Figure 4-2b), suggest certain metabolites were more 
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considerable to the separation of the groups than others. To further illustrate the impact 
each sample had on the separation, the data from the PLS-DA loading values was 
extracted and used to create a heat map of the metabolites shown in Table 4-1. The presence 
of L-alanine and valine, two common amino acids, as large impact contributors agree 
with the previous literature and 2-oxoisocaproate is a component of the 
valine/leucine/isoleucine biosynthetic pathways (Ng Hublin et al., 2013, Ng Hublin et al., 
2012). Whilst this data alone provides an intriguing insight into the effects on the host 







Table 4-1: A heatmap of compounds detected via chenomx. Their relative contributions towards the differences observed between the mice experimental groups as 
calcualted by a Partial Least Squares Analysis. Negative values (tending towards red) indicate the samples showed a greater degree of variation within sample groups 
and are therefore indicators of compounds that naturally vary in their levels, without external stimuli. Positive values (tending towards green) indicate the samples 





Figure 4-2: a) 2D graphical representation of a PLSDA Partial Least Squares Discriminant Analysis 
of the Chenomx data. Successful separation of the three experimental groups can be observed by the 
lack of overlap observed between different experimental groups. The lack of overlap between Iowa 
II (blue) and Weru (purple) groups suggest that the different strains assert consistently different 
effects on the metabolome. b) The loading plot, used in formulation of the PLS-DA. Those samples 
furthest to the extreme edges of the axis represent the samples contributing most notably to the 
differences observed, including Lactate and Alanine. 
 
8SRQH[SRUWLQJWKHUHVXOWVWR0HWDER$QDO\VWDQRQOLQH³FRPSUHKHQVLYHWRROVXLWHIRU
metabolomic data DQDO\VLV´ VHYHUDO PHWDEROLF SDWKZD\V EHFDPH LPPHGLDWHO\
highlighted as being heavily involved in the changes observed during infection (Xia et 
al., 2015). As indicated in the preliminary observations, several amino acid biosynthesis 
pathways were among the first noted, including glycine, valine and taurine pathways. The 
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metabolic pathways discovered through MetaboAnalyst were presented graphically 
(Figure 4-3a) and those pathways of greatest note determined as those furthest from the 
x, y axis intercept, representing both the overall completeness of the pathways and 
number of contributing detected metabolites detected within the data. To better 
understand to what extent these pathways were involved, the MetaboAnalyst suite can 
also render the individual pathways, highlighting the metabolites seen within the data in 
red as shown in Figure 4-3 b-d and Figure 4-4a-c. Converting the KEGG compound codes 
within the pathways reveals the metabolites that contributed towards the predictions made 
by MetaboAnalyst (Table 4-2), this allows a more critical observation of the validity of 
the predicted pathways. When comparing the compounds listed in Table 4-2 to the heat 
map in Table 4-1, it becomes clear that every compound contributed positively to the 
characterisation/differentiation of one or more conditions, even if other conditions 
showed variable levels. From this observation it can be stated that the pathways predicted 




Figure 4-3: a) A graph representing the pathways detected by MetaboAnalyst 3.0 from the Chenomx 
data. The x-axis represents the relative completeness of a pathway based on the metabolite detected. 
The y-axis represents the relative size of the entire pathway and the size of the points represents the 
combined significance of both data points. Full maps of the pathways were rendered and metabolites 
present in the data highlighted in red for the following: (b) glucoronate interconversions, (c) Valine, 







Figure 4-4: Full maps of the pathways were rendered and metabolites present in the data highlighted in red for the following: (a) glycine serine and threonine 
metabolism, (b) Galactose metabolism and (c) starch and sucrose metabolism. 
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Table 4-2: KEGG ID key. Extracting the KEGG ID tags from the produced pathway maps gives the 
following compounds, arranged by order of appearance throughout Figure 4-3 and Figure 4-4. 
KEGG 
ID Compound Name 

































One pathway of note from Figure 4-3 is that of Taurine/Hypotaurine synthesis (d). Existing 
medical reports from C. parvum infections have noted increased levels of taurine within the 
stool samples of patients. This would appear to agree with the observations from the 
experiments. Exploring the original spectra (Figure 4-1) also reveals that the difference 
observed is a relative increase in Taurine abundance. 
However, as highlighted previously, whilst this data is useful in determining markers of 
infection, alone it cannot be used to imply with certainty the exact relationships between the 
infection and affected pathways. Taking taurine as an example, the current theory is that a 
decreased absorbance of host intestinal tissue, via destruction of villi surfaces by C. parvum 
infection, results in a relative increase in taurine passing out of the host. However, this 
assumption is fundamentally flawed. Taurine is an important amino-acid that is involved in a 
wide variety of biological processes, among which many are directly involved in osmo-
regulation. Given that observations of damaged villi surfaces within the gut of patients is an 
established pathology of C. parvum and following that this damage is assumed to be the cause 
behind the watery diarrhoea that characterises cryptosporidiosis, it would be a reasonable 
assumption that osmo-regulation within the host gut would be heavily up-regulated. 
Therefore, without further evidence to support either theory it would seem premature to 
assume heightened taurine levels are a result of unabsorbed taurine and not possibly the result 
of up-regulated taurine biosynthesis. Thus, the experiments were repeated on cell culture 
models of infections as well. 
 
4.3.2 Cell culture sample extractions 
 
COLO-680N models of C. parvum infection were maintained for 10 days before 
extracting metabolites as described in 2.15.2 and 2.15.3.  The NMR spectra demonstrated 
clear differences between each strain and species of Cryptosporidium used (Figure 4-5). 
As with the mice samples, differences between creatine, creatine phosphate, taurine and 
lactate (Figures 6b-d) were readily visible in the raw spectra. As before, numerical data 
of the compound concentrations, as calculated by the Chenomx software, was exported 
into an excel graph and listing 161 total compounds of varying concentrations across 
samples when eliminating samples with no observable changes. The PLS-DA generated 
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by the same statistical analysis as before, produced ample separation of the different 
experimental conditions, (Figure 4-6a). Furthermore, the separation of the individual 
infection groups suggests that differences between both Cryptosporidium species and 
within individual strains of C. parvum, may illicit different metabolic responses in cell 
cultures, as supported by the previous in-vivo data from 4.2. The loading scores plot of 
the PLS-DA showed many amino acids contributed heavily to the separations, as well 
lactate, several fatty acid derivatives and taurine (Figure 4-6b). This data was also used to 




Figure 4-5: NMR spectra of infected cultures. Stacked Spectra produced from infected cell cultures 
after processing via the Chenomx software package, representing the average spectra obtained from 
each infection condition, including the negative control, C. hominis C. parvum Weru and Iowa II 
strain infections. Amongst other noticeable differences were the changes in peak intensities and 










Table 4-3: The first half of a heatmap of compounds detected via chenomx. Their relative contributions towards the differences observed between the 
infected cultures samples as calcualted by a Partial Least Squares Analysis. Negative values (tending towards red) indicate the samples showed a greater 









Figure 4-6: PLS-DA statistical analysis of the information provided by the Chenomx screening. 
Produced clear groupings, separating the controls (green), C. parvum Iowa infections (blue), C. 
parvum Weru infections (purple) and C. hominis infections (red). As the grouping areas do no 
overlap the separation between the infection conditions again indicates that metabolome differences 
can be at least in part explained by different Cryptosporidium strains/species. b. The loading biplot of 
the PLS-DA analysis shows lactate as a significant contributor to variation, as seen before in figure 
2b, in addition to taurine and myo-inositol among others. 
Metabolic pathway fitting via MetaboAnalyst 3.0 revealed that amino-acid biosynthesis 
pathways for glycine, alanine and arginine were influenced by infection. These were in 
addition to taurine, pantothenate and CoA biosynthetic pathways as shown in Figure 4-7a. 
As with Figures 5a-g, the graph shows a combination of how much of a pathway is 
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completed by data from the NMR, as well as simply how many metabolites were detected. 
Among other pathways, perhaps the most significant detections were glycine (Figure 
4-7b), taurine (Figure 4-7c) alanine (Figure 4-7d) and arginine (Figure 4-7g) amino acid 
pathways as well as, potentially the synthesis and degradation of ketones (Figure 4-7e) 
and pantothenate and CoA biosynthesis (Figure 4-7f). Performing the same decoding as 





Figure 4-7: Metabolic pathways detected from NMR data of infected cells. (a) Data analysed by 
MetaboAnalyst 3.0, utilising all compounds which displayed some degree of change because of 
infection, produced a graph of pathways most heavily impacted (x axis) and pathways containing the 
most amount of the given compounds (pathway impact: y-axis), with statistical significance of the 
predicted pathways increasing as the colour ranges from yellow (low) to red (high). Six pathways 
were chosen to be of interest by their position on the graph, with metabolites present in the 
experimental samples highlighted in red, including: (b) glycine, serine and threonine metabolism, (c) 
taurine and hypotaurine metabolism, (d) Alanine, aspartate and glutamate metabolism. The 






   
Figure 4-8: The remaining 3 major metabolic trees as derived from the MetaboAnalyst data, showing (a) synthesis and degradation of ketones, (b) 
pantothenate and CoA biosynthesis and (c) arginine and proline metabolism. 
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Table 4-5: KEGG ID key. Extracting the KEGG ID tags from the produced pathway maps gives the 
following compounds, arranged by order of appearance throughout Figure 4-7 and Figure 4-8. 
KEGG 





























As was the case previously, the metabolites featured in   
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Table 4-5 represent defining characteristics of at least one experimental condition, indicated 
by their green filling in the heat map. Interestingly, several of the metabolites appear to be 
substantially red for C. hominis infections, suggesting that changes seen in these metabolite 
levels (for example glutamate) should not be considered reliable indicators of a C. hominis 
infection. Alanine, Ethanol and O-Phosphocholine also appear to represent variable changes 
within the host metabolome during C. hominis infection. On the other hand, changes in 
fructose, lactate and xylitol levels appear to be uniquely regular in C. hominis infections 
compared to C. parvum. 
 
4.4.3 Comparison of mice faecal and COLO-680N metabolome changes 
 
MetaboAnalyst data from and 4.2 and 4.3, demonstrates that many altered pathways are 
shared between the mice and tissue culture metabolites, particularly taurine and amino 
acid metabolic pathways. To properly explore to what extent the two experiments may 
corroborate each other, compounds and their relative effects on the PLS-DA data were 
compared. Tabulation of only those compounds which showed positive loading values 
(reliable contribution towards separation of sample groups) generated a more succinct list 
of potential compounds of interest.   
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Table 4-6 displays the resulting compounds from C. parvum Iowa II infections, a total of 
18 different compounds were revealed to share similar PLS-DA contributions across both 




Table 4-6: Comparing the data for C. parvum Iowa II infections from 4.2 and 4.3. Eliminating 
metabolites that do not show reliable contribution towards sample differences, results in a collection 
of 18 compounds. Further exploration of the compounds and their related biochemical properties 
revealed a large proportion of the compounds (13 of 18) to be involved with mitochondrial activity 
(red text), such as ATP synthesis or control of Reactive Oxygen Species (ROS). 
Shared changes in C. parvum Iowa II infections 
  Mouse Cells Pathways Function 
1,3-Dihydroxyacetone     Glycolysis Energy supply 
3-Hydroxy-3-
methylglutarate 
    Ketogenesis Energy supply 
Anserine     Carnosine synthesis ROS scavenging 
Asparagine     Numerous Numerous 
Aspartate     AA Synthesis   
Fucose     
N-linked 
glycosylation 
Cell surface signalling 
Glycine     Purine synthesis Numerous 
Glycylproline     Collagen synthesis Connective tissue 
Isoleucine     Ketogenesis Energy supply 
N-Acetylaspartate     Numerous Numerous 
N-Acetylornithine     Waste   
N6-Acetyllysine     Epigenetics Gene regulation 





Syringate     Krebs cycle Energy supply 
Taurine     Numerous ROS, Osmoregulation 
UDP-N-Acetylglucosamine     Sugar synthesis 
Cytoskeleton and 
nuclear pore formation 








Among the individual compounds listed, several have already been noted in the literature 
as being characteristic of C. parvum infections; including taurine, aspartate and myo-
inositol. These compounds have roles in osmo-regulation, protein biosynthesis and 
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cytoskeleton assembly among others. However, almost every metabolite shares one target 
in common: the mitochondrion. As highlighted in   
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Table 4-6 by the red text, mitochondrial pathways appear frequently in the list of pathways 
each metabolite is involved in. 
Analysis of the metabolite level changes in C. parvum Weru strain infections resulted in 
a similar observation (Table 4-7). Among the compounds, those that have already been 
noted in the literature included pyroglutamate and valine. 
 
Table 4-7: Comparing the data for C. parvum Weru infections from 4.2 and 4.3. Eliminating 
metabolites that do not show reliable contribution towards sample differences, results in a collection 
of 10 compounds. Exploration of the compounds and their related biochemical properties revealed a 
large proportion of the compounds (8 of 10) to be involved with mitochondrial activity (red text), 
such as ATP synthesis or control of Reactive Oxygen Species (ROS). 
Shared changes in C. parvum Weru infections 
  Mouse Cells Pathways Function 





Acetone     Ketosis Energy supply 
Citrate     TCA Energy supply 




Formate     Folate cycle 
Metabolic regulation 
and methylation 
Levulinate     Unknown 
Potentially Ketosis 
based energy supply 



















The potential implications are numerous are not necessarily radical, as an increase in 
mitochondrial activity would not be beyond expectation in the context of infection. 
However, current theories regarding the interactions between C. parvum and the host cell 
are limited to lipid scavenging and possible membrane hijacking, unlikely to illicit such 
a comprehensive mitochondrial response as seen in this data. A potential solution to this 
disparity could also explain the many morphological individualities of C. parvum. 
Considering that C. parvum, according to in-silico predictions, is only capable of 
producing ATP exclusively via a glycolytic pathway and lacks many other mitochondrial 
processes such as fatty acid synthesis, it may be possible that C. parvum is directly 
interacting with the host mitochondria/l processes in some manner. If this hypothesis 
could be proven correct, it would provide significant insight into how C. parvum managed 
to effectively remove so many apparently essential biochemical components whilst 
maintaining significant similarities to the other apicomplexans (such as the loss of 
porphyrin synthesis with the apicoplast). 
 
4.3.4 The role of host mitochondria during C. parvum infection 
 
To investigate the potential role of host mitochondria during infection, I employed an 
Indirect Fluorescence Assay (IFA) approach to determine if the mitochondria of the host 
cells were responding to Cryptosporidium infection. Our results demonstrate that on 
multiple occasions, the host mitochondria were shown to congregate in large densities 
near the Cryptosporidium infection (Figure 4-9). With confocal microscopy, a 3D 
imitation of the infection can be rendered from z stacks and displays an even more 
intricate association between host mitochondria and parasite (Figure 4-10). Transmission 
(OHFWURQ0LFURVFRS\LPDJHVRILQIHFWHGFHOOVDOVRVKRZDEQRUPDOKRVW¶VPLWRFKRQGULDO
congregation around the parasitophorous vacuole, with evidence of cytoskeletal 
involvement (Figure 4-11a). A cartoon based upon the electron microscopy image was 
constructed to better illustrate how the observed morphology might be seen via IFA 
(Figure 4-11b). 
With the combination of microscopy and metabolomic data, it can clearly be stated that 
an intricate relationship exists between the host mitochondria and Cryptosporidium 
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parvum, possibly guided via host cytoskeletal structures, although the exact mechanism 
and biochemical drivers are unknown. 
 
Figure 4-9: High resolution confocal scans, utilising the Zeiss Airyscan acquisition method, of 
infected COLO-680N monolayers. Scans revealed numerous examples of heavily infected host cells 
(largest nuclei, DAPI, blue) that displayed substantial mitochondrial networks (Mitotracker 
CMXRos, red) associated with the parasite (SporoGlo, green). A, b and d were all visualised through 
the median portion of the host cell, while c was acquired from the surface of the cell, indicated by the 
lack of a contiguous host nucleus. In each, it can be observed that mitochondrial arrangement within 
the host cell is highly associated with parasite presence. It can also be observed that the parasite is 
exerting a significant amount of physical force on the host nuclei, evidenced by the deformed nature 




Figure 4-10: A 3D section of the same area as Figure 4-9D0LWRFKRQGULDUHGFDQEHVHHQWRµFOLPE¶
DURXQGWKHSDUDVLWHJUHHQ7KHFORVHDVVRFLDWLRQDQGµQHWWLQJ¶HIIHFWVHHQLQWKHVHLPDJHVVWURQJO\
indicates that the host mitochondria are drawn to the parasite after infection, allowing the established 
parasitophorous vacuole to become surrounded. The impacting effect of the parasite on the host 




Figure 4-11: a. Infection of a host cell by C. parvum. Mitochondria of the host cell appear to closely 
associate with the parasitophorous vacuole surrounding the parasite, while cytoskeletal structures 
appear to be associated with the organelles. b. Cartoon of image a. demonstrating the presence of 




Solution-state 1H NMR offers a novel approach to metabolomics that is especially useful 
where sample volume sizes are particularly small. Although GC-MS holds an advantage 
for detecting low-levels of metabolites with unique mass signatures, to determining the 
change in metabolite quantities, NMR provides a viable alternative. Initial analysis of our 
data showed a clear distinction between the metabolic fingerprints of infected and 
uninfected samples, even between infections of different strains of the parasite (Figure 
4-2).  
Of importance is the degree to which these results, both from the in-vitro and in-vivo, 
agree with the previous literature. Our study also demonstrates that metabolic compounds 
L-alanine, isoleucine and succinate were detected as contributors to the variance between 
the sample conditions that indicated infection. Moreover, even though valine was not 
detected in the uninfected controls, it was visible in the infected samples and in agreement 
with previous reports.  
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The predictive fits of the metabolic pathways highlighted a remarkable selection of 
pathways including several involved in amino acid biosynthesis, sugar metabolism, CoA 
biosynthesis and taurine biosynthesis. Of the predicted metabolic pathways, which have 
been previously shown to be influenced by infection in C. parvum specifically as well as 
other apicomplexans, there are several whose presence should have been projected, such 
as the amino acid biosynthesis pathways for alanine and glycine as the previous reports 
had already highlighted their potential involvement (Ng Hublin et al., 2013, Ng Hublin et 
al., 2012, Sengupta et al., 2016). 
As a parasite, Cryptosporidium is dependent on host derived biosynthetic pathways for 
survival, for example, C. parvum is incapable of producing the majority of amino acids 
de-novo, instead relying heavily on the import of host metabolites via active channelling 
(Abrahamsen et al., 2004, Rider and Zhu, 2010). One potential target of parasitism, as 
determined by my findings, was the biosynthetic pathway for glycine, threonine and 
serine which was upregulated in both cell culture and animal experimentations. C. parvum 
and C. hominis are incapable of manufacturing these amino acids de novo, instead relying 
on scavenging host serine and glycine, utilising serine and glycine hydroxy 
methyltransferases to convert one to the other when needed (Doyle et al., 1998). The 
reliance on host amino acids could provide a novel method for combating the infection, 
based upon previous studies that identified other amino acid metabolic chains as potential 
targets (Doyle et al., 1998, Zhu et al., 2010, Fritzler and Zhu, 2012, Sparks et al., 2015). 
For example, glycine reuptake inhibitors (GRIs) that are often used in treating 
schizophrenia, could be utilised to partially starve the parasite of the metabolite and offer 
an intriguing future direction of research that could incorporate statistical analysis of C. 
parvum occurrence in correlation with specific drug usage.  
In addition to the amino acid biosynthesis pathways, it is also apparent that taurine 
synthesis is implicated in the metabolic profile of the disease. Primary links between 
taurine and C. parvum infections come from excystation techniques where taurine has 
frequently been used in the past as an agent for inducing excystation for in-vitro cultures 
as sodium taurocholate (Upton et al., 1994, Gold et al., 2001, Feng et al., 2006). Previous 
metabolomic studies of faecal samples from Cryptosporidium-infected patients also 
revealed a possible link between increased taurine concentrations and C. parvum 
infections, explained at the time as the result of characteristic decline in gut absorption 
via villi malformation caused by the parasite (Ng Hublin et al., 2012, Ng Hublin et al., 
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2013). However, an even greater increase in taurine levels was observed in my 
experiments with the infected COLO-680N cell cultures, wherein malabsorption is not an 
applicable explanation as explained previously. Therefore, the malabsorption theory does 
appear to support these observations and a new hypothesis must be formed. 
To form this new hypothesis, I will draw upon the collection of observations made during 
these experiments.  In the host, taurine has several roles, those relevant to the cell types 
involved include: cell membrane integrity, osmoregulation and adipose tissue regulation. 
Combining this with the other pathways and relevant metabolites observed during the in-
vitro and in-vivo infections (Figure 4-3, Figure 4-4, Figure 4-7 and Figure 4-8) presents a 
new possibility for a metabolomics based theory of host-parasite interaction, one that 
centres heavily on the host mitochondrial processes.  
As may be expected in a theory wherein host-mitochondrial activity is affected, there is 
a substantial change in the abundance of adenosine derivatives (AMP, ADP and ATP); 
displaying increased abundance in C. parvum Iowa II infected models (cells and mice), 
with a similar increase in creatine levels in C. parvum Weru infections. This heavily 
implicates a role for the host mitochondria in the context of infection as each species and 
strain used lacks the creatine kinase needed to produce creatine phosphate therefore 
eliminating the parasite as a direct source of these compounds (Abrahamsen et al., 2004). 
Levels of pyruvate in C. hominis and pantothenate in C. parvum Iowa II infections 
highlight further a potential interaction with oxidative phosphorylation. Moreover, the 
further increase in lactate levels detected in C. hominis cell cultures and C. parvum Iowa 
II mouse infected samples, compared to the controls; indicate a strong contribution from 
anaerobic pathways most likely from the host (due to the relatively small biomass of the 
parasite and assumed corresponding contribution to metabolite levels). This suggests that 
more ATP is being produced than the oxidative capacity of the host mitochondria can 
maintain, producing a net increase in lactate as the oxygen debt increases. 
These data suggest that C. parvum and C. hominis infections may be directly or indirectly 
inducing an increase in host mitochondrial activity. If factual, this would result in many 
oxygen free radicals being produced by the metabolic machinery. Consequently, cell(s) 
would respond with a matching increase in the synthesis of antioxidants such as taurine 
(Zhang et al., 2004, Giris et al., 2008).  
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Further support for this hypothesis, that host mitochondrial activity is deliberately 
interfered with by invading C. parvum can be seen in the way host mitochondria appear 
to congregate around the infection (i.e. parasitophorous vacuole) (Figure 4-9, Figure 4-10 
and Figure 4-11).  
Nevertheless, taurine also plays another role within cells, for example as a diuretic (Lin 
et al., 2016). Taurine is involved in the maintenance of the ionised forms of magnesium 
and potassium within the cell, producing a diuretic effect that may contribute towards the 
characteristic water-loss of a patient with cryptosporidiosis. Furthermore, it has been 
found that taurine levels influence production of short chained fatty acid, another aspect 
of host biology theorised to be scavenged by C. parvum (Hansen and Grunnet, 2013, Yu 
et al., 2016). These observations and logical links place taurine at the centre of a 
metabolic web linking C. parvum parasitism, metabolism, host interactions and 
pathology.  
These observations suggest that the increase in taurine typically detected in 
FU\SWRVSRULGLRVLVSDWLHQWV¶VWRROLVPRUHWKDQVLPSO\WKHUHVXOWRIWKHJXW¶VGHFUHDVHLQ
absorptive qualities. It is likely that the intra-cellular role of taurine in this disease has 
been overlooked and that the pathophysiology of this disease is more complicated than 
currently understood, extending greatly beyond simple villi degradation. 
These results provide a promising method of determining infections via a possible 
comparative 1H NMR of patient and reference biopsies. This method offers an alternative 
approach in the medical field, where current methods of diagnosis are reliant on separate 
methods to achieve the same result as NMR, with infections detected by laborious and 
often inaccurate microscopy and strain typing dependant on successful PCR. 
Lastly, it cannot be overstated the impact of observing the close relationship between the 
host mitochondria and the parasite, biochemically and physically, which has never been 
seen before at this level of detail or reproducibility. The comprehensive alteration of 
mitochondrial associated metabolites in association with the infections indicates strongly 
that Cryptosporidium parvum and therefore possibly other members of the 
Cryptosporidia, has significant interactions with the host biochemical machinery beyond 
that previously expected. 
4-112 
 
In conclusion, I have demonstrated for the first time that the use of 1H NMR is 
indispensable in understanding host-pathogen interactions at a cellular level. With the 
application of a more user-friendly and reproducible approach of metabolomics, through 
the 1H NMR methodology described, it will be easier for the Cryptosporidium and 
apicomplexan community to further explore the remaining aspects of the disease 
PHWDERORPH LQ SDWLHQWV¶ samples. Future experiments would be best approached by 
increasing the number of strains analysed both in-vitro and in-vivo to test the relevant 
proposed hypotheses, as well as applying the techniques to entirely new species such as 
the gregarines or coccidians. Additionally, elucidating the more pathogenic influences of 
taurine biosynthesis in the pathobiology of cryptosporidiosis is critical. With these data, 






Chapter 5 Experimental evidence for a functional Iron Sulphur 
Cluster biosynthesis pathway in the mitosome of 
Cryptosporidium parvum 
 
5.1 An introduction to mitosomes and Iron Sulphur Clusters 
 
The typical eukaryote maintains a standard complement of organelles that are 
recognisable to most with basic knowledge of eukaryotic biology: a nucleus, golgi 
apparatus, endoplasmic reticulum and mitochondria. Until as recently as the late 1990s, 
LW ZDV SUHVXPHG WKDW DOPRVW DOO HXNDU\RWHV SRVVHVVHG WKH VWDQGDUG µFDQRQLFDO¶
mitochondrion. First described in the 19th century, the mitochondrion is a rod-shaped 
organelle, typically between one and five ȝPLQGLDPHWHUHQFDVHGLQDGRXEOHPHPEUDQH
and possessing characteristic cristae and matrix that provide a large surface area-to-
volume ratio for efficient biochemical processes. Chief among these processes is 
oxidative phosphorylation, the main source of ATP and thus energy for the eukaryotic 
cell.  
As mitochondria appear to be present throughout the eukaryotic tree of life, it has been 
postulated and widely accepted that during the development of the Last Eukaryotic 
Common Ancestor (LECA), an alpha-proteobacterium was engulfed, but not digested,  
instead being incorporated into the cell as a symbiotic intracellular organism, this is 
referred to as the Endosymbiotic event (Dunning Hotopp, 2011, Martin, 2017, Sagan, 
1967). Over time, through horizontal genetic transfer events to the host nucleus and 
further adaptations to their new environment, the original mitochondrial-like prokaryote 
became fully integrated into its host, becoming the mitochondria, we know today. 
Evidence of this can be observed in the double membrane of the mitochondrion (a relic 
of the original engulfment), the prokaryotic genes within the mitochondrion (with 
sequence similarity to the alpha-proteobacterium) and their independent nature of 
replication (separate from host mitosis) among other biochemical clues such as pathways 
with homologues in the alpha-proteobacteria (Sagan, 1967, Martin, 2017, Picard et al., 
2011, Kluge et al., 2013). 
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The dramatic increase in ATP availability, from the mitochondrion, within eukaryotic 
cells has been postulated to be essential to the development of the much more complex 
and eventually multi-cellular forms of eukaryotes, unseen in either of the other domains 
of life (Eubacteria or Archaea) (Huettenbrenner et al., 2003, Blackstone, 2013, Okie et 
al., 2016). This has, however, resulted in a strong dependence of the eukaryotic cell on 
the mitochondrion, with the volume of ATP produced and subsequently utilised 
preventing the loss of mitochondrial function from being anything but fatal. Further to 
WKLVXQWLOWKHODWH¶VLWZDVEHOLHYHGWKDWDQ\DPLWRFKRQGULate that was discovered 
could only be explained as the result of early evolutionary branching, occurring after 
LECA but before the endosymbiotic event (Tovar et al., 1999, Dyall and Johnson, 2000, 
Okie et al., 2016, Martin, 2017). 
However, in 1999, an amitochondriate was described that appeared to maintain several 
mitochondrial genes within its nucleus, dismissing the notion that it evolved from a 
lineage that diverged prior to the endosymbiotic event. This organism, the entero-parasite 
Entamoeba histolytica, was shown instead to possess a drastically reduced form of 
mitochondria (Tovar et al., 1999). Initial identification of the organelle was achieved 
solely from the localisation of Chaperonin CPN60, one of the putative mitochondrial 
proteins detected within the genome of E. histolytica. This organelle lacked may key 
IHDWXUHV RI µFDQRQLFDO¶ PLWRFKRQGULD LQFOXGLQJ JHQHWLF PDWHULDO FULVWDH DQG $73
generation. Localisation studies confirmed the mitochondrial nature of CPN60 and thus 
a new hypothesis was needed to explain the nature of this new organelle, now termed the 
µPLWRVRPH¶,WKDVtherefore been postulated that the mitosome is the result of reductive 
evolution from an ancestral organism with a canonical mitochondria, where function loss 
and ultra-structural changes have produced highly specialised forms of the mitochondrion 
(Dyall and Johnson, 2000, Regoes et al., 2005, Makiuchi and Nozaki, 2014). An exact 
development timeline of this and other mitochondrial related organelles (MROs) has yet 
to reach consensus (van der Giezen, 2009, Makiuchi and Nozaki, 2014, Hjort et al., 2010). 
0LWRVRPHVFDQYDU\ODUJHO\LQVL]HIURPQPWRȝPDUHRYDOVKDSHGDQGSRVVHVVLQJ
the characteristic double membrane of a mitochondrion (Tovar et al., 1999, Williams et 
al., 2002). Unlike the mitochondria, mitosomes do not possess any discernible cristae, 
membrane potential or, perhaps most notably, any form of ATP metabolism (Dyall and 
Johnson, 2000, Regoes et al., 2005, Makiuchi and Nozaki, 2014, van der Giezen, 2009, 
Tovar et al., 1999). Instead, mitosomes seem to have eschewed all but one major 
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biochemical pathway: that of Iron Sulphur Cluster biosynthesis via the ISC pathway (Ali 
and Nozaki, 2013, Makiuchi and Nozaki, 2014, van der Giezen, 2009). 
Iron Sulphur (Fe/S) Clusters are, as the name implies, compounds consisting of Iron and 
Sulphur atoms arranged in a variety of possible geometric and ionic states. Fe/S clusters 
are utilised by many metalloproteins and are produced via one of few different pathways, 
depending on the organism in question. Currently, three pathways are known to be utilised 
throughout the Prokaryotes and Eukaryotes; the Iron Sulphur Cluster (ISC), Nitrogen 
Fixation (NIF) and Sulphur Assimilation (SUF) systems. Unusually, each of these 
pathways has been described in at least a bacterium and a eukaryote, with ISC typically 
residing in the mitochondrion of eukaryotes though it can also be found in the cytoplasm, 
where Fe/S clusters are then taken up by components of the Cytosolic Iron-sulphur protein 
Assembly (CIA) machinery (Xu and Moller, 2011, Ali and Nozaki, 2013, Lill et al., 
2015). Perhaps most importantly, no organism has yet been described as lacking a form 
of Fe/S biosynthesis or usage, even among more atypical eukaryotes such as parasitic 
species (Figure 5-1) (Dellibovi-Ragheb et al., 2013). Indeed, the fact that mitosomes 
appear to have retained Fe/S cluster biosynthetic pathways and not the TCA cycle has led 
many to begin theorising, that perhaps the Fe/S pathways and not the increased production 
of ATP were the leading promoters of the endosymbiotic event (van der Giezen, 2009, 




Figure 5-1: Distribution of the Fe/S cluster biosynthetic pathways throughout eukaryotic parasites. 
Whilst most parasitic organisms have maintained the ISC and CIA pathways, E. histolytica appears 
to have replaced the ISC pathway with the more commonly bacterial SUF mechanism. P. falciparum 
(in addition to other apicomplexans) has also acquired the SUF pathway which is found within the 
apicoplast. However, C. parvum appears to have lost the SUF pathway along with its apicoplast. 
(Adapted from Dellibovi-Ragheb et al., 2013) 
 
The mitosome of Cryptosporidium parvum appears to be no different in this regard. Ultra-
structural analysis of C. parvum has shown the presence of a single, 300-500 nm long, 
double membrane bound, oval organelle, within the sporozoite of C. parvum which has 
been shown to typically associate with another cryptic organelle, the crystalloid body 
(Alcock et al., 2012, Keithly et al., 2005, Ctrnacta et al., 2006, Lemgruber and Lupetti, 
2012).  Like E. histolytica, C. parvum Cpn60 was found to target this organelle and no 
genetic material was present within (Riordan et al., 2003). The in-silico predictions have 
shown the absence of the citric acid cycle and the presence of potential ISC homologues, 
similar to the predicted contents of the rhizarian Mikrocytos mackini (Figure 5-2 and 




Figure 5-2 The hypothetical contents of C. parvum¶V PLWRVRPH. It appears to be the same as M. 
mackini, maintaining only the ISC machinery, basic import/export machinery and a cytosolic 
glycolytic pathway. (Adapted from Burki et al., 2013) 
 
Though the in-silico predictions regarding &SDUYXP¶V ISC pathway has been known for 
some time, it remains largely unexplored or verified. What little exploration there has 
been has focussed on phylogenetics and confirmation of putative mitochondrial targeting 
sequences in the sequences of CpIscS and CpIscU, with no actual proof of function or 




With the availability of a robust and easy to use cell culture, because of the efforts in 
Chapter 3, it is now possible to explore the hypothesis that C. parvum maintains an ISC 
pathway and that it is localised to within the mitosome. Secondly, it should be possible 
to use this to determine the location/nature of the mitosome in life cycle stages beyond 
the sporozoite, an unprecedented feat.  
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To achieve these goals, I propose to develop specific antibodies to several key 
components of the ISC pathway predicted to be within the genome of C. parvum; 
Frataxin, IscS and IscU (henceforth referred to CpFxn, CpIscS and CpIscU respectively). 
Doing so will add to the growing body of evidence behind the importance of Iron Sulphur 
clusters; in the evolution of the mitosome. Furthermore, the successful use of the new 




5.3.1 Identification of ISC homologues in C. parvum 
 
Potential ISC homologues were identified via a tblastn (protein to translated nucleotide) 
search of the C. parvum genomes listed in the NCBI. The search parameters were 
constructed using S. cerevisiae components of the ISC pathway; Nfs1p (IscS homologue), 
Isu1p (IscU homologue) and Yfh1p (Frataxin homologue). The closest matches to each 
within the genome of C. parvum, as determined via a blastn (protein sequence to 
translated nucleotide sequence) search, were chosen as the targets going forward (Table 
2-2, Figure 5-3). Both putative Isu1p and Nfs1p homologues showed encouraging 
conservation of sequence whereas the putative Yfh1p sequence showed little amino acid 
conservation. However, the putative Yfh1p sequence did maintain a conserved secondary 
structure as predicted by two separate secondary structure prediction programs (PSIPRED 
and JPRED4) to contain mitochondrial frataxin like domains (McGuffin et al., 2000, 




Figure 5-3: CLUSTALO alignments of S. cerevisiae and putative C. parvum ISC protein sequences. 
a. Nfs1p and IscS, Yfh1p and Frataxin, and finally Isu1p and IscU. Yfh1p and Frataxin similarities 
are more apparent in secondary structures than primary sequences. 
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The sequences were then parsed through a further search, using blastx (translated 
nucleotide to protein search) to identify and align the C. parvum sequences with similar 
proteins in other Apicomplexa (Figure 5-4 and Figure 5-5)(Altschul et al., 1990, States and 
Gish, 1994). Similar sequences for IscS and IscU were found throughout the 
Apicomplexa, but not frataxin, which was only present in a small selection, as had been 
previously demonstrated in past studies of apicomplexan Fe/S cluster pathways (Seeber 
et al., 2008). This remains true even when searching via predicted secondary structures 
using PredictProtein.com (Rost et al., 2004). Each gene was also processed through 
Mitoprot to determine the possibility of a mitochondrial targeting sequence, if any (Table 
5-1)(Claros and Vincens, 1996). Genes of interest were then produced via PCR for 
recombinant integration into plasmids. 
 
Table 5-1: Possibility of mitochondrial targeting sequence within the ISC peptides, as determined by 
Mitoprot. 
Putative ISC protein Accession number Probability of 
mitochondrial 
targeting 
C. parvum Iowa II frataxin like 
protein (CpFxn) 
XM_625594 81.1% 
C. parvum Iowa II IscU-like 
NifU protein (CpIscU) 
XM_627477 96.1% 





Figure 5-4: CLUSTALO alignment, via Seaview, of the putative C. parvum IscS protein and IscS 
proteins from other Apicomplexans, in descending order of similarity. The sequences were obtained 




Figure 5-5: CLUSTALO alignments, of IscU (a) and Frataxin (b) sequences identified via blastx 





5.3.2 Amplification and cloning ISC genes 
 
Amplified ISC genes were produced via the PCR protocols described in chapter 2.7, (i.e. 
the gene of interest, plus complimentary restriction sites) and confirmed via an agarose 
gel separation (Figure 5-6). Integration of the construct into the pET14b vector was 
confirmed via select digestion and agarose gel separation, yielding the correct fragment 
sizes. Aliquots of the pET14b constructs, purified from the agarose gel, were sent for 
sanger sequencing at Eurogentec facilities, were mutations could be detected, allowing 
the selection of only those plasmids containing genes identical to the NCBI record. This 
was done to prevent the potential corruption of epitopes that would be detrimental to the 
final specificity/sensitivity of the produced antibodies. The recombinant plasmids 
identified as having identical insert sequences to those on the NCBI database were 
transformed into the expression E. coli strain, BL21(DE3)pLysS, and identified by the 
acquired Ampicillin resistance. 
 
Figure 5-6: PCR product detection of target recombinant proteins. Black and white images of 
Ethidium bromide agarose gels, exposing DNA fragments via UV exposure. Initial attempts were 
successful in producing IscU and IscS sequences (a) whilst Frataxin proved more difficult, succeeding 
in a subsequent run (b). 
 




Optimum expression conditions for each recombinant were determined via multiple, 
tandem experiments utilising 50 ml cultures. Optimal conditions were defined as those 
that produced the most amount of protein within a six-hour period, detectable using an 
anti-poly-his tag antibody (Figure 5-7a). Optimal temperatures for all ISC recombinants 
was determined to be 37°C, CpFxn and CpIscU were best expressed utilising a final IPTG 
concentration of 0.5 mM and harvested at four hours post-induction. CpIscS, however, 
was most optimally expressed under 0.2mM IPTG induction and harvesting after six 
hours. NiCl affinity column-based purification of the large scale (2 L) cultures produced 
detectable and sufficient amounts of recombinant protein, as identified by western blot 
and comparable Coomassie brilliant blue staining. Excised acrylamide slices were then 
stored in 50ml screw-top tubes and received by Cambridge Research Biochemicals, who 
then produced the corresponding polyclonal antibodies. ELISAs, constructed from 
protein extracted from the gel slices, were used to estimate anti-body sensitivity (Figure 
5-8). Anti-CpFxn gave a strong curve, indicating a high sensitivity. Anti-CpIscS and Anti-
CpIscU provided poor curves; this was determined to be an issue with extracting the 
sample from the acrylamide slices, as subsequent western-blot analysis using 
recombinant protein extracts showed specific and sensitive binding of the antibodies 
(Figure 5-7b). None of the custom antibodies produced detectable signal in western blots 
of protein extracted from uninfected COLO-680N or non-expressing control strains of E. 




Figure 5-7: ISC Detection in C. parvum samples by Western Blot. Antibodies raised against the 
recombinant ISC proteins, in rabbits (anti-CpIscS) and rats (anti-CpIscU and anti-CpFrataxin), 
were used in a western blot assay of samples from C. parvum oocysts and control samples from 
uninfected COLO-680N cells. Development via Enhanced, luminol-based, Chemiluminesce (ECL) 
produced evidence that the antibodies used were able to detect the presence of their intended targets 




Figure 5-8: Determination of Recombinant ISC raised, Antibody Sensitivity to targets via ELISA. 
ELISA kits were prepared by Cambridge Research Biochemicals using protein extracted from the 
same acrylamide slices used to inoculate the animals. The antibodies produced were then tested for 
sensitivity via these ELISAs and the results recorded graphically   a. anti-CpFxn from Rat 2 produced 
a very strong response curve, indicated by the high absorbance present across serum dilutions. b. 
and c. are poor absorbance curves, potentially because of acrylamide contamination in the 
preparation of the ELISA. Subsequent analysis via western blot confirmed a strong specific and 
sensitive response of both CpIscU and CpIscS. 
 
5.3.3 Localisation of C. parvum ISC components in an infected culture 
 
COLO-680N infection model systems were incubated for the standard 10 days, as 
established in chapter 3, in chamber slide cultures. The protocols demonstrated in Chapter 
2.9.2 were then followed, utilising various combinations of cryptosporidial marker 
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antibodies, genetic material dyes and the custom made anti-CpFxn/IscU/IscS antibodies 
(visualised by the addition of TRITC conjugated anti-rat or anti-rabbit secondaries). 
Localisation of the various proteins within the oocyst of C. parvum was achieved by co-
staining with Crypt-a-glo a, FITC conjugated, monoclonal antibody with high sensitivity 
and more importantly high specificity for a Cryptosporidium oocyst wall protein. 
Localisation within other stages of C. parvum, sporozoites and intracellular stages for 
example, was achieved by co-staining with SporoGlo, a sensitive, FITC conjugated 
polyclonal antibody raised against C. parvum sporozoites. 
By using different combinations of the anti-C. parvum and anti-ISC antibodies, in 
addition to the DAPI nuclear stain, it was possible to determine the localisation of the ISC 




Treatment of infected cultures with the anti-CpIscS revealed a life cycle-dependant 
expression pattern of CpIscS (Figure 5-9). During the extracellular sporozoite and 
merozoites life cycle stages, IscS could be detected as punctate areas of signal (Figure 
5-10). Often, the signal was restricted to regions typically between 500-800 nm in 
diameter. This agrees with the description of the mitosome as an approximately 500 nm 
oval shape. 
DAPI stained oocysts of C. parvum showed successful permeation as the four nuclei of 
the contained sporozoites could reliably be observed. However, no convincing IscS signal 
could be observed within these sporozoites, with an absence of detectable fluorescence. 
It is entirely possible that this is due to the size difference between the DAPI molecule 
(~0.270kDa) and the antibody (~150kDa) and thus cannot be considered a signifier of any 
significance without further investigation. 
IFA of the other life cycle stages revealed that whilst IscS remained expressed at 
detectable levels, its localisation did not remain consistent. In detectable extracellular life 
cycle stages, determined as any detectable SporoGlo not within/closely associated with a 
KRVWFHOODQGOHVVWKDQȝPLQGLDPHWHU,VF6FRXOGEHIRXQGFRQFHQWUDWHGLQDUHJLRQlike 
that observed in the sporozoites. This indicates the presence of an organelle matching the 
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physical descriptions of the mitosome, corroborating the hypothesis that at least one 
aspect of the ISC pathway would localise to the mitosome of C. parvum. However, IFA 
of intracellular life cycle stages, determined by positive SporoGlo detection, proximity to 
host nucleus, amorphous/round shape and an approximate parasite size exceeding 4 ȝP
IscS appeared to be more diffuse. Indeed, it is hard to discern any regularly observable 
structural association with IscS expression in intracellular stages. Furthermore, in areas 
where many zygotes/maturing oocysts were present, IscS staining appeared to decrease 
inversely proportional to the diffusion of genetic material indicating that IscS expression 
declined in the final stages as the sporozoites were formed. This quality appears to offer 
a biochemical basis for determining when a zygote has become an oocyst, a state 




Figure 5-9: Confocal images of infected COLO-680N cultures, stained with anti-CpIscS. A variety of 
IscS localisation patterns were observed, although appearing to remain consistent based on parasite 
life cycle stage. C. parvum oocysts (O), determined by the circular Crypt-a-glo staining and 3-4 
detectable punctate DAPI stains (denoting sporozoite nuclei), routinely showed no detectable levels 
of IscS. However, oocyst like structures, that lacked discernible sporozoite nuclei contained 
detectable levels of expressed IscS, this is most noticeable in panels d, where diffuse TRITC signal 
could be detected. These structures were determined to be Zygotes (Z) in various stages of maturity, 
with the hypothesis that lowered IscS signalling, corresponding to more concentrated DAPI stain, 
indicated the zygote was entering the final stage as an immature oocyst (O/Z). Multiple other sites of 
IscS expression were also detected, either as punctate extracellular signal (M) or as diffuse but high 






   
Figure 5-10: IFA of infected COLO-680N cultures with SporoGlo (green) and anti-CpIscS (red) with a DAPI nuclear stain (blue) revealed 
multiple incidences of co-localisation between punctate IscS signal and C. parvum sporozoites/extracellular stages. This agrees with the previous 
findings that the extracellular stages expressed detectable levels of IscS, which remained confined to an approximately 500 nm region within 
the parasite. It was not uncommon for IscS signal to be detected where there was no SporoGlo. Subsequent attempts to replicate this in 






Anti CpIscU produced similar results to that of CpIscS when observed via IFA (Figure 
5-11). Life cycle stage dependant expression continued to be present; with Crypt-a-glo 
stained oocysts presenting DAPI stained sporozoite nuclei but no detectable CpIscU 
signal. Conversely, several extracellular life cycle stages could be detected by residual 
Crypt-a-glo labelling or punctate DAPI stain which did display detectable levels of 
CpIscU. However, CpIscU signal appeared to be more diffuse than that of CpIscS 
throughout all life cycle stages (Figure 5-12). This would indicate that CpIscU may not be 








Figure 5-11: IFA of infected COLO-680N cultures, with Crypt-a-glo (green), anti-CpIscU (red) and DAPI nuclear stain (blue). Highly 
stained (by Crypt-a-glo) C. parvum oocysts did not display any detectable IscU signal. However, IscU expression could be detected 
WKURXJKRXWWKHFXOWXUHRIWHQFRUUHODWLQJZLWKUHJLRQVRIKRVWQXFOHLWKDWDSSHDUHGµLQGHQWHG¶ZKLOVWODFNLQJFRUUHVSRQGLQJ&rypt-a-glo 












Figure 5-12: IFA of infected COLO-680N cultures, with SporoGlo (green), anti-CpIscU (red) and DAPI nuclear stain (blue). Detectable CpIscU was 
always detected in tandem with SporoGlo labelling and vice versa. Though IscU stain was relatively diffuse in extracellular stages compared to IscS, 
it becomes drastically more so in Intracellular stages, suggesting a lack of localisation of CpIscU at the intracellular portions of C. parvum¶VOLIH







Anti-CpFxn results were again similar to those of CpIscS and CpIscU. CpFxn antibody 
labelling of infected cultures showed, again, a lack of CpFxn in mature oocysts but 
abundance in other life cycle stages (Figure 5-13 and Figure 5-14). Most notably, CpFxn 
signal remained intense even in late stage zygotes, denoted by the intense Crypt-a-glo 
VLJQDOWKDWODFNHGWKHFKDUDFWHULVWLFµULQJ¶RIDPDWXUHRRF\VW7KLVLVLQFRQWUDVWWRERWK
CpIscS and CpIscU that showed decreasing levels of expression leading up to zygote 
maturation. 
CpFxn signal also remained relatively diffuse throughout the life cycle, although 
dramatically more so in intracellular stages, like CpIscU. This is not entirely unexpected, 
as previous studies have revealed that cytoplasmic IscU can be found associated with 
Frataxin. However, CpFxn labelling in sporozoites appeared considerably more localised 
than any other life cycle stage, appearing to congregate in a defined, approximately 500 








Figure 5-13: IFA of infected COLO-680N cultures treated with anti-CpFxn (red), Crypt-a-glo (green) and DAPI nuclear stain (blue). Whilst some co-
localisation of C. parvum oocysts stained with Crypt-a-glo can be seen to occur with the CpFxn labelling, no CpFxn signal can be detected in 





Figure 5-14: Frataxin detection in C. parvum in culture. a. IFA of an infected COLO-680N culture, 
labelled with anti-CpFxn (red), SporoGlo (green) and a DAPI nuclear stain (blue). CpFxn signal co-
localises with SporoGlo, demonstrating that putative Frataxin homologue is expressed by the 
SDUDVLWH6FDOHEDUȝPE$'KLJKUHVROXWLRQFRQIRFDOLPDJHRIDC. parvum sporozoite in an 
infected COLO-680N culture. Clear labelling of CpFxn (red) highlights an approximately 700 nm 
wide oval (arrow) at the apical end of the parasite, a red outline has been drawn to illustrate the 
shape of the parasite and to highlight the location of the mitosome c. The same image rotated through 
90° on the x-axis. Scale bars a-FȝP  
 
5.3.4 Cloning of C. parvum ISC components into Saccharomyces cerevisiae 
 
It was decided that to further validate the discovery of the ISC pathway in C. parvum, it 
would be necessary to demonstrate that at least one of the proteins was metabolically 
active as an ISC protein. To do this, a simple complementation experiment was designed, 
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to determine if the target protein could recover a lethal knockout of its homologue in the 
yeast Saccharomyces cerevisiae. IscS was selected to be the target of the yeast 
experiments, as previous studies have shown the protein to be non-toxic even when over-
expressed, therefore already eliminating a potential difficulty (LaGier et al., 2003). 
Additionally, IscS is the only protein of the 3 examined here that is a lethal knockout in 
the model yeast S. cerevisiae and as such represents the experiment with the least 
ambiguous result and thus the best indicator of whether C. parvum ISC components 
perform the same function as their putative homologues (Muhlenhoff et al., 2004). The 
recombinant plasmid construct, on the pBEVY-L backbone (Figure 2-3), was assembled 
via selective restrictive digest as before. The PCR insert was derived using the plasmid 
DNA from the expression experiments as the template, to best minimise the possibility 
of non-specific binding and thus unwanted products. Again, successful constructs were 
identified via selective digestion and agarose gel analysis. 
The IscS recombinant construct was transformed into a heterozygous Nfs1p (IscS) 
knockout, strain YCL017C, where a homozygous knockout is fatal. In the Knockout 
strain of YCL017C IscS is replaced by a G418 resistance marker, on chromosome III. 
 
5.3.5 Confirmation of Sporolating and mating type 
 
Colonies of transformants were grown on leucine knockout plates to select for S. 
cerevisiae containing the plasmid. Liquid cultures were then grown from selected 
colonies and sporolated. Examination of CpIscS transformed S. cerevisiae was performed 
via microscopic analysis of aliquots from the culture, to identify the characteristic 
formation of spores (Figure 5-15). Sporolated S. cerevisiae was detected in all three 
experimental replicates. Microscopic analysis was used again to confirm the successful 
production of spheroblasts by the lyticase exposure. Successfully sporolated and 
spheroblasted cultures were vortexed to induce separation and plated on non-selective 
YPD plates. Once sufficiently grown, colonies were picked and re-plated onto selective 




Figure 5-15: Sporulation of yeast. The sporulation of S. cerevisiae was confirmed by microscopy 
analysis of culture samples. Spores can be identified via distinct triplets or quadruplet collections of 
cells, approximately the same size of a single non-sporolated cell. Each spore would be homozygous 
for all genes and therefore either homozygous knockouts or wild type NFS1. 
 
Figure 5-16: Colony PCR of colonies formed from sporolated culture. The lower weight bands are 
primer dimers and expected. The higher bands, approximately 400 ESUHSUHVHQWHLWKHUĮRUDPDWLQJ
types. The lack of dual banding in these areas (ignoring the primer dimers) indicates each colony is 
homozygous for the mating type and therefore all other chromosomal genes. Primer dimers are not 




5.3.6 Functional complementation of Nfs1p with CpIscS 
 
Selected colonies which displayed only a single mating type were placed on the leucine 
knockout and G418 plates in matching sequence. Pattern observation and decoding can 
be done via reference to Figure 5-17. Sporulated, homozygous strains were capable of 
producing matching colonies on both selective media plates, indicating the presence of 
the G418 resistance marker and pBEVY-L as well as the absence of the lethal phenotype 
(Figure 5-18 a and b). 
 
Figure 5-17: A cartoon flow chart of the possible outcomes after sporulation. In the case that CpIscS 
can successfully recover the fatal NFS1 knockout, colonies should be able to grow on both plate 
conditions. Only a successful complementation will produce matching colonies on both plates. 
Colonies that can only grow on leucine deficient plates do not contain the G418 resistance marker 
and therefore still maintain a wild-type gene. *Actual transformants would distribute copies of the 




Figure 5-18: pBEVY-L/CpIscS selection plates. pBEVY-L/CpIscS plasmid transformed and 
sporolated S. cerevisiae colonies were grown on a non-selective YPD plate then picked and used to 
seed Leucine deficient minimal media (a) and G418 (b) antibiotic selective YPD plates. 19 out of the 
23 (82.5%) colonies contained the pBEVY-l/CpIscS construct. Colony formation on a. was indicative 
of a successful transformation, with pBEVY-L conferring survival in the absence of environmental 
Leucine. Survival (48%) on b. was indicative of the G418 resistance marker that had replaced yeast 
NFS1 and therefore a lethal knockout. Therefore, any colony that survived plate b and was positive 
for only a single mating type must be a knockout; else it would not contain the resistance marker for 
G418 in place of NFS1 (IscS). As NFS1 knockouts are invariably lethal, the only method by which 




In-silico analysis of the genome of C. parvum revealed a full complement of possible ISC 
pathway proteins. These included the sulphur donor IscS, the iron donor Frataxin and the 
scaffold protein IscU. Each showed a high similarity to their putative homologues in the 
model organism S. cerevisiae, NFS1, YFH1 and ISU1 respectively. Furthermore, the 
presence of potential mitochondrial targeting peptides, as predicted by further in-silico 
analysis, in organism lacking a canonical mitochondrion, appeared to suggest that the 
pathway proteins would localise to C. parvum¶VPLWRVRPH Considering the lengths to 
which C. parvum appears to have gone to streamline its genome, it would be unusual to 
have maintained a non-functional localisation sequence. In turn this would suggest that 
during the evolution of this organelle, the production of Fe/S clusters within a specialised 
organelle was more essential to C. parvum than the efficient production of ATP and thus 
the TCA cycle was lost and the ISC pathway conserved. To date, only recombinant C. 
parvum Frataxin has been expressed; localised to the mitochondrion of S. cerevisiae. 
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However, until now the nature of the ISC pathway, including its localisation and life cycle 
expression patterns remained entirely unexplored for all three proteins. 
As shown above, I have successfully produced recombinant proteins of C. parvum IscS, 
IscU and Frataxin and subsequently utilised them to produce effective antibodies to the 
corresponding proteins. In doing so, I have shown that the proteins are indeed expressed 
during the life cycle of C. parvum and are not simply remnants of inherited pathways. 
Furthermore, the fluorescent microscopy analysis of infected cultures, made possible only 
by the new culturing system developed in Chapter 3, has shown that not only do the 
proteins localise to an approximately 500 nm, oval organelle, but that this is dependent 
on life cycle stage.  Although the much more diffuse signalling of CpIscU during all life 
cycle stages suggests that CpIscU is also present in WKHSDUDVLWH¶VF\WRSODVPDVLVWKHFDVH
for many IscU homologues throughout eukaryotes. This would agree with the currently 
understood role of IscU, where the otherwise potentially toxic intermediates of ionised 
iron and sulphur are now assembled into a Fe/S cluster on the IscU scaffold, it would no 
longer be necessary to exclude the remaining process from the cytosol. To this end, IscU 
is frequently localised to both the mitochondria and cytoplasm of expressing organisms, 
theoretically supplying the CIA machinery directly with Fe/S clusters. 
CpIscS, CpIscU and CpFxn appear to lose all localisation during intracellular life cycle 
stages. Given the extremely unlikely (and unprecedented) prospect that the mitosome has 
disappeared at any point during the life cycle, the simplest explanation is a shift in 
localisation from organelle to cytoplasm. This is of particular interest as it had been 
hypothesised that the ISC pathway was localised to mitochondria/mitosomes to protect 
cells from high levels (found naturally in the mitochondria) of the iron and sulphide ions 
produced during Fe/S cluster biosynthesis (Horowitz and Greenamyre, 2010, Dlouhy and 
Outten, 2013, Lill et al., 2012). It is, however, worth noting that whilst detailed knowledge 
of C. parvum life cycle stages beyond sporozoites remains limited, mitosomes have not 
been demonstrated in stages other than sporozoites and potentially merozoites. This poses 
another question, if the contents of canonical mitochondria were largely superfluous to 
C. parvum, such that they were readily lost, why has C. parvum maintained the mitosome 
at all if its seemingly only pathway appears not to require the organelle. 
Furthermore CpIscS, IscU and Fxn were all absent from any detectable mature oocysts, 
although as discussed this may be due to a failing in the permeabilization method. 
5-142 
 
However, whilst Crypt-a-glo repeatedly generated high quality images of C. parvum 
oocysts, SporoGlo performance was continually sub-standard. Before the implication of 
the ISC anti-bodies it was already a foregone conclusion that SporoGlo was not detecting 
all parasites within a culture. Comparing SEM, TEM and basic microscopy imaging with 
SporoGlo imagery revealed that SporoGlo was underestimating parasite populations. 
Whilst this does not undermine the results of any experiments performed with SporoGlo 
as a means of localisation, it does call into question the reliability of SporoGlo in an 
epidemiological setting. Especially now that some papers are reporting the possibility that 
C. parvum and other Cryptosporidium are potentially not obligate parasites and therefore 
may exist in the wild in extra-cellular life stages, although this appears unlikely 
considering the number of essential amino acids and other metabolites the parasites would 
not have access to in such environments (Hijjawi et al., 2010, Clode et al., 2015, Ryan et 
al., 2016). Regrettably SporoGlo remains the only commercially available anti-
sporozoite/non-oocyst antibody for C. parvum. Other antibodies, such as those that target 
proteins in the apical complex are available but only in limited amounts as they are made 
to order by non-dedicated laboratories. However, as the apical complex is only present in 
the extra-cellular stages, this still would not completely resolve the problem. Therefore, 
the production of three new effective antibodies that appear to be able to detect all but the 
oocyst stage of C. parvum is a significant result in of its self.  
The final and perhaps most important result of these experiments is the confirmation of a 
functional IscS in CSDUYXP¶V genome. The Iron Sulphur Cluster assembly protein IscS 
is an essential part of the ISC pathway, serving as the primary donator of Sulphur, via 
cysteine residues, to the scaffold protein IscU. Due to the seemingly ubiquitous and 
predominant nature of Fe/S proteins in biology, it is therefore no surprise that silencing 
IscS expression can have a lethal effect on an organism. This can be seen in the non-
viable knockout of IscS in S. cerevisiae, hence the reliance on heterozygous knockouts 
and sporulation for complementation studies. The introduction and expression of the 
recombinant putative IscS, found within the genome of C. parvum, appears to recover 
this lethal edit. With both selective criteria (-Leu and G418 survival) present and the PCR 
confirmation of haploid mating type, I have shown conclusively that the lethal double 
knockout phenotype of S. cerevisiae can be recovered with the expression of the 
recombinant IscS from the genome of C. parvum. This offers significant evidence that 
the ISC pathway present in the mitosome of C. parvum is a functionally conserved 
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homologue to the ISC pathway found in the mitochondrion of S. cerevisiae. This strongly 
supports the hypothesis that the mitosome of C. parvum shares a common ancestor with 
the mitochondrion of S. cerevisiae. Furthermore, the conserved presence of an Fe/S 
cluster biosynthetic pathway and not a form of the TCA cycle adds considerable weight 
to the emerging hypothesis that suggests Fe/S cluster pathways played a significant role 
in endosymbiotic event, perhaps even more so than ATP generation (Dellibovi-Ragheb 
et al., 2013). 
These results also establish proof of a functional ISC pathway within the gregarines, 
where previously only in-silico predictions existed and even then, restricted to a single 
organism (Toso and Omoto, 2007, Templeton et al., 2010). That C. parvum has 
maintained this pathway, despite disregarding the apicoplast and much of the 
mitochondria, without appearing to have obtained many further unique adaptations, 
further adds weight to the concept of C. parvum as an essential model for the essential 
adaptations of gregarines and the Apicomplexa to a parasitic lifestyle. 
Therefore, it can be said with some confidence that my hypothesis was correct; C. parvum 
maintains a functional ISC pathway which localises to the mitosome. Furthermore, it 
appears that the ISC pathway is not always localised to the mitosome. However, using 
the antibodies generated during these experiments, I have demonstrated a possible 




Chapter 6 Discussion 
6.1 Purposes and findings of the study 
 
The aims of this project were primarily twofold; to develop a novel model system for the 
observation and experimentation of C. parvum and to use this system to explore the 
adaptations present in C. parvum that enable it to successfully survive via parasitism. The 
latter goal was to be split into two separate areas of study; the broad analyses of the effects 
Cryptosporidium infections have on host metabolism and the metabolic role of C. 
SDUYXP¶s relict mitochondrion like organelle: the mitosome (Figure 6-1). 
 
Figure 6-1: The proposed contents of the mitosome. The proteins/pathway of interest highlighted 
which have now been proven experimentally to be expressed within C. parvum and localised to the 




6.1.1 Maintenance of infection in a COLO-680N cell line 
  
6.1.1.1 Development of an in-vitro C. parvum culture 
 
In order to further the field of Cryptosporidium research it had become abundantly clear 
that a new in-vitro model of infection was required. Although previous work had 
identified such systems as HCT-8, MDCK and Caco-2 cell lines as potential solutions, 
they had were unsuccessful in their attempts to reliably produce: a repeatedly completing 
life cycle, long term sustained infections or economically/ergonomically viable options 
of studying an important pathogen (Upton et al., 1994, Hijjawi et al., 2001, Arrowood, 
2002, Girouard et al., 2006, Alcantara Warren et al., 2008, Hijjawi, 2010, Yin et al., 2010, 
Muller and Hemphill, 2013, Morada et al., 2016, Striepen, 2013). Therefore, it was the 
goal of this thesis to produce not only a system capable of maintaining a repeated life 
cycle for extended periods of time, but one that could do so in as simple and cost-effective 
manner as possible. The latter aspect is increasingly important, as set-up costs are often 
prohibitive and few research labs already study C. parvum (Striepen, 2013). 
Fortunately, this study was able to demonstrate such a culture; utilising the Oesophageal 
Squamous Cell Carcinoma COLO-680N cell line, discovered by a semi random 
investigation of a panel of potential cultures. In doing so, I was able to produce structural 
and topographic imagery of life cycle stages which until now remained woefully 
understudied outside of in-vivo investigations. However, the results are broadly consistent 
with the findings of the previous in-vivo research, identifying each life cycle stage 
previously reported (Current et al., 1986, Arrowood, 2002, Borowski et al., 2010, Leitch 
and He, 2012, Ryan et al., 2016). This serves to add credibility to the model as a viable 
model of infection. In addition to sporozoites and novel oocysts, the COLO-680N culture 
was identified as containing: merozoites, meronts, gamonts (both micro and macro) and 
zygotes. The latter stages are frequently reported as absent in other in-vitro models of C. 
parvum infection (Arrowood, 2002, Girouard et al., 2006, Hijjawi, 2010, Yin et al., 2010, 
Karanis and Aldeyarbi, 2011, King et al., 2011). 
The successful development of this culture allowed me to investigate in greater depth the 
nature of C. parvum infections and the biology of the parasite itself, utilising tools that 
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had previously been unavailable to the community as a result of the short falls present 
within other culture solutions. 
 
6.1.1.2 Development of novel protocols to examine C. parvum 
 
Protocols for the examination of C. parvum oocysts by Mass spectrometry (MS) 
lipidomics and proteomics and Atomic Force Microscopy (AFM) were two such 
outcomes of this research, in addition to other methodologies that are further expanded 
upon in the other two results chapters. By utilising commercially sourced oocysts as 
controls, I was able to demonstrate the value of a MALDI-TOF lipidomics approach to 
identifying differences between commercial and culture produced C. parvum oocysts. 
Though differences were not absolute, which showed the validity of the in-vitro culture, 
there were nonetheless noticeable variations in the abundance of several key lipids 
(identified via their relative abundance). These techniques open wide the door to further 
study of the nature of Cryptosporidium oocysts; including potential identification of 
species specific markers and indicators of infection. 
Likewise, AFM showed promising results. Primarily, AFM was capable of producing 
high fidelity topographic scans of oocyst surfaces. This allowed me to conclusively 
demonstrate that the surface of the cattle-produced and many in-vitro C. parvum oocysts 
were virtually indistinguishable. However, during this investigation, I also described a 
second set of oocysts, present only within the in-vitro population. These oocysts appeared 
OHVVVWUXFWXUDOO\ULJLGPRUHµGHIODWHG¶DQGPRUHHORQJDWHGWKDQWKHSRSXODWLRQSUHVHQWLQ
both in-vitro and in-vivo sources. It was determined that these oocysts may be 
UHSUHVHQWDWLYHRIWKHµWKLQ-ZDOOHG¶RRF\VWDOHVVZHOOGHVFULEHGDOWHUQDWLYHHQGOLIe cycle 
stage of C. parvum. Thin walled oocysts characteristically have a much thinner and less 
environmentally robust oocyst wall, theoretically due to this version being adapted to an 
autoinfection life cycle and are therefore not found in in-vivo sources of C. parvum 
oocysts. This was an encouraging observation, as it not only indicated a full life cycle 
present within the COLO-680N model, but also because previous studies had failed to 
report the presence of both oocyst subsets. It is, therefore, possible that the absence of a 
thin-walled variant in previous in-vitro systems prevented the autoinfection life cycle 
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from occurring, or at least can be seen as a reliable signal that a C. parvum culture is 
unhealthy/failing. 
Now that an AFM protocol has been established, future experiments are able to take it 
further. Unlike conventional, emitter (photon/electron) based microscopic techniques, 
AFM can intuit mechanical properties. By analysing peak force and surface strength 
properties, it will be possible to greatly enhance our understanding of the physical 
properties of the oocyst in addition to their biochemical. 
  
6.1.1.3 Possible importance of thin-walled oocyst populations 
 
These findings are of particular interest as they would indicate that it is the nature of the 
final stage of the life cycle that could be hindering the progress of the previous culture 
systems. Combining the observations from the lipidomics and AFM, as well as previous 
studies, I propose that the limiting factor, present in most failed in-vitro systems, is the 
ability of the host cell to effectively produce thin-walled oocysts. It is possible that the 
changes seen in the lipidomics, between in-vivo and in-vitro produced C. parvum, are the 
result of the thin walled oocyst populations, which could be expected to have a different 
OLSLGILQJHUSULQWWRWKDWRIWKLFNZDOOHGRRF\VWV$KRVWFHOO¶VLQDELOLW\WRSURYLGHNH\OLSLG
components could potentially prevent the successful maturation of thin-walled oocysts, 
if their lipid make-up is different from the thick-walled variant. This is in keeping with 
the understanding of C. parvum biology, as it is entirely reliant on the host cell for de-
novo lipid synthesis. My hypothesis, therefore, was that COLO-680N lipid synthesis was 
substantially different from those cultures previously used and was instead sufficient for 
the production of either oocyst variant. This theory was supported further by the published 
observation that COLO-680N produces significantly high levels of lipids (Orita et al., 
2010). 
  
6.1.1.4 Observations of FASN activity in infection models 
 
To further explore the implications that lipid synthesis by the host was a potential 
indicator of viable in-vitro cultures, I examined the nature of FASN expression levels in 
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a variety of known permissible and non-permissible infected cultures. Unsurprisingly and 
in agreement with publications, COLO-680N produced a strong signal of FASN 
expression. However, this signal was negligibly stronger than HCT-8 and substantially 
weaker than DLD-1. Conversely, DLD-1 did not show promise as an in-vitro model of 
infection in earlier experiments. PLD2 levels were also consistent across the tested cell 
types. However, unlike HCT-8 and DLD-1, COLO-680N displayed an increase in FASN 
expression upon infection. It is possible, therefore, that the native levels of lipid 
production are not the determining factors behind the suitability of a cell type as C. 
parvum hosts. Instead it would appear as if a yet unexplored susceptibility or 
compatibility between C. parvum and an aspect of COLO-680N biology allows the 
parasite to hijack the lipid biosynthesis of this cell type and not the others. The concept 
of C. parvum influencing host cell metabolism is also not unprecedented, as recent work 
has begun to show that C. parvum exports mRNA into the host cytoplasm and lipid 
synthesis could be a potential target of this export (Wang et al., 2017). 
 
6.1.1.5 Issues with modern nomenclature 
 
At this point, I would like to take issue with a worrisome trend that is emerging within 
the C. parvum FRPPXQLW\WKHXVHRIWKHWHUPµeSLFHOOXODU¶3UHYLRXVO\C. parvum has 
been referred to as an intracellular/extra-cytoplasmic parasite. This is in reference to the 
observable parasitophorous vacuole that forms as a result of host cell invasion by 
extracellular life cycle stages of C. parvum. The material for the vacuole is derived from 
host membranous extrusions, determined in at least one species of Cryptosporidium as a 
specific host response to Cryptosporidium infection. The end result is the encapsulation 
of the parasite in a host-membrane derived vacuole that does not fully enter the host 
cytoplasm, instead occupying an inter-membranous region of the phospholipid bi-layer. 
The work of this thesis also supports this version of events, as demonstrated by the 
unusual morphologies of infected host nuclei, which suggest strong mechanical forces 
being applied by the parasite without actually puncturing a membrane, ergo the parasite 
is within the boundaries of the host cell, not simply associating with it. However, recent 
SXEOLFDWLRQVKDYHEHJXQXVLQJWKHWHUPµHSLFHOOXODU¶WRGHVFULEHC. parvum (Thompson et 
al., 2005, Valigurova et al., 2008, Clode et al., 2015) . This is a misleading use of the 
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term, as epicellular pathogens by definition associate with host membrane but remain 
outside of the boundaries of the host cell. Most likely this misunderstanding is a result of 
overinterpreting field emission scanning electron microscopy images. Whilst at first 
glance the images present clearly distinguishable host and parasite, many confocal and 
electron microscopy images show that the distinction is not so clear cut, as supported by 
the findings I present in the various figures of this thesis. The boundaries of a cell are 
defined by the outer most aspect of the phospholipid bilayer, anything within that 
boundary is intracellular and anything associating with, however closely, but remaining 
outside is epicellular. Giardia lamblia is one such epicellular parasite, utilising a concave 
VXUIDFHDUFKLWHFWXUHWRµVXFWLRQFXS¶RQWRKRVWFHOOV,QFRQWUDVWC. parvum is enveloped 
by host membrane and therefore should not be described as epicellular. Doing so 
otherwise is encouraging a false description of the infection cycle and is 
counterproductive to understanding the organism. 
As an addendum, I would also like to call in to question the observation that C. parvum 
oocysts maintain an active glycolytic pathway. The sole evidence for this is given in a 
paper wherein their method of extraction for the assay was essentially an excystation. 
Therefore, the glycolytic activity observed was more likely the result of activating 
sporozoites, following excystation, rather than an indicator of activity whilst encysted. I 
propose this study be repeated, with 1H NMR and 13C NMR studies, utilising the 
metabolite extraction processes detailed in this thesis to better determine whether the 
glycolytic pathway is active inside an oocyst. 
 
6.1.2 A Host-pathogen metabolome hints at mitochondrial involvement 
 
As a result of developing a novel, robust and easy to use culturing system of C. parvum, 
a number of new areas of research were made available. One such area was that of 
metabolomics. As a parasite, it is a foregone conclusion that C. parvum likely 
interacts/interferes with host processes of some description. The nature of these 
processes, however, was largely unknown and understudied due to the aforementioned 
lack of suitable models of infection. Metabolomics is a particularly underexplored aspect 
of C. parvum. Indeed, pre-existing literature covers only the faecal metabolome of human 
and mouse infections and via a single method of examination: Mass-spectrometry (MS). 
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Whilst there is nothing inherently wrong with the Mass-spectrometry technique, it is 
nonetheless a relatively complex protocol, with sample loss a significant issue during 
preparation. This would not be an issue in situations where sample is abundant, but is 
extremely prohibitive in hostile conditions, such as fieldwork. Furthermore, whilst gas 
chromatography mass-spectrometry (GC-MS) is a highly sensitive technique, it lacks the 
ability to quantify compound abundance. Therefore, it was the purpose of this study to 
use the novel COLO-680N C. parvum infection model to explore a viable alternative to 
MS: 1H NMR metabolomics. 
 
6.1.2.1 Development of a 1H NMR protocol 
 
1H NMR has successfully been used to examine the metabolomes of many 
microorganisms, including the yeast S. cerevisiae and apicomplexan P. falciparum 
(Gonzalez et al., 1997, Balog et al., 2011, Li et al., 2011, Lamour et al., 2012, Teng et al., 
2014, Sengupta et al., 2016). Whilst this study examined the metabolome of the infection 
model in its entirety, I decided to draw upon these existing protocols so as to best ensure 
that both host and parasite were effectively treated for metabolite extraction. 
Additionally, the use of high temperatures (80°C) to rapidly denature enzymes and 
prevent metabolite degradation, provided an advantage to field sample preparation where 
higher temperatures are easier to obtain than lower.  
The results were promising and showed some immediately obvious differences between 
the spectra of infected and uninfected cultures. To expand upon and potentially add 
further depth to these observations, I introduced several other Cryptosporidium species 
to the dataset. While the COLO-680N culture system was developed with the C. parvum 
Iowa II strain, it had also proven permissive to the Weru strain. Additionally, C. hominis 
also displayed some ability to propagate within the culture. I therefore decided to collect 
metabolomics data from COLO-680N cultures of these parasites as well. The resultant 
spectra from these infections were immediately distinguishable from each other. Before 
whole-spectra analysis was performed, specific peak analysis of the revealed that 
creatine, taurine and lactate levels of the infected samples were both different from the 
controls and also from each other. These preliminary results were promising and 




 6.1.2.2 Involvement of host mitochondria in infection 
 
The observation that the most obvious differences in the spectra were related to host 
mitochondrial metabolism were not entirely surprising. Earlier Transmission Electron 
Microscopy images from the development of the COLO-680N culture, in addition to 
previous literature, suggested a close association at least physically between the host 
mitochondria and the parasite. This is also supported by the revelation that host fatty acid 
synthesis, which largely takes part associated with the mitochondrion, is potentially 
hijacked by C. parvum. To this end, infected COLO-680N cultures were observed 
XWLOLVLQJ =HLVV¶V 6XSHU-resolution Airyscan. The resulting images agreed with the 
hypothesis, as they too showed co-localisation between high host mitochondrial 
concentration and C. parvum. This is a promising avenue of research, which may explain 
how or why C. parvum has survived after drastically reducing the functionality of its own 
mitochondrion. 
  
6.1.2.3 The first recorded metabolome of a C. parvum in-vitro culture 
 
After further analysis of the NMR spectra, utilising the Chenomx NMR suite, full lists of 
metabolites present in each experimental condition were produced and compared. The 
concentrations of the various compounds were used to construct PCA models, which 
showed clear differences in metabolic fingerprints between the various infections but 
more so between any infection and the uninfected control. This data represents the first 
time 1H NMR had been used to examine the metabolome of any cryptosporidia but also 
the first time the metabolome of a C. parvum infected tissue culture has ever been 
explored. 
  




By using the values ascribed by the PCA from both in-vitro and in-vivo experiments, it 
was then possible to elucidate those compounds which most profoundly differed between 
the conditions. For both C. parvum strains, Iowa II and Weru, the lists predominantly 
contained metabolites involved in energy supply or other typically mitochondrial 
processes. This further supports the theory of close host-mitochondria and C. parvum 
interaction. Of those identified, Taurine was perhaps one of the most interesting. High 
levels of taurine are frequently observed in stool samples of C. parvum patients, however 
this had been theorised to be a result of reduced Taurine uptake, as a result of damaged 
microvilli by the infection. As there is not external source of Taurine in the in-vitro 
cultures, I offer an alternative explanation. In keeping with the observation that C. parvum 
infections appear to mostly affect the mitochondrial metabolism of the host, the observed 
increase in Taurine levels may in fact be a protective response by the host cell. Taurine is 
a multi-role metabolite and is involved in many pathways depending on cell type and 
localisation. One such role is as an antioxidant and barrier to oxidative stress. As is shown 
in the effects on other metabolic compounds, the infection appears to have a drastic effect 
on mitochondrial activity. Up-regulation in protective compounds, therefore, seems a 
logical response to this. This new interpretation of increased Taurine levels, among other 
similar responses seen throughout the results, promises a new interpretation of old 
observations and could be the key to understanding the host-parasite interaction in greater 
detail. 
  
6.1.2.5 Future of 1H NMR and MS approaches 
 
As a result of these experiments, I have shown both the validity and utility of a 1H NMR 
approach to C. parvum metabolomic studies. However, this does not mean to say that 
NMR should replace MS approaches to metabolomics, on the contrary it would serve best 
to develop future methodologies that combined the two approaches. The sensitivity of 
MS and quantification of NMR could further our understanding of the underlying 
metabolic exchanges between the host and parasite even further. Additionally, these 
techniques and the differences observed between the metabolic profiles of individual 
species suggest that NMR could become a very powerful yet easy to use tool for 




6.1.3 C. parvum maintains a functional ISC pathway, with life cycle stage dependant 
expression patterns 
 
6.1.3.1 Successful identification of putative ISC components 
The purpose of this study was to experimentally demonstrate the existence and function 
of the ISC components purported to be within the genome of C. parvum and potentially 
the only complete pathway within its mitosome (Figure 6-2)(Abrahamsen et al., 2004). 
Successful recombinant constructs, derived from the gene sequences identified via a blast 
search, were used to create antibodies that identified expression of their protein 
counterparts in parasite cultures. Analysis of the sequences via Mitoprot also revealed 
that each translated genes contained peptide chains that were likely to be mitochondrial 
targeting sequences. This has been explored previously for the ISC components CpIscS 
and CpIscU which localised to the mitochondria when expressed in S. cerevisiae and were 
the only experimental evidence of a functional ISC pathway within C. parvum until this 
work (LaGier et al., 2003). With direct experimental evidence of the expression of these 
ISC homologues, from the western blots of infected cultures, it was possible to explore 
further and examine in greater detail the nature of ISC expression in C. parvum. 
  
6.1.3.2 The ISC components of C. parvum localise to an approximately 500 nm organelle 
 
The original intent of this study was to confirm the hypothesis that the ISC components 
would localise to the mitosome of C. parvum. This was achieved via the observed 
localisation of CpFxn, CpIscU and CpIscS to a small, approximately 500 nm organelle. 
This suggests that the mitochondrial targeting signal, identified via Mitoprot prediction 




Figure 6-2: Cartoon of the mitosome of C. parvum.  is purported to contain only 1 complete, active 
pathway: the ISC Fe/S biosynthetic pathway. The key components of this pathway are the sulphur 
donating IscS, the supposed iron storage protein Frataxin and the scaffold protein IscU. Once 
constructed, the Fe/S cluster, potentially still attached to IscU, is exported into the cell cytoplasm for 
use by the CIA pathway and other enzymes. 
  
6.1.3.3 The expression and localisation of ISC components of C. parvum is life cycle stage 
dependant 
 
However, what was not expected was the observation that the localisation and even 
expression of the components would be dependent on the life cycle stage. Though no 
mitosome has been observed within the intracellular life cycle stages of C. parvum, it was 
presumed that the ISC pathway would remain active and localised throughout even these 
stages. This is due to the conservation of an active Fe/S cluster biosynthetic pathway 
throughout all known cellular life. There is precedent for cytoplasmic localisation for 
each protein studied, though only in addition to organellar expression. Furthermore, the 
ISC components studied are not expressed at detectable levels within the oocysts. 
Although the functional parts of the oocyst are essentially sporozoites, they are 
metabolically different from the excysted forms. This could be explained as a form of 
PHWDEROLF µKLEHUQDWLRQ¶ WKRXJK WKH IHZ VWXGLHV WKDW KDYH H[SORUHG WKH PHWDEROLVP RI
oocysts appear to show an active glycolytic pathway. 
 




Though the localisation of the proteins proves the hypothesis of their presence in the 
mitosome, it does not prove that they function as intended or at all. Therefore, it was 
important to demonstrate functional complementation by at least one of the identified 
proteins. CpIscS was chosen for this due to its status as an essential protein in the model 
organism, S. cerevisiae and therefore a suitable target for lethal knockout recovery. 
Expression of the recombinant CpIscS was shown to successfully recover the lethal 
phenotype and it can therefore be stated that CpIscS is indeed a functional homologue of 
S. cerevisiae Nfs1p and, more importantly, a strong indicator that the ISC pathway within 
the mitosome of C. parvum functions in a manner like the other documented examples of 
ISC. 
This provides yet another example of an MRO, in this case a mitosome, where a complete 
Fe/S pathway has been conserved. Throughout the examples of MROs, pathways such as 
the TCA cycle are repeatedly absent and yet a Fe/S is always present, even in the rare 
cases where the typical mitochondrial ISC pathway has been replaced with the more 
bacterial SUF system (such as in E. histolytica) (Burki et al., 2013, Makiuchi and Nozaki, 
2014, Tovar et al., 1999). The main implications of these findings are that Fe/S cluster 
biosynthesis and not ATP synthesis is the primary role of the mitochondrion, as the loss 
of ATP pathways from MROs has occurred multiple times independently, yet not one 
example of an MRO lacking an Fe/S cluster pathway has been found. Furthermore, due 
to the functional complementation of CpIscS of yeast Nfs1p and the respective positions 
of C. parvum and S. cerevisiae in the eukaryotic tree of life it can also be asserted with 
increasing confidence that LECA contained a mitochondrion and therefore all examples 
of organisms appearing to lack canonical mitochondria that may arise are more likely 
examples of further reductive evolution of the mitochondrion, as opposed to diverging 
before the endosymbiotic event. Together, these conclusions have potentially massive 
implications on the currently accepted timeline of mitochondrial evolution in relation to 
eukaryotes. 
 
6.2 Avenues of future research 
 




Following the discovery of the thin-walled oocysts in in-vitro culture and their possible 
relation to host lipid content, future investigations into new culture design should 
prioritise cell cultures that display high levels of lipid synthesis. Additionally, further 
experimentation regarding the potential interaction between host and parasite, in regard 
to FASN and other fatty acid pathways could produce greater detailed information 
regarding this hypothesis. 
 Moreover, it may be worth using cell types with known high levels of mitochondrial 
activity, such as hepatic cell lines. Previous work had touched on this, with MDCK cells 
being amongst those cultures that preceded COLO-680N. Likewise, it would be 
interesting to observe the effects, if any, that attempting to infect cell lines with low levels 
of mitochondrial activity would have. To this end, detailed examination of mitochondrial 
activity in any infected culture could further shed light on this hypothesis, such as the 
colorimetric MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) or 
Rezasurin mitochondrial respiration assays or oxygen consumption assays. The implied 
importance of host fatty acid machinery could also pose an interesting, potential drug 
target that could be explored through the COLO-680N system. 
Now that the cultures have been established in earnest, it would also be possible to utilise 
the cultures in mass drug screens. By utilising the COLO-680N cultures of C. parvum it 
will be possible to determine with more confidence than previously possible whether a 
given drug will be effective. The robust nature of the infection model will also allow the 
exploration of longer term drug regimens and to develop drugs that can remain effective 
throughout the different life cycle stages of C. parvum. The latter provides a potential 
solution to the current lack of drugs for the immune-compromised as autoinfection stages 
are currently not available for proper drug studies utilising past culture systems (Striepen, 
2013). 
 
6.2.2 Expanding 1H NMR applications 
 
Whilst the 1H NMR studies were expansive, and certainly novel, they were by no means 
exhaustive. As was observed in both the mice and cell cultures, individual strains of C. 
parvum, in addition to different Cryptosporidium species, all presented metabolic 
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fingerprints that were distinguishable by PCA analysis. Expanding future 1H NMR 
research to include the metabolomes of other in-vitro cultures as well as other 
strain/species could serve only to increase our understanding of the infection metabolome. 
Most importantly it could enhance the theory that Cryptosporidium heavily influence host 
mitochondrial metabolism. Potentially, this could show whether the interaction is related 
to the mitosome of C. parvum and C. hominis or not dependant on the differences 
observed in cultures of the mitochondrion containing C. muris. 
13C NMR could also use this developed protocol and would offer a much higher 
resolution, opening up the possibility of tracking the flux of metabolites during an 
infection and confirming the hypothesis set out in the discussion and Chapter 4. This 
would allow the Cryptosporidium community the opportunity to finally observe what 
aspects of the host are actually parasitized by C. parvum. A natural partner in this 
investigation would be the use of transcriptomics, with the combination of the two 
approaches potentially providing insight into the host-parasite interface, another first for 
Cryptosporidium study as well as the gregarines. 
Lastly, the proven effectiveness and field-work friendly preparation technique can be 
applied outside of C. parvum work and has already seen applications in other 
parasitological studies. If 1H NMR were to be more broadly adopted as either an 
alternative or companion to MS based metabolomics, it could vastly increase our 
knowledge of host-pathogen interactions for parasites and other neglected tropical 
diseases. 
The new model will also finally allow for a comprehensive study of the crystalloid body 
organelle, utilising a combination of the utility of the COLO-680N culture and 
effectiveness of the various novel methodologies presented throughout this thesis. 
 
6.2.3 Future applications of fledgling genetic tools 
 
The most unexpected feature of the ISC pathway, uncovered by my investigation, was 
undoubtedly its life cycle stage dependant expression levels. Further investigations into 
this, such as mRNA sequencing of oocysts or further MS/MS proteomics could elucidate 
how C. parvum has appeared to shun other heavily conserved biological pathways, 
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including most of the amino-acid biosynthetic pathways. It would also be prudent to 
investigate the nature of CIA expression in C. parvum, to determine whether the life cycle 
dependant aspects of ISC expression are mirrored in the cytosolic pathway. 
Although it is currently not possible to genetically alter C. parvum in any efficient or 
effective manner, there have been promising advances with a CRISPR construct (Vinayak 
et al., 2015). One such barrier to an effective methodology had been the lack of an 
effective culturing method. With the advent of the COLO-680N model of infection, one 
roadblock has been lifted. Therefore, a future angle of research could be to remove the 
mitochondrial targeting sequence from the ISC compounds, via selective mutation, and 
observe if the cytoplasmic localisation is toxic or not. With the observation that the ISC 
pathway is not localised to a compartment during intracellular stages, this could add 
weight to the argument that mitochondrial localisation of Fe/S cluster biosynthetic 
pathways is either not one based on intermediate toxicity or that C. parvum maintains an 





6.3 Major findings; a summary 
(Pictorial summary viewable in Figure 6-3) 
x COLO-680N is a suitable cell culture and viable alternative for the propagation 
and study of C. parvum in-vitro  
o This opens the field of Cryptosporidium for study to many labs that were 
previously incapable of affording the start-up costs (in either equipment 
or training) 
x C. parvum appears to interact heavily with host mitochondrial processes and 
localises to areas of high host mitochondrial activity 
o This highlights new avenues of study and understanding of the host-
parasite interaction of Cryptosporidium species and potentially the 
gregarines group as a whole 
x NMR metabolomics can detect species specific changes in host-parasite 
metabolomes 
o This potentially offers new methods for diagnosing and tracking 
infections, an invaluable epidemiological tool   
x C. parvum maintains expression of ISC homologues within the mitosome in 
extracellular stages and in the cytoplasm during intracellular stages but not in the 
oocyst 
o CpIscS is a functional homologue of yeast Nfs1p and therefore the ISC 
pathway, in addition to its localisation, adding evidence for the 




Figure 6-3: A cartoon summarisation of the major accomplishments and findings of this thesis. Each 
arrow has been colour coded corresponding to the relevant chapter: Chapter 3: Green, Chapter 4: 
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Comprehensive list of figures and tables 
 
Figure 1-1: Phylogeny of the Apicomplexa. A recent phylogenetic placement of Cryptosporidium 
spp. (highlighted in red) removed them from the coccidia and placed them with the gregarines 
DOVRLQUHG7KLVQHZSODFHPHQWZDVLQIRUPHGYLD³6U'1$DOLJQPHQWVDQGD3K\OR%D\HV
CAT-GTR-GAMMA tree and 1577 well-DOLJQHGQXFOHRWLGHSRVLWLRQV´DVGHPRQVWUDWHGLQ
Cavalier-Smith (2014, Figure 4). Although not a universally accepted model, it nonetheless 
highlights the interesting nature of &U\SWRVSRULGLXP¶V genetic heraldry. 1-3 
Table 1-1: Host specificity of Cryptosporidium. Although members of the Cryptosporidia display 
relatively specific host specificity, several them can infect humans in addition to their typical 
hosts. In this table, the column entitled; Major hosts,lists the animal in which the species of 
Cryptosporidium is most commonly found. The authors listed are typically the preliminary 
publishers of human infection. *Additionally, though originally described as a parasite of 
many ruminants, C. parvum is increasingly detected within Humans and in some studies had 
comparable or even higher incidences in human populations than C. hominis, which is 
considered to have the highest preference for humans of the Cryptosporidia (Xiao, 2010) 1-5 
Figure 1-2: The general life cycle of Cryptosporidium species. Upon consumption of the oocyst by 
the host, typically through drinking water, the parasite passes into the gut and undergoes the 
process of excystation. At this point 4 sporozoites, each haploid, emerge from the 
approximately 5-ȝPGLDPHWHURRF\VWDQGSURFHHGYLDDJOLGLQJPRWLOLW\WRLQWHUDFWZLWKDQG
invade host epithelial cells, developing into trophozoites and soon merozoites. This represents 
the asexual stages of replication within the life cycle. (Adapted from Bouzid et al., 2013) 1-9 
Figure 1-3: The spectrum of Mitochondrial Related Organelles (MROs). The distribution of 
structural changes between canonical mitochondria (1, from chicken cerebellum), 
hydrogenomes (2 and 3 from Neocallimastic patricarium and Tritrichomonas foetus) and 
mitosomes (4-6 from Entamoeba histolytica, Trachipleitophora hominis and Giardia 
intestinalis). The size of the mitosome can vary greatly between species, with some reaching 
VHYHUDOȝPLQVL]HVXFKDVWKRVHVHHQLQEntamoeba histolytica (4) to others of less than 500nm 
such as those found in Trachipleistophora hominis and Giardia intestinalis (5 and 6). The scale 
bars represent 100nm from 1-4 and 50nm for 5-6.  (Reproduced from van der Giezen and 
Tovar, 2005) 1-16 
Figure 1-0HWDEROLFSDWKZD\VRIWKHµW\SLFDO¶PLWRVRPH7KHPHWDEROLFFRQWHQWRIWKHPLWRVRPH
within C. parvum as predicted so far via the published genome has both a basic glycolytic and 
ISC iron-sulphur cluster biosynthesis pathways, with putative mitochondrial/mitosomal 
targeting sequences. Mitochondrial targeting of recombinant Isu1/2 (IscU), Ferrodoxin (Fd1) 
and Nfs1 (IscS) has been confirmed within yeast expression systems although no experimental 
evidence exists replicating this in a mitosome. (Adapted from Mogi and Kita, 2010) 1-18 
Table 1-2: Essential and non-essential amino acids of Cryptosporidium parvum. Although C. parvum 
lacks the metabolic functions to produce most of amino acids de novo, it retains some limited 
capacity to produce most of the uncharged and a single hydrophobic amino acid through 1 or 
2 step processes. This list is split into two major columns: essential and non-essential amino 
acids. It is important to note, that except for proline, C. parvum cannot produce any amino 
acid without obtaining already complex molecules from an external source (Zhu and Guo, 
2014, Rider and Zhu, 2010). 1-21 
 1-21 
Table 2-1: PCR Primers. Custom Nucleotide sequences of the PCR primers used in Chapter 5 to 
produce recombinant ISC structures in a selection of plasmids. Sequences are colour coded to 
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highlight GC clamp (blue) and restriction site (red). Each was designed based on sequences 
obtained from using Blasting yeast ISC sequences against published C. parvum genomes. 2-31 
Table 2-2: Fluorophore Emission and Excitation peaks. A variety of fluorescent antibodies and 
stains were used in the experiments to detect and visualise the infection and a variety of 
organelles. This list encompasses the various wavelengths utilised by these fluorophores and 
the colour used to represent them in the relevant figures. 2-32 
Figure 2-1: Confirmation of a mouse infection via modified aniline-carbol-methyl stain. Following a 
similar rationale as acid fast staining, the purple methyl-violet stain cannot be decoloured by 
ethanol when taken up by the oocyst. This leaves Cryptosporidium oocysts as bright purple 
objects, as indicated by the arrows. Estimates regarding parasite-load of the animal can be 
made from the enumeration of average oocysts per oil field (shown is an image representative 
of a 1000x magnification oil field from a mouse of typical infection). 2-38 
Table 2-3: Accession numbers of the putative C. parvum ISC genes identified via a blastn search 
and the corresponding S. cerevisiae homologues. These sequences were used to identify 
potential mitochondrial targeting sequences in addition to the design of suitable primers for 
gene amplification via PCR. 2-41 
Figure 2-2 Site map of pET14b. Map obtained from addgene 2017, restriction sites utilised in these 
experiments have been underlined with red (BamHI and NdeI). pET14b was utilised for its 
combination of restriction sites that would allow universal insertion of any of the 3 target 
recombinant sequences without conflicting restriction sites. 2-42 
Figure 2-3: Site map for pBEVY-L. Obtained from addgene in 2017, restriction sites utilised in 
these experiments have been underlined in red (SmaI and SacI). Selection of this plasmid was 
based on optimum insertion site restriction sequences, absent from the target recombinant 
sequence and a high expression ratio. 2-46 
Table 2-5: Yeast mating type primers. Oligonucleotide sequences of specific primers for the 
detection of yeast mating types via PCR, used in the complementation experiment to detect 
alpha, A or heterozygous mating types. 2-48 
Figure 2-4: The mating cycle of the yeast Saccharomyces cerevisiae. Under normal conditions, the 
yeast replicates asexually, via budding and the creation of a daughter cell (Budding). Under 
stressful conditions, such as insufficient environmental nutrients, the yeast replicates sexually 
via the production of haploid spores through meiosis (Sporolation). The use of KAc as a 
growth media, immediately after growth in glucose rich YPD instigates the sexual 
reproduction cycle. 2-49 
Figure 3-1: C. parvum culture screen results. (a) Oocysts recovered from culture after an initial 
inoculum of 1x105 and a 2-week incubation period. Initial tests showed a clear disparity 
between a single cell type, COLO-680N, and the other cultures. COLO-680N appeared to 
demonstrate a much higher capacity for producing C. parvum oocysts than the previous gold-
standard HCT-8 (b) culture lifespans of infected COLO-680N and HCT-8, when compared, 
showed that COLO-680N was capable of maintain a viable and productive culture for a longer 
period than HCT-8. Although uninfected cultures showed similar disparities and therefore 
this result should be interpreted as an innate advantage of COLO-680N, independent from 
HLWKHUFHOOW\SH¶VVSHFLILFUHVSRQVHWRLQIHFWLRQFRRF\VWSURGXFWLRQRI+&7-8 and COLO680N 
cultures over the course of a culture lifespan. 3-53 
Figure 3-2: Optimisation of C. parvum detection via PCR. Custom primers, designed for specificity 
towards C. parvum gene segments (with the exemption of Hs18S which was used as a positive 
control to test for host DNA), were used in PCR performed on C. parvum DNA purified from 
whole oocyst fractions and on COLO-680N DNA from 25cm2 flasks to select for the greatest 
sensitivity and specificity to C. parvum DNA and not host DNA. Primers HSP70F4/R4 and 
Cr18s2F/JR2 were selected for further experiments. 3-54 
Figure 3-3: Detection of C. parvum in culture via PCR. Successful detection of C. parvum DNA after 
a period of six days was achieved by the HSP70 primers. Although slight, successful detection 
of C. parvum was also achieved by 18sRNA primers at nine days post-infection. 3-55 
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Figure 3-4: Infection detection via Indirect Immunofluorescence Assay (IFA). COLO-680N 
infections as visualised by a variety of commercially available IFA techniques including: (a-f) 
a FITC conjugated anti-oocyst wall protein COWP-1 antibody, Crypt-a-glo, (g-l) a FITC 
conjugated anti-apicomplexan sporozoite antibody, SporoGlo, and (m and n) TRITC 
conjugateGOHFWLQ99/6FDOHEDUVFDQGIȝPLDQGOȝPPDQGQȝP(DFK
method produced corroborating imagery of cultures containing roughly spherical bodies, 
approximating 5-ȝPLQGLDPHWHUPDWFKLQJWKHGHVFULSWLRQRIDW\SLFDOC. parvum oocyst. The 
oocysts were also visible via conventional light microscopy, but typically were considerably 
hard to spot without guidance from the IFA. 3-56 
Figure 3-5: Confirmation of novel C. parvum production, via DAPI nuclear staining. (a) C. parvum 
oocyst stained with Crypt-a-glo retained its fluorescence after ten days in RPMI-1640, 
providing evidence that any original oocysts from the infection could be detected by 
fluorescence. (b i and iv) IFA of the ten-day cultures could not detect any green fluorescence, 
indicating that none of the original oocsysts from the infection remained in culture, being 
successfully removed during the post-infection wash step. (ii and V), nuclear DNA staining by 
DAPI revealed multiple circular structures that suggested the presence of C. parvum oocysts. 
(iii and vi) Phase contrast imaging of the same areas produced corroborating imagery of 
oocyst like structures that aligned with the structures from ii and v, strongly suggesting that 
there was a successful infection and the oocysts observed where not simply the remnants of the 
RULJLQDOLQIHFWLRQ$OOVFDOHEDUVUHSUHVHQWȝP 3-58 
Figure 3-6 Scanning Electron Microscopy of purified oocysts recovered from a COLO-680N 
culture. 7KHVSKHULFDOERGLHVDSSUR[LPDWHO\ȝPLQGLDPHWHUPDWFKWKHSURILOHRIDW\SLFDOC. 
parvum oocyst and further confirmed the successful propagation of the parasite within the 
culture. 3-59 
Figure 3-7: Detection of oocysts within COLO-680N cultures after resuscitation from 
cryoconservation. An upward trend in oocysts recovered from the culture, confirmed via IFA, 
suggests that oocysts survived the initial freezing process and can undergo the typical life 
cycle, producing oocysts, after resuscitation via typical mammalian cell cryoconservation 
methodology. 3-61 
Figure 3-8: Infected culture growth patterns. Graphical representations of culture viability as 
detected by the xCELLigence cell viability detection system. The xCELLigence experiment 
monitored the changes in cell growth rates, utilising electroconductivity as an indirect 
measure of total cells in population. COLO680N cultures (a) displayed some degree of 
reactivity to infection, with certain ratios of parasite to host cell appearing to increase host 
longevity. HCT-8 cells (b) displayed no significant interaction, both the negative and infected 
samples confirmed the long observed notion that HCT-8 has a markedly short life-span in 
culture and undergoes rapid senescence at the end of a 7-8 culture cycle. 3-62 
Figure 3-9: : MALDI-TOFF Protein fingerprinting of C. parvum infections. (a) PCA analysis of the 
raw data showed substantial separation between COLO-680N control and infected cultures. 
However, little to no separation could be established between HCT-8 cultures, suggesting a 
greater shift in protein content in the COLO-680N scenario, likely due to an increase in 
parasite. Manual analysis of the graphical data produced (b-e) identified 4 protein peaks in 
the infected culture (e) which differed from the relative pattern displayed in the uninfected 
control (d). Closer examination (f) revealed these peaks to approximate proteins of 12kDa, 
12.4kDa and 15kDa. The y-axis was adjusted to display the patterns in their most comparable 
state, y-axis units (intensity, were arbitrary and not directly comparable, instead the relative 
sizes of the peaks are used to gauge differences between samples. 3-64 
Figure 3-10: COLO-680N growth patterns. COLO-680N cultures were infected with either 
standard, commercially available oocysts (purple) or oocysts purified from COLO-680N 
cultures (orange). ANOVA and correlation statistical tests were used to determine the results 
reliability/significance. Uninfected cultures were used as the negative control. No differences 
in cell growth patterns could be determined from comparing the two populations infected with 
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the different oocysts, confirming that the effect on growth rate was independat of extraneous 
factors such as potential protein/supplement from the source material the commercial oocysts 
were initially purified from. 3-65 
Figure 3-11: Lipidomic fingerprinting of the lipid contents of lab produced and commercially 
sourced oocysts. The spectra produced by both the positive (a-b) and negative (c-d) sampling 
sets appeared to be similar. PCA (e and f) analysis revealed that some differences could be 
detected between the Commercial and lab grown populations of oocyst. Y-axis units are 
arbitrary and not useful in direct comparison, instead graphs are compared via relative peak 
heights. However, the analysis was unable to resolve the two sets completely, suggesting that 
whilst differences existed, they were not substantial enough to rule out the use of lab oocysts as 
an alternative to commercially sourced oocyst. 3-66 
Figure 3-12: EM images of a C. parvum infection. the main stages of C. parvum during an infection. 
Starting from top left and going row by row the stages are: Sporozoite (a), trophozoite (b), 
meront, macrogamont (c), microgamont (d), zygote (e), immature oocyst (f) and matured 
oocyst (g and h). During these stages many structures become apparent including the 
mitosome (ms), crystalloid body (cb), micro gametes (mg), the oocyst wall (ow), formation of 
VSRUR]RLWHVVSDVZHOODVKRVWRUJDQHOOHVVXFKDVWKHPLWRFKRQGULRQPW6FDOHEDUVDȝP
b, d-IȝPFȝPKȝP 3-69 
Figure 3-13:  EM images of C. parvum structures of interest. (a) Clearly visible is the feeder 
organelle of an intracellular stage of C. parvum, most likely a meront. An enhanced image of 
the region (ai) reveals interesting topology of the organelle, suggesting that it may derive from 
the host machinery as invagination is clearly shown to occur on the parasite (arrows). (b) A 
merozoite, the same as imaged in Figure 3-12, reveals a number of interesting organelles 
including the nucleus (n), crystalloid body (cb), C. parvum¶VVLQJOHUKRSWU\UDQGWKHDSLFDO
complex (ac). Also visible is the remnant mitochondrion that C. parvum possess, the mitosome 
(bi). The individual layers of the characteristic double membrane are clearly visible in the 
close-up (arrows). 3-70 
Figure 3-14: Atomic force microscopy (AFM) imaging of purified oocysts from COLO-680N 
cultures revealed two distinct populations. Population (a) is believed to be representative of 
the thin walled variant of an oocyst, indicated by its slumped posture and comparatively less 
rigid structure when compared to oocysts from population (b), which are believed to be thick 
walled oocysts. Current understanding of C. parvum life cycle biology places the thick-walled 
oocyst (b) as essential for completing the life cycle and passing from the host into the 
environment whereas thin walled oocysts (a) are believed to be responsible for maintaining C. 
parvum autoinfection in healthy individuals where the asexual life cycle does not continue 
indefinitely (unlike in immunocompromised patients) 3-71 
Figure 3-15: AFM captured images of commercial (a) and COLO-680N produced (b) oocysts. 
Whilst both commercial and COLO-680N produced oocysts displayed similar structures, 
typical of those described in the literature, commercially supplied oocysts showed a greatly 
enhanced likelihood of grouping together. This resulted in all AFM image captures of 
commercial oocysts capturing at least 2 and never a lone oocyst. 3-72 
Figure 3-16: Anti-FASN western blot of various cancer cell lines and their subsequent response to 
C. parvum infection. Each sample was obtained from identically aged, 5 days post-infection, 
2D, 75cm2, 30ml cultures and adjusted via dilution with ddH2O to obtain identical cell 
numbers. DLD-1 displayed the highest natural expression of FASN, whereas only COLO-
680N and HCT-8 levels responded to infection. 3-74 
Figure 4-1: NMR spectra of infected mice intestinal samples. a) Stacked Spectra produced from 
infected mice samples after processing via the Chenomx software package, representing the 
average spectra obtained from each infection condition (from triplicate), including the 
negative control and Weru and Iowa II infections. Amongst other noticeable differences were 
the changes in peak intensities and shapes, displayed overlaid are the peaks for creatine and 
creatine phosphate (b), taurine (c) and Lactate (d). In each case higher peaks can be observed 
7-165 
 
for the Iowa II infections, indicating more abundant amounts of these metabolites were 
present in Iowa II infected cultures. Further experimentation would be required to determine 
definitively if this was a result of over production or under-utilisation. 4-81 
Table 4-1: A heatmap of compounds detected via chenomx. Their relative contributions towards 
the differences observed between the mice experimental groups as calcualted by a Partial 
Least Squares Analysis. Negative values (tending towards red) indicate the samples showed a 
greater degree of variation within sample groups and are therefore indicators of compounds 
that naturally vary in their levels, without external stimuli. Positive values (tending towards 
green) indicate the samples contributred more towards differences between sample groups. 
Compounds that did not show any difference between conditions were excluded 4-83 
Figure 4-2: a) 2D graphical representation of a PLSDA Partial Least Squares Discriminant 
Analysis of the Chenomx data. Successful separation of the three experimental groups can be 
observed by the lack of overlap observed between different experimental groups. The lack of 
overlap between Iowa II (blue) and Weru (purple) groups suggest that the different strains 
assert consistently different effects on the metabolome. b) The loading plot, used in 
formulation of the PLS-DA. Those samples furthest to the extreme edges of the axis represent 
the samples contributing most notably to the differences observed, including Lactate and 
Alanine. 4-84 
Figure 4-3: a) A graph representing the pathways detected by MetaboAnalyst 3.0 from the 
Chenomx data. The x-axis represents the relative completeness of a pathway based on the 
metabolite detected. The y-axis represents the relative size of the entire pathway and the size 
of the points represents the combined significance of both data points. Full maps of the 
pathways were rendered and metabolites present in the data highlighted in red for the 
following: (b) glucoronate interconversions, (c) Valine, leucine and isoleucine biosynthesis and 
(d) Taurine and hypotaurine metabolism. 4-86 
Figure 4-4: Full maps of the pathways were rendered and metabolites present in the data 
highlighted in red for the following: (a) glycine serine and threonine metabolism, (b) Galactose 
metabolism and (c) starch and sucrose metabolism. 4-87 
Table 4-2: KEGG ID key. Extracting the KEGG ID tags from the produced pathway maps gives 
the following compounds, arranged by order of appearance throughout Figure 4-3 and Figure 
4-4. 4-88 
Figure 4-5: NMR spectra of infected cultures. Stacked Spectra produced from infected cell cultures 
after processing via the Chenomx software package, representing the average spectra 
obtained from each infection condition, including the negative control, C. hominis C. parvum 
Weru and Iowa II strain infections. Amongst other noticeable differences were the changes in 
peak intensities and shapes, displayed overlaid are the peaks for creatine and creatine 
phosphate (b), taurine (c) and Lactate (d). 4-91 
 4-92 
Table 4-3: The first half of a heatmap of compounds detected via chenomx. Their relative 
contributions towards the differences observed between the infected cultures samples as 
calcualted by a Partial Least Squares Analysis. Negative values (tending towards red) indicate 
the samples showed a greater degree of variation within sample groups. Positive values 
(tending towards green) indicate the samples contributred more towards differences between 
sample groups. 4-92 
Table 4-4: The second half of the heatmap. 4-93 
 4-93 
Figure 4-6: PLS-DA statistical analysis of the information provided by the Chenomx screening. 
Produced clear groupings, separating the controls (green), C. parvum Iowa infections (blue), 
C. parvum Weru infections (purple) and C. hominis infections (red). As the grouping areas do 
no overlap the separation between the infection conditions again indicates that metabolome 
differences can be at least in part explained by different Cryptosporidium strains/species. b. 
The loading biplot of the PLS-DA analysis shows lactate as a significant contributor to 
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variation, as seen before in figure 2b, in addition to taurine and myo-inositol among others. 4-
94 
Figure 4-7: Metabolic pathways detected from NMR data of infected cells. (a) Data analysed by 
MetaboAnalyst 3.0, utilising all compounds which displayed some degree of change because of 
infection, produced a graph of pathways most heavily impacted (x axis) and pathways 
containing the most amount of the given compounds (pathway impact: y-axis), with statistical 
significance of the predicted pathways increasing as the colour ranges from yellow (low) to red 
(high). Six pathways were chosen to be of interest by their position on the graph, with 
metabolites present in the experimental samples highlighted in red, including: (b) glycine, 
serine and threonine metabolism, (c) taurine and hypotaurine metabolism, (d) Alanine, 
aspartate and glutamate metabolism. The remaining 3 are represented in Figure 4-8. 4-96 
Figure 4-8: The remaining 3 major metabolic trees as derived from the MetaboAnalyst data, 
showing (a) synthesis and degradation of ketones, (b) pantothenate and CoA biosynthesis and 
(c) arginine and proline metabolism. 4-97 
Table 4-5: KEGG ID key. Extracting the KEGG ID tags from the produced pathway maps gives 
the following compounds, arranged by order of appearance throughout Figure 4-7 and Figure 
4-8. 4-98 
Table 4-6: Comparing the data for C. parvum Iowa II infections from 4.2 and 4.3. Eliminating 
metabolites that do not show reliable contribution towards sample differences, results in a 
collection of 18 compounds. Further exploration of the compounds and their related 
biochemical properties revealed a large proportion of the compounds (13 of 18) to be involved 
with mitochondrial activity (red text), such as ATP synthesis or control of Reactive Oxygen 
Species (ROS). 4-102 
Table 4-7: Comparing the data for C. parvum Weru infections from 4.2 and 4.3. Eliminating 
metabolites that do not show reliable contribution towards sample differences, results in a 
collection of 10 compounds. Exploration of the compounds and their related biochemical 
properties revealed a large proportion of the compounds (8 of 10) to be involved with 
mitochondrial activity (red text), such as ATP synthesis or control of Reactive Oxygen Species 
(ROS). 4-104 
Figure 4-9: High resolution confocal scans, utilising the Zeiss Airyscan acquisition method, of 
infected COLO-680N monolayers. Scans revealed numerous examples of heavily infected host 
cells (largest nuclei, DAPI, blue) that displayed substantial mitochondrial networks 
(Mitotracker CMXRos, red) associated with the parasite (SporoGlo, green). A, b and d were 
all visualised through the median portion of the host cell, while c was acquired from the 
surface of the cell, indicated by the lack of a contiguous host nucleus. In each, it can be 
observed that mitochondrial arrangement within the host cell is highly associated with 
parasite presence. It can also be observed that the parasite is exerting a significant amount of 
physical force on the host nuclei, evidenced by the deformed nature of the typically oval 
nucleus. 4-106 
Figure 4-10: A 3D section of the same area as Figure 4-9a. Mitochondria (red) can be seen to 
µFOLPE¶DURXQGWKHSDUDVLWHJUHHQ7KHFORVHDVVRFLDWLRQDQGµQHWWLQJ¶HIIHFWVHHQLQWKHVH
images strongly indicates that the host mitochondria are drawn to the parasite after infection, 
allowing the established parasitophorous vacuole to become surrounded. The impacting effect 
of the parasite on the host nucleus (blue) can also be seen to greater effect. 4-107 
Figure 4-11: a. Infection of a host cell by C. parvum. Mitochondria of the host cell appear to closely 
associate with the parasitophorous vacuole surrounding the parasite, while cytoskeletal 
structures appear to be associated with the organelles. b. Cartoon of image a. demonstrating 
the presence of mitochondria, cytoskeleton, nuclear material and Cryptosporidium. 4-108 
Figure 5-1: Distribution of the Fe/S cluster biosynthetic pathways throughout eukaryotic parasites. 
Whilst most parasitic organisms have maintained the ISC and CIA pathways, E. histolytica 
appears to have replaced the ISC pathway with the more commonly bacterial SUF 
mechanism. P. falciparum (in addition to other apicomplexans) has also acquired the SUF 
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pathway which is found within the apicoplast. However, C. parvum appears to have lost the 
SUF pathway along with its apicoplast. (Adapted from Dellibovi-Ragheb et al., 2013) 5-116 
Figure 5-2 The hypothetical contents of C. parvum¶VPLWRVRPH,WDSSHDUVWREHWKHVDPHDVM. 
mackini, maintaining only the ISC machinery, basic import/export machinery and a cytosolic 
glycolytic pathway. (Adapted from Burki et al., 2013) 5-117 
Figure 5-3: CLUSTALO alignments of S. cerevisiae and putative C. parvum ISC protein sequences. 
a. Nfs1p and IscS, Yfh1p and Frataxin, and finally Isu1p and IscU. Yfh1p and Frataxin 
similarities are more apparent in secondary structures than primary sequences. 5-119 
Table 5-1: Possibility of mitochondrial targeting sequence within the ISC peptides, as determined 
by Mitoprot. 5-120 
Figure 5-4: CLUSTALO alignment, via Seaview, of the putative C. parvum IscS protein and IscS 
proteins from other Apicomplexans, in descending order of similarity. The sequences were 
obtained via a blastx (translated nucleotide to protein) enquiry. 5-121 
Figure 5-5: CLUSTALO alignments, of IscU (a) and Frataxin (b) sequences identified via blastx 
searches, using C. parvum Iowa II sequences as the query. Frataxin is not present in many 
apicomplexans. 5-122 
Figure 5-6: PCR product detection of target recombinant proteins. Black and white images of 
Ethidium bromide agarose gels, exposing DNA fragments via UV exposure. Initial attempts 
were successful in producing IscU and IscS sequences (a) whilst Frataxin proved more 
difficult, succeeding in a subsequent run (b). 5-123 
Figure 5-7: ISC Detection in C. parvum samples by Western Blot. Antibodies raised against the 
recombinant ISC proteins, in rabbits (anti-CpIscS) and rats (anti-CpIscU and anti-
CpFrataxin), were used in a western blot assay of samples from C. parvum oocysts and control 
samples from uninfected COLO-680N cells. Development via Enhanced, luminol-based, 
Chemiluminesce (ECL) produced evidence that the antibodies used were able to detect the 
presence of their intended targets in the C. parvum samples but not in the negative, COLO-
680N controls. 5-125 
Figure 5-8: Determination of Recombinant ISC raised, Antibody Sensitivity to targets via ELISA. 
ELISA kits were prepared by Cambridge Research Biochemicals using protein extracted from 
the same acrylamide slices used to inoculate the animals. The antibodies produced were then 
tested for sensitivity via these ELISAs and the results recorded graphically   a. anti-CpFxn 
from Rat 2 produced a very strong response curve, indicated by the high absorbance present 
across serum dilutions. b. and c. are poor absorbance curves, potentially because of 
acrylamide contamination in the preparation of the ELISA. Subsequent analysis via western 
blot confirmed a strong specific and sensitive response of both CpIscU and CpIscS. 5-126 
Figure 5-9: Confocal images of infected COLO-680N cultures, stained with anti-CpIscS. A variety 
of IscS localisation patterns were observed, although appearing to remain consistent based on 
parasite life cycle stage. C. parvum oocysts (O), determined by the circular Crypt-a-glo 
staining and 3-4 detectable punctate DAPI stains (denoting sporozoite nuclei), routinely 
showed no detectable levels of IscS. However, oocyst like structures, that lacked discernible 
sporozoite nuclei contained detectable levels of expressed IscS, this is most noticeable in panels 
d, where diffuse TRITC signal could be detected. These structures were determined to be 
Zygotes (Z) in various stages of maturity, with the hypothesis that lowered IscS signalling, 
corresponding to more concentrated DAPI stain, indicated the zygote was entering the final 
stage as an immature oocyst (O/Z). Multiple other sites of IscS expression were also detected, 
either as punctate extracellular signal (M) or as diffuse but high levels, lacking Crypt-a-glo 
VWDLQLQJLQW6FDOHEDUVDȝPEȝPFȝPGȝP 5-129 
Figure 5-10: IFA of infected COLO-680N cultures with SporoGlo (green) and anti-CpIscS (red) 
with a DAPI nuclear stain (blue) revealed multiple incidences of co-localisation between 
punctate IscS signal and C. parvum sporozoites/extracellular stages. This agrees with the 
previous findings that the extracellular stages expressed detectable levels of IscS, which 
remained confined to an approximately 500 nm region within the parasite. It was not 
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uncommon for IscS signal to be detected where there was no SporoGlo. Subsequent attempts 
to replicate this in uninfected controls did not produce similar stains, eliminating the 
possibility that this was background/cross-reactivity of the anti-body. Scale bars for a. and b. 
DUHȝP 5-130 
Figure 5-11: IFA of infected COLO-680N cultures, with Crypt-a-glo (green), anti-CpIscU (red) and 
DAPI nuclear stain (blue). Highly stained (by Crypt-a-glo) C. parvum oocysts did not display 
any detectable IscU signal. However, IscU expression could be detected throughout the 
FXOWXUHRIWHQFRUUHODWLQJZLWKUHJLRQVRIKRVWQXFOHLWKDWDSSHDUHGµLQGHQWHG¶ZKLOVWODFking 
corresponding Crypt-a-glo signal. This indicated the presence of C. parvum, expressing IscU, 
that was not detectable by Crypt-a-glo, such as merozoites or gamont stages. Scale bars for a. 
DQGEDUHȝP 5-132 
Figure 5-12: IFA of infected COLO-680N cultures, with SporoGlo (green), anti-CpIscU (red) and 
DAPI nuclear stain (blue). Detectable CpIscU was always detected in tandem with SporoGlo 
labelling and vice versa. Though IscU stain was relatively diffuse in extracellular stages 
compared to IscS, it becomes drastically more so in Intracellular stages, suggesting a lack of 
localisation of CpIscU at the intracellular portions of C. parvum¶VOLIHF\FOH7KLVVXJJHVWVWKDW
IscU is localised, to some degree, in extracellular stages. Though there may be cytosolic 
expression also. Scale bars for a. and b. DUHȝP 5-133 
Figure 5-13: IFA of infected COLO-680N cultures treated with anti-CpFxn (red), Crypt-a-glo 
(green) and DAPI nuclear stain (blue). Whilst some co-localisation of C. parvum oocysts 
stained with Crypt-a-glo can be seen to occur with the CpFxn labelling, no CpFxn signal can 
be detected in circumstances where the Crypt-a-glo is not reacting with immature stages of 
oocyst development. CpFxn signal appears to be relatively diffuse within the parasite. Scale 
bars for a DQGEDUHȝP 5-135 
Figure 5-14: Frataxin detection in C. parvum in culture. a. IFA of an infected COLO-680N culture, 
labelled with anti-CpFxn (red), SporoGlo (green) and a DAPI nuclear stain (blue). CpFxn 
signal co-localises with SporoGlo, demonstrating that putative Frataxin homologue is 
H[SUHVVHGE\WKHSDUDVLWH6FDOHEDUȝPE$'KLJKUHVROXWLRQFRQIRFDOLPDJHRIDC. 
parvum sporozoite in an infected COLO-680N culture. Clear labelling of CpFxn (red) 
highlights an approximately 700 nm wide oval (arrow) at the apical end of the parasite, a red 
outline has been drawn to illustrate the shape of the parasite and to highlight the location of 
the mitosome c. The same image rotated through 90° on the x-axis. Scale bars a-cȝP 5-136 
Figure 5-15: Sporulation of yeast. The sporulation of S. cerevisiae was confirmed by microscopy 
analysis of culture samples. Spores can be identified via distinct triplets or quadruplet 
collections of cells, approximately the same size of a single non-sporolated cell. Each spore 
would be homozygous for all genes and therefore either homozygous knockouts or wild type 
NFS1. 5-138 
Figure 5-16: Colony PCR of colonies formed from sporolated culture. The lower weight bands are 
SULPHUGLPHUVDQGH[SHFWHG7KHKLJKHUEDQGVDSSUR[LPDWHO\ESUHSUHVHQWHLWKHUĮRUD
mating types. The lack of dual banding in these areas (ignoring the primer dimers) indicates 
each colony is homozygous for the mating type and therefore all other chromosomal genes. 
Primer dimers are not present in colonies 20-23 due to space restrictions on the gel. 5-138 
Figure 5-17: A cartoon flow chart of the possible outcomes after sporulation. In the case that 
CpIscS can successfully recover the fatal NFS1 knockout, colonies should be able to grow on 
both plate conditions. Only a successful complementation will produce matching colonies on 
both plates. Colonies that can only grow on leucine deficient plates do not contain the G418 
resistance marker and therefore still maintain a wild-type gene. *Actual transformants would 
distribute copies of the plasmid to all spores, this discrepancy is deliberate and for illustrative 
purposes only. 5-139 
Figure 5-18: pBEVY-L/CpIscS selection plates. pBEVY-L/CpIscS plasmid transformed and 
sporolated S. cerevisiae colonies were grown on a non-selective YPD plate then picked and 
used to seed Leucine deficient minimal media (a) and G418 (b) antibiotic selective YPD plates. 
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19 out of the 23 (82.5%) colonies contained the pBEVY-l/CpIscS construct. Colony formation 
on a. was indicative of a successful transformation, with pBEVY-L conferring survival in the 
absence of environmental Leucine. Survival (48%) on b. was indicative of the G418 resistance 
marker that had replaced yeast NFS1 and therefore a lethal knockout. Therefore, any colony 
that survived plate b and was positive for only a single mating type must be a knockout; else it 
would not contain the resistance marker for G418 in place of NFS1 (IscS). As NFS1 knockouts 
are invariably lethal, the only method by which the colony could survive would be via 
functional complementation, utilising the recombinant CpIscS. 5-140 
Figure 6-1: The proposed contents of the mitosome. The proteins/pathway of interest highlighted 
which have now been proven experimentally to be expressed within C. parvum and localised to 
the mitosome. (adapted from Mogi and Kita, 2010) 6-144 
Figure 6-2: Cartoon of the mitosome of C. parvum.  is purported to contain only 1 complete, active 
pathway: the ISC Fe/S biosynthetic pathway. The key components of this pathway are the 
sulphur donating IscS, the supposed iron storage protein Frataxin and the scaffold protein 
IscU. Once constructed, the Fe/S cluster, potentially still attached to IscU, is exported into the 
cell cytoplasm for use by the CIA pathway and other enzymes. 6-154 
Figure 6-3: A cartoon summarisation of the major accomplishments and findings of this thesis. 
Each arrow has been colour coded corresponding to the relevant chapter: Chapter 3: Green, 
Chapter 4: Blue, Chapter 5: Red. 6-160 
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AA Amino Acid 
ABC ATP-Binding Cassette 
ADP Adenosine Diphosphate 
AFM Atomic Force Microscopy 
AMP Adenosine Monophosphate 
ANOVA Analysis of Variance 
AOX Alternative Oxidase 
ATP Adenosine Triphosphate 
CB Crystalloid Body 
CIA Cytosolic Iron sulphur cluster Assembly (pathway) 
CoA Coenzyme A 
CpClec Cryptosporidium parvum C-type lectin 
CPN60 Chaperonin protein 60 
CpX Protein (X) of Cryptosporidium parvum origin 
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats 
CSL Cryptosporidium Circumsporozoite-Like glycoprotein 
DAPI 4',6-diamidino-2-phenylindole 
DNA Deoxyribonucleic Acid 
DSS 3-(Trimethylsilyl)-1-propanesulfonic acid  
EM Electron Microscopy 
ETC Electron Transport Chain 
EU European Union 




GC-MS Gas Chromatography Mass Spectrometry 
GRI Glycine Reuptake Inhibitor 
HCT-8 Human Colo-Rectal Carcinoma 
HetDip Heterozygous and Diploid 
HIV Human Immunodeficiency Virus 
HSP-70 Heat Shock Protein 70 
IFA Indirect Fluorescent Assay 
ISC Iron Sulphur Cluster (pathway) 
IscS Iron Sulphur Cluster pathway component S 
IscU Iron Sulphur Cluster pathway component U 
KEGG Kyoto Encyclopedia of Genes and Genomes 
LACA Last apicomplexan Common Ancestor 
LB Lysogeny Broth 
LECA Last Eukaryotic Common Ancestor 
LEU Leucine 
MALDI-
ToF Matrix-Assisted Laser Desorption/Ionization Time of Flight 
MDCK Madin Darby Canine Kidney 
MRO Mitochondrial Related Organelle 
MS Mass Spectrometry 
MTP MALDI Target Plate 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
NADP Nicotinamide adenine dinucleotide phosphate 
NCBI National Center for Biotechnology Information 
NFS1 Yeast Cysteine Disulphurase Gene 
Nfs1p Yeast Cysteine Disulphurase Gene product/protein 
NHS National Health Service 
NIF Nitrogen Fixation 
NMR Nuclear Magnetic Resonance 
PBS Phosphate Buffered Saline 
PCA Principal Componenet Analysis 
PCR Polymerase Chain Reaction 
PLS-DA Partial Least Squares Discriminant Analysis 
PNO Pyruvate-NADP+ Oxidoreductase 
PV Parasitophorous Vacuole 
rDNA Ribosomal Deoxynuceleic Acid 
SCID Severe Combined Immunodeficiency 
SDS PAGE Sodium Dodecyl Sulphate Poly-Acrylamide Gel Electrophoresis 
SEM Scanning Electron Microscopy 
SUF Sulphur Formation (pathway) 
TCA Tricarboxylic Acid 
TEM Transmission Electron Microscopy 
UV Ultra Violet 
VVL Vicia Villosa Lectin 
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YFH1 Yeast Frataxin Homologue gene 
Yfh1p Yeast frataxin homologue protein 
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